A Novel Role for NF-κB in Proximal T Cell Signaling by Watson, Crystina Bronk
University of South Florida
Scholar Commons
Graduate Theses and Dissertations Graduate School
11-18-2014
A Novel Role for NF-κB in Proximal T Cell
Signaling
Crystina Bronk Watson
University of South Florida, crystinacb@yahoo.com
Follow this and additional works at: https://scholarcommons.usf.edu/etd
Part of the Biochemistry Commons, and the Immunology and Infectious Disease Commons
This Dissertation is brought to you for free and open access by the Graduate School at Scholar Commons. It has been accepted for inclusion in
Graduate Theses and Dissertations by an authorized administrator of Scholar Commons. For more information, please contact
scholarcommons@usf.edu.
Scholar Commons Citation
Watson, Crystina Bronk, "A Novel Role for NF-κB in Proximal T Cell Signaling" (2014). Graduate Theses and Dissertations.
https://scholarcommons.usf.edu/etd/5619
 
 
 
 
 
A Novel Role for NF-κB in Proximal T Cell Signaling 
 
 
 
by 
 
 
 
Crystina Bronk Watson 
 
 
 
 
A dissertation submitted in partial fulfillment 
of the requirements for the degree of 
Doctor of Philosophy 
Department of Cell Biology, Microbiology, and Molecular Biology 
College of Arts and Sciences 
University of South Florida 
 
 
Major Professor: Amer A. Beg, Ph.D. 
Pearlie K. Epling-Burnette, Pharm.D., Ph.D. 
Javier Pinilla, M.D., Ph.D. 
Shari Pilon-Thomas, Ph.D. 
 
 
Date of Approval: 
November 18, 2014 
 
 
 
Keywords: Zap70, IKKβ, PLCγ, NF-AT, calcium 
 
Copyright © 2014, Crystina Bronk Watson 
 
 
 
 
 
 
 
 
 
 
 
DEDICATION 
This work is dedicated to Douglas Allen Gordon and Ryan Matthew MacCaull; 
two amazing men whose lives were cut short by cancer. 
  
 
 
 
 
 
ACKNOWLEDGMENTS 
 I would first like to thank Dr. Amer Beg for all of his scientific and financial 
support as my PI throughout my dissertation research.  I would also like to thank my 
committee members, past and present: Dr. Xue-Zhong Yu, Dr. Esteban Celis, Dr. 
Pearlie K. Epling-Burnette, Dr. Javier Pinilla, and Dr. Shari Pilon-Thomas.  Their advice, 
inquisition, equipment, and reagents were vital to this research. 
 I would also like to thank Dr. Wasif Khan for the time and effort he put forth in 
serving as my external chair. 
 I also extend my gratitude to the Moffitt Core Facilities.  I chose to do my 
research at Moffitt Cancer Center, because of the phenomenal equipment and 
infrastructure they have in place.  Throughout my tenure I have realized that Moffitt 
would be nothing without the people that provide these services.  Thank you to Holly 
Barber, Sean Yoder, Tanya Mesa, Laura Hall, Jodi Kroeger, Kate Shapland, Joe 
Johnson, Mark Lloyd, Dr. Kenyon Daniel, Kathy Merkler, and Susan Sharpe 
 I would like to extend a huge thank you to Dr. Ken Wright and Cathy Gaffney for 
allowing me into and supporting me through the Cancer Biology Program. 
 I would also like to thank my mentor Brian Springer for his professional guidance.  
I additionally extend my gratitude to Dr. Latanya Scott, Dr. Haskell Adler, and Jarett 
Rieger, J.D. for the opportunity to intern with the Office of Technology Management and 
Commercialization. 
 Finally, I would like to thank my fellow scientists and lab members (past and 
present) that have been an invaluable source of help and comrade.  Dr. Emily Hopewell, 
Aga Kasprzak, Dr. Adam Mailloux, Dr. Valentina Schneeberger, Dr. Kate Bailey,  Dr. 
Kelly Barios, Dr. Kelly Haarburg, Dr. Cristina Iclozan, Dr. Shengyu Yang, Dr. Jianwei 
Sun, Dr. Leah Cook, Dr. Junmei Wang, Dr. Weipeng Zhaou, Jing Zhang,  Michael and 
Christopher Massengill, Tahira Khan, Hiba Gohair, Dr. Hong Zheng, and  Mengyu Xie. 
 
 
 
 
i 
 
 
 
 
 
 
TABLE OF CONTENTS 
 
List of Tables ................................................................................................................... iv 
 
List of Figures .................................................................................................................. v 
 
Abstract .......................................................................................................................... vii 
 
Chapter 1. Literature Review of T Cell Signaling ............................................................. 1 
 1.1. The Immune Synapse ................................................................................... 1 
 1.2. Signal Transduction ....................................................................................... 5 
  1.2.1. The Regulation and Role of Lck ....................................................... 6 
  1.2.2. The Regulation and Role of Zap70 .................................................. 8 
  1.2.3. The Regulation and Role of LAT and Slp76 ................................... 12 
  1.2.4. The Regulation and Role of PLCγ1 ................................................ 14 
 1.3. CD28 Signaling in T Cell Activation ............................................................. 19 
 1.4. Activation of AP-1 NF-κB and NF-AT .......................................................... 24 
  1.4.1. Activation of AP-1 .......................................................................... 24 
  1.4.2. NF-κB  ........................................................................................... 28 
   1.4.2.1 The NF-κB Family of Proteins ........................................... 28 
   1.4.2.2 The Role of NF-κB in T Cells ............................................. 30 
1.4.2.3 Using p50-/-cRel-/- Mice to Explore the Role of  
 Canonical NF-κB in T Cells ...................................................... 33 
  1.4.3. Activation of NF-κB ........................................................................ 34 
   1.4.3.1. The Regulation and Role of  
Protein Kinase C (PKC) θ ....................................................... 34 
    1.4.3.1.1. PKCθ in the Immune Synapse............................ 35 
    1.4.3.1.2. PKCθ in Signal Transduction .............................. 36 
1.4.3.2. The Regulation and Role of the  
CARMA1/Bcl-10/MALT1 (CBM) Complex .............................. 39 
1.4.3.3. The Regulation and Role of the IKK Complex .................. 46 
    1.4.3.3.1. The Role of IKKγ in T Cell Activation .................. 46 
    1.4.3.3.2. The Role of IKKα in T Cell Activation ................. 46 
    1.4.3.3.3. The Role of IKKβ in T Cell Activation.................. 47 
  1.4.4. Activation of NF-AT ........................................................................ 53 
   1.4.4.1. Calcium-Dependent NF-AT Activation ............................. 53 
   1.4.4.2. Calcium Independent NF-AT Activation ........................... 57 
  1.4.5. Pathway Interplay .......................................................................... 59 
   1.4.5.1. Dimers of AP-1 and NF-AT .............................................. 59 
   1.4.5.2. Calcium Impacts NF-κB Signaling .................................... 59 
 1.5. Summary of T Cell Activation ...................................................................... 62 
ii 
 
 1.6. Goal of Dissertational Research .................................................................. 66 
 1.7 Objectives ..................................................................................................... 68 
 
Chapter 2. A Novel Role for NF-κB in Proximal T Cell Signaling, Regulating  
Calcium Influx and Activation of NF-AT ................................................................... 70 
  2.1. Abstract ....................................................................................................... 70 
  2.2. Introduction .................................................................................................. 71 
  2.3. Methods and Materials ................................................................................ 73 
   2.3.1. Mice and Primary T Cells ............................................................... 73 
   2.3.2. T Cell Proliferation Assay ............................................................... 74 
   2.3.3. In Vivo T Cell Expansion and FACS Analysis ................................ 74 
   2.3.4. Microarray Studies ......................................................................... 75 
    2.3.4.1. Sample Processing for Microarray Analysis ..................... 75 
    2.3.4.2. Probe Arrays .................................................................... 75 
    2.3.4.3. Data Analysis ................................................................... 76 
   2.3.5. Calcium Assay ............................................................................... 77 
   2.3.6. Electrophoretic Mobility Shift Assay (EMSA) ................................. 77 
   2.3.7. Relative Quantitative RT-PCR (RT-qPCR) .................................... 78 
   2.3.8. Western Blotting............................................................................. 79 
   2.3.9. Statistical Analysis ......................................................................... 80 
  2.4. Results......................................................................................................... 80 
 2.4.1. p50-/-cRel-/- CD8 T Cells Exhibit Pronounced Clonal  
Expansion Defects In Vitro and In Vivo .............................................. 80 
 2.4.2. Differential Impact of p50+cRel versus PKCθ Absence on 
Activation-Induced Gene Expression in T Cells .................................. 83 
 2.4.3. p50-/-cRel-/- T Cells Have Defects in NF-AT and AP-1  
Activation and Calcium Influx ............................................................. 86 
 2.4.4. Defects in Calcium Influx Are Due to Impaired PLCγ1  
Activation, Not Reduction in Calcium Channel Proteins in  
p50-/-cRel-/- T Cells ........................................................................... 89 
 2.5. Discussion ................................................................................................... 92 
 
Chapter 3. Loss of p50 and cRel Lead to a Reduction of IKKβ and Deficient    
Phosphorylation of Proximal TCR Signaling Proteins .............................................. 95 
  3.1. Abstract ....................................................................................................... 95 
  3.2. Introduction .................................................................................................. 96 
  3.3. Methods and Materials ................................................................................ 98 
   3.3.1. Mice and Primary T Cells ............................................................... 98 
   3.3.2. Cultured Cells, Transfections, and Infections ................................. 98 
   3.3.3. Electrophoretic Mobility Shift Assay (EMSA) ................................. 99 
   3.3.4. Relative Quantitative RT-PCR (RT-qPCR) .................................. 100 
   3.3.5. Flow Cytometry ............................................................................ 101 
   3.3.6. Western Blotting........................................................................... 101 
   3.3.7. Spectraphotometer Based Calcium Assay ................................... 102 
   3.3.8. Confocal Microscopy .................................................................... 103 
   3.3.9. Statistical Analysis ....................................................................... 103 
iii 
 
   
3.4. Results....................................................................................................... 104 
  3.4.1. Proximal T Cell Signaling is Impaired in the Absence of  
p50 and   cRel .................................................................................. 104    1 
  3.4.2. IKKβ/γ Protein levels are Reduced in the Absence of  
   p50 and cRel .................................................................................... 106    
  3.4.3. Using Jurkat T Cells to Explore Molecular Mechanisms  
and the Role of IKKβ/γ ..................................................................... 108 
  3.4.4. Using Hek293 Cells to Explore the Relationship Between 
IKKβ and Zap70 ............................................................................... 112 
 3.5. Discussion ................................................................................................. 114     
 
Chapter 4. Constitutively Active IKKβ Does Not Increase Expression of CRAC  
or Purinergic Calcium Channel Proteins ................................................................ 119 
 4.1. Abstract ..................................................................................................... 119 
 4.2. Introduction ................................................................................................ 120 
 4.3. Methods and Materials .............................................................................. 123 
  4.3.1. Cultured Cells, Transfections, and Infections ............................... 123 
  4.3.2. Relative Quantitative RT-PCR (RT-qPCR) .................................. 124 
  4.3.3. Western Blotting........................................................................... 125 
  4.3.4. Spectraphotometer Based Calcium Assay ................................... 125 
  4.3.5. Statistical Analysis ....................................................................... 126 
 4.4. Results....................................................................................................... 126 
  4.4.1. The Effect of Enhanced and repressed NF-κB on Calcium 
Release and Activation Channel (CRAC) Proteins ........................... 126 
  4.4.2. The Effect of Enhanced and repressed NF-κB on Store  
Purinergic Calcium Receptors .......................................................... 129 
 4.5. Discussion ................................................................................................. 132 
   
Chapter 5. Concluding Remarks and Attributions of NF-κB in T Cell Signaling ........... 135 
 5.1. A Novel Role for NF-κB in Proximal T Cell Signaling, Regulating  
Calcium Influx and Activation of NF-AT ....................................................... 136 
 5.2. Loss of p50 and cRel Lead to a Reduction of IKKβ and Deficient    
Phosphorylation of Proximal TCR Proteins ................................................. 139 
 5.3. Constitutively Active IKKβ Does Not Increase Expression of CRAC  
or Purinergic Calcium Channel Proteins ..................................................... 141 
 5.4. Concluding Remarks ................................................................................. 142 
    
Chapter 6. Citations  .................................................................................................... 144 
 
Chapter 7. Appendices ................................................................................................ 158 
 Appendix A. Institutional Animal Care and Use Committee Approval ............... 159 
 Appendix B. Wiley-VCH Permission to Reprint................................................. 161 
 
    
iv 
 
 
 
 
 
 
LIST OF TABLES 
 
Table 2.1. Chapter 2 Primer Sequences ........................................................................ 78 
 
Table 2.2. Differential Gene Regulation by PKCθ and p50/cRel .................................... 84 
 
Table 3.1. Chapter 3 Primer Sequences ...................................................................... 100 
 
Table 4.1 Chapter 4 Primer Sequences ...................................................................... 124 
 
  
 
 
v 
 
 
 
 
 
 
LIST OF FIGURES 
Figure 1.1.    The Regulation and Role of Lck in T Cell Signaling ................................... 7 
Figure 1.2.   The Regulation and Role of Zap70 in T Cell Signaling .............................. 10 
Figure 1.3.   The Regulation and Role of LAT and Slp76 in T Cell Signaling ................ 13   
Figure 1.4.   The Regulation and Role of PLCγ in T Cell Signaling ............................... 18 
Figure 1.5.   The Regulation and Role of CD28 in T Cell Signaling ............................... 22 
Figure 1.6.   Activation of AP-1, NF-AT, and NF-κB ...................................................... 24 
Figure 1.7    The Regulation and Role of AP-1 in T Cell Signaling ................................ 25 
Figure 1.8.   The Role of NF-κB in Naïve and Memory T Cells ..................................... 32 
Figure 1.9.   The Regulation and Role of PKCθ in T Cell Signaling .............................. 38 
Figure 1.10. The Regulation and Role of the CBM Complex in T Cell Signaling ........... 41 
Figure 1.11. The Regulation and Role of IKKβ in T Cell Signaling ................................ 52 
Figure 1.12. The Regulation and Role of NF-AT in T Cell Signaling ............................. 56 
Figure 1.13. The Role of Calcium in NF-κB Signaling ................................................... 61 
Figure 1.14. T Cell signaling in the Absence of p50/cRel .............................................. 67 
Figure 2.1.   Activation and Proliferation are Defective in the  
 p50-/-cRel-/- T Cells .......................................................................... 82 
 
Figure 2.2.   Confirmation of Microarray Reported Deregulated Genes ........................ 85 
 
Figure 2.3.   Activation of NF-AT and Calcium Influx are Reduced in the  
 p50-/-cRel-/- T Cells .......................................................................... 87 
 
Figure 2.4.   Defects in Calcium Influx is Persist Despite Route of Stimulation or 
Duration, but Require Absence of p50+cRel ..................................... 89 
 
Figure 2.5.   The Role of Calcium Channel proteins and PLCγ in Mediating  
Defects in p50-/-cRel-/- T Cells ......................................................... 91 
 
 
vi 
 
Figure 3.1.    Phosphorylation of Proximal Signaling Proteins is Impaired in the 
            p50-/-cRel-/- T Cells ...................................................................... 105 
Figure 3.2. Expression of IKKβ & IKKγ are Reduced in the  
p50-/-cRel-/- T Cells ....................................................................... 107 
 
Figure 3.3. Using Jurkat T Cells to Explore Molecular Mechanisms and the 
Role of IKKβ & IKKγ in T Cell Signaling ......................................... 110 
 
Figure 3.4. Evaluation of IκBα Transduced Jurkat T Cells ....................................... 112 
 
Figure 3.5 IKKβ Phosphorylates Zap70 In Vitro ...................................................... 113 
 
Figure 3.6 IKKβ Enhances Phosphorylation of Proximal TCR Signaling 
Proteins ............................................................................................ 115 
 
Figure 4.1. The Effect of Enhanced and repressed NF-κB on Store Operated       
Calcium Entry (SOCE) Receptors .................................................... 127 
 
Figure 4.2. The Effect of SOCE Inhibitors on NF-κB Transduced Jurkat T Cells ..... 128 
 
Figure 4.3. The Effect of Enhanced and repressed NF-κB on Purinergic 
Calcium Receptors ........................................................................... 130 
 
Figure 4.4 The Effect of Purinergic Inhibitors on NF-κB Transduced Jurkat T 
Cells ................................................................................................. 131 
vii 
 
 
 
 
 
 
ABSTRACT 
The interrogation of T cell signaling over the past fifty years has led to the 
discovery of amazingly intricate cascade networks and elaborate descriptions of 
individual proteins’ domains and functions.  A complex landscape has been rendered in 
which proteins relay messages from the extracellular ligation of the TCR by a cognate 
peptide loaded MHC via changes in sub-cellular location, phosphorylation, and binding 
affinities and partners to enact nuclear localization of three key transcription factors 
required for cellular effector function and proliferation: AP-1, NF-AT, and NF-κB.  
Dogma has favored activation of each of these transcription regulating elements to be a 
linear and parallel activity, thus very little interaction between pathways has been 
highlighted by previous findings in the molecular immunology community.  The focus of 
this dissertation explores the role of NF-κB in T cell signaling with emphasis on subunits 
p50, cRel, IκBα, and IKKβ, and with respect to NF-κB’s ability to modulate calcium and 
NF-AT signaling, proximal TCR phosphorylation, and CRAC and purinergic calcium 
channel proteins. 
The role of NF-κB in T cells can be a difficult thing to establish, as this thirteen 
member family innervates almost every cellular process from homeostasis to activation, 
and even functions in the opposing processes of survival and apoptosis.  To convolute 
the investigation further, many family members also fulfill redundant tasks, as a result of 
their high evolutionarily conserved sequence homology.  To this end, we discovered the 
viii 
 
best way to evaluate the function of NF-κB in the activation of T cells was to knockdown 
two family members: p50 and cRel.  In doing this, we rendered mice that were viable 
(unlike knockdown of RelA) and fertile, but possessed T cells that were highly 
unresponsive to strong stimulation (anti CD3/CD28) or foreign antigen (OVA) presented 
to mice bearing the correct transgenic TCRs (OT-1) by professional antigen presenting 
cells (APC).    
Through in vitro assays, we discovered that in addition to the specific defects in 
NF-κB activation, NF-AT signaling was also greatly disrupted in these cells, sequela to 
retarded calcium influx and signaling.  This was of great interest, as while several 
studies have shown that calcium signaling has the ability to amplify and fine tune NF-κB 
activation, there is a dearth of studies and publications highlighting the effect of an 
activated NF-κB pathway on calcium influx and signaling leading to the activation of NF-
AT.  Another fascinating discovery, that explicated the calcium reduction and NF-AT 
inhibition, was that ablation of p50 and cRel led to decreases in mRNA and protein 
levels of two additional NF-κB family members: IKKβ and IKKγ.  The results presented 
here suggest that it is the reduction in IKKβ and IKKγ that leads to impaired 
phosphorylation of the key TCR proximal proteins: Zap70 and PLCγ1, and it is the 
decrease in activated PLCγ1 that renders less IP3, and ultimately abrogates calcium 
signaling.  
Overall, this thesis highlights the ability of IKKβ to enhance general proximal TCR 
protein phosphorylation (and specifically Zap70) leading to a greater influx of calcium 
(perhaps aided by IKKβ also augmenting the function of the CRAC protein, STIM1) 
ix 
 
which leads to superior activation of NF-AT, and amplifies downstream cellular effector 
functions such as IL-2 production and proliferation.   Moreover, this work demonstrates 
that NF-κB subunits likely form supermolecular clusters, and ablation of certain subunits 
(i.e. p50 and cRel) can lead to instability and decreased levels of other family members 
(i.e. IKKβ and IKKγ.) 
 
.     
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CHAPTER 1 
 
LITERATURE REVIEW OF T CELL SIGNALING 
Signaling through the T Cell Receptor (TCR) to enact activation of a T cell is one 
of the most eloquent and precise biological mechanisms as yet discovered.  The way 
each protein interacts with others in a tightly temporal and spatially relevant manner is 
more beautiful and strategically choreographed than any Capoeira [1].  All transduction 
begins with the ligation of a cell surface receptor, and in the case of CD8 T cells, this 
would be the “lock and key” effect of perfectly aligning the TCR with a Major 
Histocompatability Complex (MHC) molecule loaded with a linear cognate peptide.  If 
the binding affinity is high, this is all that is required to completely alter the landscape of 
the T cell, and to enact thousands of biochemical processes culminating in specific 
gene transcription, cellular proliferation, and asymmetrical cellular division [2].   
 
1.1. Immune Synapse 
The landscape change is due to the formation of an Immune Synapse (IS).  The 
IS can be broken down into three regions: the central Super Molecular Activating 
Complex (c-SMAC), the peripheral SMAC (p-SMAC) and the distal SMAC (d-SMAC). 
TCR recognition of its cognate peptide on a MHC molecule, presented by a dendritic 
cell (DC), causes microclusters of signaling components to form in the p and d-SMAC 
[3]. Much work has been done by the Shaw lab to illustrate the importance and antigen 
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requirements of signaling and receptor down regulation / destruction in the c-SMAC.  
They were able to conclusively demonstrate that the c-SMAC is, in fact, an area of 
enhanced signaling by measuring the amount of sites phosphorylated on the TCRζ 
chain.  In the p-SMAC, where the microclusters nucleated, an average of four sites were 
phosphorylated, by the time the cluster had migrated to the c-SMAC, all six sites were 
tagged with the addition of phosphate groups. Moreover, there is an accumulation of 
Phosphatidylinositol 4,5-bisphosphate (PIP2) (the precursor of downstream effectors 
diacyglycerol (DAG) and inositol triphosphate (IP3), whose roles in signal transduction 
will be elucidated further in proceeding sections) only in the c-SMAC.  Additionally, they 
were able to show that this enhancement of signaling, due to clustering of receptors, 
was necessary to elicit T cell activation from weak agonistic peptides;   weak agonists 
need the c-SMAC for concentrated signaling; strong agonists do not [4]. This leads to a 
situation where the c-SMAC can be either activating or degrading based upon the 
TCR’s affinity for the peptide presented in the MHC cleft.    The Shaw lab also nicely fit 
the opposing models of the c-SMAC being a site of enhanced signaling while also being 
the site of enhanced receptor degradation, as one begets the other.  Clustered signaling 
brings in more proteins whose natural downstream targets will eventually draw in 
ubiquitinases and additional negative signaling components, thus terminating the signal 
post effective propagation.  
Arguably, the single most important factor in the IS is the actin cytoskeleton 
which begins shuttling these microclusters into the center, and it is through size 
exclusion that different molecules collect in distinctive areas of the IS.  Larger 
molecules, such as CD45 and CD43, remain in the d-SMAC, LFA and Talin are the 
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main components of the p-SMAC, and in a robust IS, TCR – MHC, CD28, Linker of 
Activated T cells (LAT), and  Protein Kinase C θ (PKCθ) will cluster in the c-SMAC [4].  
Michael Dustin’s lab further showed that CD28-CD80 clusters were responsible for 
bringing PKCθ to the IS, and that would explain their co-segregation in the c-SMAC [3].  
Chemokine receptors (CCR5 and CXCR4) are also brought into the IS; it is believed 
that this switches the receptors from Gi to Gq, and thus they lose their ability to signal 
for chemotaxis, thus contributing to the more stable interaction between the T-cell and 
APC [5]. 
Another function of actin reorganization during the formation of the IS, as shown 
by the Hoth lab, is to reposition mitochondria at the border of the c and p-SMAC [6]. 
This allows the mitochondria to act as calcium sinks, maintaining a low level of 
cytoplasmic calcium, and allowing the cell to maintain a favorable ionic polarity; thus 
promoting the constant influx of calcium across the cytoplasmic membrane.  This flow is 
required for calcium to act as an operational second messenger, another topic that will 
be explored in further sections. 
It was another major contribution by the Dustin lab that exposed the role of 
ubiquitin and TSG101 (a critical component of the ubiquitin recognizing, ERCRT-1 
family) in the formation of the c-SMAC.  They were able to show that in the presence of 
MG132 (a proteosome inhibitor – that ultimately leads to a severe increase in poly-
ubiquitinated proteins and a corresponding decrease in the free ubiquitin pool) TCR-
MHC microclusters, although fully phosphorylated and active, could not translocate to 
the c-SMAC.  Once ubiquitin was proven necessary for c-SMAC formation, they 
extended their inquiry to TSG101 [7], and found that this protein was also essential for 
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homing TCR-MHC microclusters to the c-SMAC, and ultimately for TCR down 
regulation.  Moreover, they implicate TSG101 as the sorting complex that causes the 
segregation of PKC-CD28 containing microclusters from MHC-TCR microclusters once 
they have arrived in the c-SMAC, bundled from the p-SMAC [8]. 
Finally, the Swat lab was able to show a role for Vav (a Ras–Guanine Nucleotide 
Exchange Factor (GEF)) in the homing of TCR-MHC microclusters towards the c-SMAC 
that was independent of its catalytic activity.  They elegantly demonstrated that 
VavNULL (missing all three isoforms) T cells could not relocate, fully phosphorylate, and 
activate TCR clusters from the periphery to the c-SMAC, and they were able to attribute 
this to Vav as an adaptor protein tethering TCR to F-actin [9].  Dubiously, this effect was 
rescued by using a GEF-inactive mutant of Vav, demonstrating a role for Vav1 as an 
adaptor protein promoting the formation of an efficient IS, not just a Guanine Nucleotide 
Exchange Factor protein that will ultimately lead to the activation of Ras.  However, this 
was actually an additional layer of cytoskeletal reorganization orchestration by Vav, as 
the Takesono lab had already shown that Vav was responsible for creating active 
Cdc42 and Rac1 (through the catalytic activity of Vav’s GEF domain).  Cdc42 and Rac1 
then activate WASp and WAVE2, respectively; the activation of these two proteins is 
essential for actin polymerization leading to cytoskeletal reorganization [10], thus 
allowing the formation of a proper IS that will link the T cell and APC for the duration of 
stimulation. 
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1.2. Signal Transduction 
The proteins, and motifs contained within them, used to transduce the signals 
from the TCR, are relatively simplistic, few, and conserved across a multitude of 
eukaryotic biological processes.  The proteins include protein kinases, protein 
phosphatases, ubiquitin ligases, and protein adaptors (while proteases play necessary 
roles, they are not characterized as signal transducers [11]).  The motifs of signal 
transduction break down into four categories that mirror the protein classes: 
phosphorylation, dephosphorylation, ubiquitylation, and protein-protein interactions (with 
the fourth motif usually requiring modifications of one or all interacting proteins, by one 
of the other 3 motifs to create a conformation change or docking site.)   
Undoubtedly, the most important motif for cellular transduction appears to be 
phosphorylation, as 90% of signal transduction is modulated by the addition of a 
phosphate group to an acceptor amino acid [12].  Phosphorylating a protein by either a 
Serine/Threonine or a Tyrosine Kinase, can lead to: 1.) a conformation change of the 
protein, perchance unveiling its catalytic domain 2.) creation of specific docking sites for 
other proteins, especially those containing SH2 domains [13] 3.) a change in binding 
affinities of peptides 4.) restriction of protein movement or aid in protein localization to 
other compartments 5.) activation of enzymes 6.) deactivation of enzymes. Ironically, 
while Tyrosine phosphorylation only comprises 4% of global, cellular phosphorylation 
[14], it is unquestionably the most abundant and necessary for T cell activation [15].  In 
fact, elegant biochemical assays have revealed that the TCR (which lacks a cytoplasmic 
signaling domain, but is non-covalently attached to six CD3 chains (3 distinct dimers of 
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CD3δε, CD3γε, and CD3ζζ)) is activated through tyrosine phosphorylation of these 
ITAMs, thus beginning T cell signaling [16]. 
 
1.2.1. The Regulation and Role of Lck  
There are two main tyrosine kinases  that are involved in the initiation of signal 
transduction from successful binding of a peptide loaded MHC – TCR: Lck, a Src family 
member, and Zap70, a Syk family member [17].  Lck is a membrane bound protein 
containing both myristolated and palmitylated sites, that is non-covalently linked to CD4 
or CD8 (as shown in Figure 1.1) depending on lymphocyte subset [18].  Lck is regulated 
by two main proteins: C-terminal Src kinase (Csk) (a tyrosine kinase that 
phosphorylates Lck at a Tyr 505, rendering it inactive) and CD45 (a phosphatase that 
strips the phosphate from Tyr 505 allowing for conversion of Lck into its catalytically 
active form.)   The Weiss lab has contributed much of the known body of work on the 
interaction between these three molecules, and ruled that there is dynamic interplay (a 
constant phosphorylation/dephosphorylation of Tyr505) in resting T cells.  As shown in 
Figure 1.1 (far left side), this balance only needs to be slightly perturbed during the first 
moments of TCR-pMHC interaction, to favor sequestration of Csk, and activation of Lck 
[19].  Notably, the Winkler lab showed a role for serine phosphorylation as an additional 
negative regulator of Lck activity.  Moreover, this phosphorylation event is most likely 
committed by PKCθ, a serine/threonine protein kinase which is activated several 
interactions downstream of activated Lck, making this part of an activation induced  
negative feedback loop, not a method of blocking signal initiation [20] (Figure 1.1 – right 
side.) 
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phosphorylate, change conformation, and phosphorylate the protein adaptor LAT and 
the protein adaptor, and fellow kinase and Syk family member, SLP-76 [22].  
 
1.2.2. The Regulation and Role of Zap70 
The Griffith lab has done extensive studies on the function of Zap70 during T cell 
activation, and one of their first findings was that formation of the Immunological 
Synapse is impaired, both structurally and constituently in the absence of a catalytically 
active Zap70 [23].  Additional work by the Huttenlocher lab helped  to map the defect in 
structure to the mis-localization of Talin, which is required to bring F-actin into the 
synapse [24], as shown in Figure 1.2.  Unsurprisingly, defects in ERK, LAT and 
PLCγ1phosphorylation / activation were also noted in the Zap70 deficient Jurkat cells 
created by the Griffith lab.  Thus showing a role for Zap70 in the regulation of the IS, 
however, it still best known for its role in TCR signal propagation. 
Most of the protein tyrosine kinases in mammalian cells require that a tyrosine 
site, within their activation loop, be phosphorylated in order to ascertain a catalytic 
phenotype.   Zap70 is not an exception to this rule, as there are multiple tyrosine and 
serine residues phosphorylated on activated Zap70.  However, in the case of Zap70, it 
is an auto-phosphorylation in the activation loop.  While phosphorylation of Y493 is 
necessary and sufficient to enact activation of Zap70, many events are precursor to this 
occurrence, as shown in Figure 1.2.  One such event is phosphorylation at serine 520, 
which was discovered through the use of S to A mutant generation by the Couture lab 
[25].  The 520 region was chosen as it begins a well conserved motif, S520DVWS524, 
shared by many other protein serine/threonine kinases.  The S520A mutant led to an 
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almost complete lack of signaling from the TCR receptor.   Interestingly, the mutation 
did not block the binding of Zap70 to the TCRζ chain (as was previously thought to be 
imperative for Zap70 activation); it actually stopped Zap70 from migrating to the plasma 
membrane.  Elegant experiments involving addition of a myristolation site to the mutant, 
fully recovered activation of Zap70 and TCR signaling, as measured by robust 
transcription of IL-2, showing that phosphorylation of S520, and the resulting localization 
to the plasma membrane are required for Zap70 activation. 
Because T cell activation must be a tightly controlled process, protein regulation 
falls into many classes, from localization, to activation, to inactivation, and finally 
degradation.  Additionally, other proteins, such as the TCRζ chain, are actually recycled 
to propagate the signal of activation, especially in models of low antigen quantity, where 
the recycling is based upon serine phosphorylation of TCRζ by PKCθ [24]. During 
periods of high antigen quantity, by tyrosine phosphorylation enacted through Lck and 
Fyn, the TCRζ chain is internalized and degraded, and the Valitutti lab has 
demonstrated that other proteins associated with the TCRζ chain, notably Zap70, suffer 
a similar fate [26].  Through multiple methods, they were able to demonstrate that 
degradation of Zap70 and TCRζ have identical kinetics; although the timing is 
synchronized for degradation of these linked proteins, the mechanism of destruction 
appears to differ greatly.  The first piece of evidence to support this theory is that use of 
bafilomycin A1 (known to block lysosome based degradation of TCRζ [27]) did not 
rescue Zap70 from demise.  However, when calpeptin (a specific inhibitor of the 
calcium-dependent neutral protease calpain) was used, Zap70 degradation was 
ablated.  Interestingly, this also blocked degradation of the TCRζ chain, evincing a role 
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As Zap70 affects and amplifies the signaling to several downstream targets, it is 
of little surprise that it is tightly regulated at multiple levels.  One unlikely candidate, 
LAT, believed by most in the field to be a positive regulator (or at worst a benign 
cornerstone) was shown to contribute to the dephosphorylation, and thus reduction of 
activation, by the Acuto lab.  They found that in the absence of LAT, both Zap70 and 
CD3ζ showed an increase in phosphorylation, meanwhile, their downstream direct and 
indirect targets (PLCγ1and Erk) actually showed decreased phosphorylation and 
activation [14]. This points to the LAT signalisome as a strict regulator of TCR signaling, 
in which it allows CD3ζ and Zap70 to stay phosphorylated and active, only as long as 
required for the signal to be passed on to the next set of effector proteins.  Then, 
presumably, HPK1, a negative regulator of TCR signaling, and phosphatase associated 
with the LAT signalisome, dephosphorylates both Zap70 and CD3ζ [12].  This would 
effectively clamp TCR signaling and tightly regulate the LAT signalisome without the 
need for complex disintegration or protein degradation. 
A final way Zap70 positively perpetuates TCR signaling is through inhibition of 
negative regulators.  The Bierer lab was able to show that active Zap70 has the ability 
to inhibit  CD2-dependent formation of the Dok1-Crk-L complex [29].  As this complex is 
known to down regulate kinase activity in the cell [30], blocking its formation allows 
signaling to propagate at the correct strength.  However, it was revealed in 2007, that 
there is quite a bit of pushback from both Dok1 and Dok2 towards inhibiting TCR 
signaling at the level of Zap70 activation, as shown in Figure 1.2.  The Yamanashi lab 
showed that knockdown of both Dok1 and 2 led to enhanced phosphorylation of Zap70, 
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LAT, and Erk upon CD3 stimulation. Meanwhile, the reciprocal was also true: over 
expression of Dok1 and 2 led to inhibition of Zap70 through competitive binding of the 
phosphorylated ITAMs on the CD3ζ chain; thus Zap70 could not bind to the TCR and 
remained inactivated [31]. 
 
1.2.3. The Regulation and Role of LAT and Slp-76 
All further signal transduction (albeit amplified by CD28 help) is mediated by the 
formation of the LAT signalisome.  Under normal signaling conditions, Zap70 will bind 
the phosphorylated TCRζ chain and phosphorylate LAT (as shown in Figure 1.3); the 
seeding of this relatively small protein with nine phosphorylated residues allows the 
binding of many additional proteins that themselves nucleate even larger multi-protein 
complexes which ultimately leads to the activation of second messengers including 
calcium and Ras.  LAT forms the backbone for the appropriately named LAT 
signalisome (docking such SH2 motif containing proteins as Grb2, PI3K, PLCγ1, and 
Itk) [32] and phosphorylated SLP-76 (which is bound to LAT via Grb2) becomes the 
docking site for Vav1 and Itk.  This dual docking of Itk is necessary to lock it in the 
signalisome and bring PLCγ1 into direct contact with Itk for phosphorylation [33], and is 
shown in Figure 1.3.  
  Another well characterized function of Slp-76 is its ability to enact LFA-1 and 
integrin signaling through its association with ADAP, demonstrated on the right side of 
Figure 1.3.  In studies using Slp-76 deficient T cells, the cells lacked the ability to 
become motile, and showed severe inhibition of IL-2 production, as demonstrated by 
the Rudd lab [34].  The LAT signalisome, although crucial for bringing kinases into 
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inhibitory proteins are shown in the LAT signalisome in Figure 1.3) and Dok2.  They first 
demonstrated that Dok1 and Dok2 were phosphorylated immediately following TCR 
binding to MHC.  Interestingly, they found the inhibitors SHIP1 and Dok2 to be weakly 
associated in unstimulated T cells, however, with the administration of CD3, this 
association increased, and also led to the binding of SHIP1 to Dok1, as well. They next 
showed this association to be imperative for their recruitment into the LAT signalisome, 
and the inhibitory complex is recruited through SHIP1 binding to Grb2 [35]. Although the 
LAT signalisome will eventually become heavily laden with negative regulators, and the 
complex will disintegrate, this is long after the signal has disseminated to the next level: 
activation of PLCγ1. 
 
1.2.4. The Regulation and Role of PLCγ1 
PLCγ1 is one of the most important and pivotal molecules in the signaling 
cascade leading to T cell activation.   It is known to be regulated at the gene expression 
level by the transcription factor Bcl11b/Ctip2, which also regulates expression of CD8 
[36].  With respect to activation of PLCγ1, the Berg lab was one of the first labs to link 
Itk function to activation of PLCγ1 in 1998 [37].  While other labs had documented the 
decrease in calcium signaling associated with loss or down regulation of Itk, the Berg 
lab elucidated the mechanism.  By showing that phosphorylation of PLCγ1 (and the 
subsequent cleavage of phosphatidylinositol 4,5-bisphosphate (PIP2) into DAG and IP3) 
was greatly reduced post TCR stimulation in Itk deficient T cells.  Furthermore, they 
were able to show that this was a direct effect on PLCγ1, as neither the TCRζ chain nor 
Zap70 showed a reduction in tyrosine phosphorylation/activation in the absence of Itk. 
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The Yablonski lab took it a step further in 2007, when they showed that Slp76 
was the main inducer and maintainer of Itk activity [38].  This lab delineated the 
mechanism by which a small pool of Itk was constitutively associated with Slp76, and 
that this fraction was responsible for 90% of the catalytic activity of Itk.  They went on to 
demonstrate that separating the two proteins, even post activation of Itk, rendered Itk 
catalytically non functional; thus indicating that Slp76 not only played a role in the 
activation of Itk, but that it’s constant association was required to maintain that 
activation.  Finally, they were able to show that Itk directly phosphorylated PLCγ1 at 
tyrosine residues 775 and 783, two sites critical for the activation of PLCγ1.  
Stabilization of Itk by Slp76 and phosphorylation of PLCγ1, by Itk, is shown in Figure 
1.4A. 
In 2006, the Samelson lab took a biochemical approach and completely mapped 
and assigned functional importance to each of the domains of PLCγ1 [33].  They were 
able to show that the SH2 domain at the N-terminal region of PLCγ1 was necessary, but 
not sufficient for recruitment of PLCγ1 to the LAT signalisome.  They further evinced 
that the C-terminal SH2 and SH3 domains were required to maintain stability of the 
complex, and that all three SH domains were vital for the phosphorylation of tyrosine 
residue 783. 
While dogma dictates that several proteins in the TCR signaling cascade 
(predominately LCK, Zap70, and Itk) are ultimately important for activation of PLCγ1, it 
was the Burkhardt lab in 2012 [39] that reinforced the importance of microcluster and IS 
formation in this process.  More acutely, they were able to tease apart differences in 
actinomyosin dynamics, and show that it was F-actin retrograde flow (as opposed to 
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myosin IIA stability) that was required for phosphorylation / activation of PLCγ1. Most 
likely this effect is enacted through F-actin’s ability to govern Slp76 microcluster 
centralization, thus providing the correct docking substrate for PLCγ1, although it does 
not affect the phosphorylation status of Zap70 or Slp76.  Additionally, this work seems 
to be the missing piece of the puzzle, as in 2010, the Boussiotis lab proved that RIAM 
(Rap1-GTP-interacting adaptor molecule) was necessary for correct localization of 
PLCγ1 [40], and RIAM, a MRL (Mig-10/RIAM/Lamellipodin) family member, plays a 
critical role in actin reorganization during IS formation following TCR ligation of an MHC 
I molecule loaded with the correct peptide.  Therefore, RIAM is the perpetrator of PLCγ1 
localization in the LAT signalisome by affecting PLCγ1’s interaction with the actin 
cytoskeleton; this is demonstrated in Figure 1.4B. 
Vav1 is also a key molecular player in the regulation of PLCγ1.  It was first shown 
by the Tybulewicz lab that Vav1 was required for full activation of PLCγ1 and the 
ensuing calcium Influx [41] , because Vav1 is the GEF responsible for the activation of 
Rac1, which is the GTPase that activates PI3K (which was reduced in Vav1-/- cells). 
From there, PI3K transforms PIP3 into PIP2, which brings Itk to the plasma membrane 
through association with Itk’s  pleckstrin homology domain [42] (activated Itk was also 
deficient in Vav1-/- cells).  From this discrepancy of Itk localization, it is a linear path to 
the additional downstream defects in activation of PLCγ1 and calcium signaling.   
Additionally, they realized that Vav1-/- cells not only had defects in activation of PLCγ1, 
but that PLCγ1 did not home to the LAT signalisome in the absence of Vav1.  While 
originally this homing defect was thought to be an additional (PI3K independent) 
mechanism of regulation, this was later disproven by the Burkhardt lab.  In 2009, they 
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brought the story full circle, when the demonstrated that HS1 (hemopoetic lineage cell-
specific protein 1) co-immunoprecipitated with Itk in stimulated T cells [43].  This 
complex is illustrated in Figure 1.4B.  This led to the new working model, wherein HS1 
is an effector of Itk; meanwhile Itk is responsible for homing HS1 to the IS, where it 
orchestrates the spatial organization of the LAT signalisome.  This explained how Vav1-
/- could cause issues with the localization and activation of PLCγ1 entirely through a 
PI3K-dependent pathway, still involving Itk.  
Extending the chain of defects as far up as PI3K, not only demonstrates how 
tightly controlled and intercalated these proteins and signaling events are, but 
additionally, it opens up the field to more distal negative regulators of PLCγ1.  To this 
extent, it was of little surprise when the Wange lab reported that deletion, inactivation, or 
expression of a dominant negative PTEN (the main negative regulator of the PI3K 
pathway) led to constitutively active Itk and hyper responsive T cells [44], illustrated in 
Figure 1.4A. 
The significance of Vav1 in activation of PLCγ1 was further trumpeted by the 
Braiman lab.  They chose to focus on Vav1’s interaction with PLCγ1 during TCR 
activation, and found that truncation of the N-terminus of Vav1 greatly decreased 
phosphorylation of PLCγ1 through instability of the LAT signalisome [45].  This 
important finding was a bit counter intuitive, as Vav1 was already known to attenuate 
calcium signaling (far downstream of PLCγ1) through its interaction with Calmodulin 
[46].  Moreover, this specific mutant of Vav1 is known to be oncogenic and robustly 
activates many other pathways and transcription factors in T cells, all while abrogating 
calcium signaling. 
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upon TCR-pMHC binding.   The downstream effects of this interaction were elucidated 
using a CD4 lineage specific LKB1-/- mouse model, that displayed subpar 
phosphorylation/activation of PLCγ1, with the corresponding loss of calcium influx.  
Furthermore, colocalization experiments revealed that PLCγ1 was only associated with 
the LAT signalisome in the presence of LKB1, despite route of stimulation [47]. 
A final, negative, regulator of PLCγ1 in T cells is E3 Ubiquitin ligase Cbl-b, shown 
in Figure 1.4B.  The Penninger lab was able to elucidate this role, by showing that Cbl-
b-/- T cells were able to be fully activated, and had no difference in calcium signaling, 
despite high concentrations of ionomycin pretreatment, which would render WT T cells 
anergic [48].  They further went on to show that in the absence of Cbl-b, PLCγ1 not only 
showed an increase in phosphorylation / activation after restimulation, but total protein 
levels were also increased; thus Cbl-b plays a pivotal role in the ubiquitination and 
subsequent degradation of PLCγ1. 
When TCR signaling proceeds through Zap70 and the LAT signalisome, PLCγ1 
will be phosphorylated and become conformationaly active.  From there, PLCγ1 cleaves 
phosphatidylinositol 4,5-bisphosphate into DAG (which will feed into the activation of NF-
κB and AP-1) and IP3 (necessary for the generation of calcium influx [49].)  
 
1.3. CD28 Signaling in T cell Activation 
There is no doubt that costimulation of T cells is imperative for optimal T cell 
activation, and of the many co-stimulatory molecules, none are more storied and 
studied than CD28.  CD28 is ligated by either CD80 or CD86 on APCs, and enhances 
TCR signaling at every level. The relatively small molecule (44kD) has an illustrious 
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cytoplasmic tail with several protein binding domains. Directly after ligation of CD28 by 
its cognate ligand CD80/86, CD28 is phosphorylated at Y191 by both Lck and Fyn [50].  
CD28 has then been shown to bind to the p85 subunit of PI3K through phosphorylation 
of its YMNM motif, and, downstream, its proline rich domain binds the SH3 domains of 
Itk, Lck, and Grb2 [51, 52].  Interestingly, all molecules are known constituents of the 
LAT signalisome attached to the TCR; delineating just how difficult it can be to tease 
these two pathways apart, as shown in the left side of Figure 1.5.   
Much focus is placed on the binding of CD28 to PI3K, as this produces PIP2 and 
PIP3, and localizes them to an area where molecules with pleckstrin homology domains 
can bind.  One such molecule is phosphoinositide-dependent protein kinase 1 (PDK1) 
who conveys the activating phosphorylation onto PKCθ (allowing it to activate CARMA1 
and canonical NF-κB signaling – discussed later) [53], although the Lee lab has since 
shown that PDK1 may also directly interact with CARMA1 [54].  Additionally, the Ghosh 
lab was able to clearly delineate that in T cells lacking PDK1, the activation of the NF-κB 
pathway is abrogated; meanwhile activation of AP-1 and NF-AT remains unhampered.  
They further went on to show that CD28 signals were integrated into TCR signaling via 
the molecule PDK1, whose localization and phosphorylation is dependent on CD28 [55].  
They also demonstrated that PDK1 has the ability to localize both PKCθ and CARMA1 
to the CD28 microcluster, and confirmed that, mechanistically, PDK1  has the ability to 
phosphorylate PKCθ at Thr538 leading to stabilization of PKCθ and laying the 
groundwork for activation of this protein  [56], as shown in the top portion of Figure 1.5. 
It was, in fact, the association of CD28 and PKCθ that was one of the first ways 
CD28 signaling was shown to positively impact TCR signaling, by aiding in the 
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localization of PKCθ to the c-SMAC of the IS.  The Dustin lab showed, conclusively, that 
in the absence of CD28 signaling, PKCθ remained in the p-SMAC [57].  Recently, the 
Altman lab was able to mechanistically explain this phenomenon as the C-terminal 
sequence YQPYAPP of CD28 binds FLNa (a large actin –binding protein capable of 
binding over 70 proteins and mainly expressed in the hemopoetic lineage) which then 
binds PKCθ [58], as shown in Figure 1.5. 
While the PI3K pathway is clearly an important part of CD28-mediated NF-κB 
activation, roles have also been shown for other binding proteins, including Grb2.  While 
Grb2 has no intrinsic catalytic function, it is the adaptor that brings Vav1 (discussed 
extensively in the preceding section) into the CD28 microcluster, and leads to the direct 
activation of NF-AT and the indirect activation of NF-AT (through PLCγ1regulation) and 
NF-κB (through a MEKK1 mediated pathway [59]). 
Another role for CD28 signaling in T cells is to activate Tec (the founding 
member of the Tec family of kinases.)  While Itk (another family member) has been 
established as the kinase responsible for activation of PLCγ1 [37], the Olive lab 
demonstrated that knock down of Tec abolished production of IL-2, while knock down of 
Itk only ablated production of IL-2 [60].  While this research delineates Tec as the more 
prominent Tec family kinase for TCR signaling, one caveat is that these studies were 
performed using PMA and ionomycin, a stimulation which bypasses the need for 
canonical TCR signaling and activation of PLCγ1.   Because the family members Tec 
and Itk share structural characteristics, it is of little surprise that they bind the same 
proline rich motif of CD28; interestingly, they demonstrated that, quantitatively, the 
amount of Tec and Itk that bind to the CD28 receptor are equivalent.  Paradoxically, the 
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cells, the Gajewski lab, in 2011, was able to link the pleiotropic effects of CD28 
signaling to one molecule: Ras (shown in Figure 1.5). They first realized that cross 
linking of CD28 with a monoclonal antibody, or use of professional APC stimulation via 
B7H1 led to an increase in the activity of Ras (as measured by downstream 
phosphorylation of ERK, AKT and JNK) and that Ras was consistently associated with 
CD28 containing microclusters post stimulation [62].  The most convincing piece of 
evidence, however, came with the ability to replace CD28 signaling with activated Ras, 
as the use of the constitutively active molecule led to proliferation and IL-2 production 
with no additional costimulation.   Moreover, while this effect relied on TCR signaling, it 
could accommodate a much lower antigen threshold.  This demonstrated not only that 
activated Ras could be a surrogate for CD28 signaling, but reinforced the role of 
costimulation in amplifying weak TCR signals brought about by quantitatively or 
qualitatively subpar antigen [62].   
More interestingly, work of late has shown that strong CD28 signaling (in the 
absence of TCR signaling) has the ability to activate NF-κB.  Surprisingly, although the 
activation of NF-κB still requires full phosphorylation and activation of upstream 
constituents (including Vav1 and slp-76), there is no activation of other downstream 
transcription factors, NF-AT or AP-1.  This illustrates that CD28 signaling is ultimately 
biased towards promoting the activation of NF-κB [59].  Evidence to explain this 
phenomenon comes from CD28’s ability to home and activate IKKα, independent of the 
IKK complex, and points to the role of non-canonical NF-κB signaling in T cell 
homeostasis and survival [63].  This pathway is depicted at the bottom of Figure 1.5 
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Outside of Ras activation in the LAT signalisome, AP-1 activation is also 
enhanced by the PKC pathway, through phosphorylation of the Fos kinase [66], and 
through the CD28 co-stimulatory pathway, through the activation of PI3K, and the 
resulting acidic sphingomyelinase [67].   Additionally, the Schmitz lab delineated a 
function for PKCθ in the Vav1 mediated activation of AP-1.  They demonstrated 
synergistic activation of AP-1 when a constitutively active form of PKCθ and Vav1 were 
overexpressed in Jurkat T cells; and achieved the opposite phenomena when these 
molecules were knocked down, suggesting that the pathways leading to activation are 
independent, but not exclusive [68].  Moreover, they showed that Vav1 and PKCθ were 
constitutively associated in resting Jurkat T cells (depicted in Figure 1.7), and validated 
that it was Vav1’s ability to bind and orchestrate actin polymerization that homed both 
proteins to the correct macromolecular complex [69]. 
Another molecule bridging the gap between TCR ligation and activation of Ras leading 
to AP-1 nuclear translocation and transcriptional regulation is Src kinase-associated 
phosphoprotein 55kDa (SKAP55), shown in Figure 1.7.   Experiments in the Mustelin 
lab demonstrated that if SKAP55 protein expression was deregulated, through 
overexpression or ablation, TCR signaling became uncoupled from the Ras activation 
as measured by decreases in Erk phosphorylation and AP-1 activity.  Furthermore, this 
effect could be reversed by use of constitutively active Ras or Raf1, additional molecular 
experiments defined a mechanism whereby SKAP55 binds RasGRP1 and enhances 
the activation of Ras [70]. 
The Delovitch lab did a wonderful job, in 1999, of delineating how the activation 
of AP-1 is brought about through ligation of the TCR receptor.  Through multiple 
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methodology, they were able to show that CD28 enhances the Zap-70 dependent 
phosphorylation of Vav1 [71].  This more activated form of Vav1 further charges the 
entire downstream pathway, by acting as a GDP releasing factor (GRF) for Rac-1 [72]. 
This allows Rac-1 to more easily adopt the (GTP bound) conformation of activation.  
From there, Rac-1 feeds forward to the activation of PAK1 and p38 MAPK [73], leading 
to the activation of c-Jun as outlined above.     Moreover, the Crabtree lab showed a 
role for calcium in the activation of AP-1, as addition of cyclosporin A caused reduced 
activation of AP-1 [74] (interplay between signaling cascades will be discussed in further 
sections.) 
An additional way that CD28 signaling enhances AP-1 function is through the 
activation of mitogen-activated protein kinase / extracellular-signal-related kinase  
kinase-1 (MEKK1), which will feed forward to phosphorylate JNK.  The August lab 
showed that overexpression of MEKK1 had the ability to activate AP-1 and the CD28 
response element; meanwhile knockdown of this protein, or use of a kinase dead 
mutant, ablated CD28 signaling to activate AP-1 [75].  They further demonstrated that 
this molecule likely integrated both TCR and CD28 signaling, and that AP-1 nuclear 
translocation and DNA binding involved MEKK1 activation of both NF-κB and JNK, as 
inhibitors against proteins in either pathway blocked the enhanced signaling witnessed 
in MEKK1 overexpressing cells. Ironically, pathways utilizing MAP kinase/ERK kinase1 
(MEK1), NF-κB inducing kinase (NIK), Calcineurin, or p38 had no effect on this 
phenomena. Finally, they also delineated an opposing function for lymphocyte-oriented 
kinase (LOK), as overexpression of this protein also reversed the effect of MEKK1 
activation [75].  This point is illustrated in figure 1.7. 
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Another negative regulator of AP-1 activation by TCR ligation is Cbl-b.  The 
Bonvini lab evinced ablation of AP-1 activation by overexpression of Cbl-b, regardless 
of cell stimulation route (anti-CD3 or PMA).  They further elucidated the mechanism 
responsible for these results, by showing that Cbl-b could competitively bind Grb2, 
blocking SOS ability to bind, and shunting Ras activation via SOS.  Under physiological 
signaling conditions, Cbl-b is constitutively ( weakly) associated with Grb2, until Cbl-b is 
modified, through phosphorylation and ubiquitination, and displaced post TCR ligation 
and initiation of TCR signaling [76], as shown at the top of Figure 1.7.  
 
1.4.2. NF-κB 
 
1.4.2.1. The NF-κB Family of Proteins 
 The NF-κB family is comprised of 13 members.  Five are transcriptionally active 
and consist of RelA (p65), RelB, cRel, p105/p50 (NF-κB1), and p100/52 (NF-κB2).  
While RelA and p50 are ubiquitously expressed, the expression of p52, cRel, and RelB 
is mainly limited to cells of the hemopoetic lineage [77].  Although many studies have 
aimed to divide this subgroup along canonical (p50, RelA, cRel [78, 79]) and non-
canonical (RelB, p52) party lines, their high degree of homology makes redundancy in 
function an almost certainty, especially in lymphocytes where all five family members 
are expressed [77, 80] .  Work by several groups have attempted to determine the role 
of each NF-κB family member through the use of knockout mice and specific inhibitors 
[81].  To date, we know that whole mouse deletion of IKKβ, IKKγ, and RelA are 
embryonic lethal due to liver degeneration [82, 83], thus most studies utilize tissue and 
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differentiation stage specific conditional knockout models, which will be discussed in 
further sections. 
To further complicate matters, many of the transcription factors within the NF-κB 
family have been shown to regulate the expression of additional family members [84].  
This makes it extremely difficult to diagnose whether deficiencies evinced in a single 
family member knock out study are the result of that missing transcription factor or the 
result of reduced expression of another family member whose transcription is regulated 
(and thus diminished) by the missing family member.    
The next subgroup of proteins is the inhibitors of κB, whose main job is to retain 
transcriptional subunits in the cytoplasm until the correct stimuli allows for the 
degradation of these inhibitors and the release of the transcriptional subunits.  The 
proteins are IκBα, IκBβ, IκBε, IκBζ, and Bcl-3.  Once again, expression is tissue specific, 
with IκBα and IκBβ being the predominate repressors in lymphocytes [85].  Moreover, 
Cheng et al recently used a knock in system to express IκBβ under the IκBα promoter 
(thus concurrently knocking out IκBα) and showed that the two proteins had almost 
entirely redundant functions [86].  Additionally, it is believed that IκBε favors the 
repression of cRel and RelA containing homo and heterodimers [87], and that IκBζ has 
the ability to exert repression in the nucleus and cytoplasm [88].   
The third class of proteins within the NF-κB family is the inhibitors of kappa 
kinase (IKK).  This group of three members is divided into two activation members with 
kinase domains (IKKα and IKKβ) and one regulatory subunit (IKKγ aka NEMO).  The 
purpose of this subgroup is to mark the IκBs for degradation, thus effecting the release 
of the transcriptional proteins of the family [85, 89].  This subgroup must form a complex 
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to exert its inhibitory effects and exact degradation of the IκBs; this can be a trimer 
composed of all three subunits, or a homodimer of two IKKβ subunits with one IKKγ 
subunit.   Much work has been done to flush out the role of each activating kinase (IKKα 
and IKKβ) and current dogma holds that while IKKβ is the key member for transmitting 
signals pertaining to inflammatory stimuli and lymphocyte specific (TCR/BCR) signals 
[90], IKKα is more prevalent in signaling pertaining to growth receptors and the 
lymphotoxin pathway [91].   
While it is clear that each kinase has its preferred targets and signaling 
pathways, conditional knockout studies have demonstrated that there is a great deal of 
redundancy between these two family members.  The Verma lab showed that deletion 
of IKKβ reduced, but did not ablate, canonical activation of NF-κB, as long as IKKα was 
present, whereas elimination of both family members fully abrogated canonical signaling 
[92].  Finally, using conditional knockouts, the Pasparakis lab has been able to show 
that IKKγ is essential for T cell canonical activation of NF-κB, and that while IKKα can 
perform most of IKKβ’s duties, T-regulatory and NK-T cells are severely 
underrepresented in mice missing IKKβ [89]. 
 
1.4.2.2. The Role of NF-κB in T cells 
The Molinero lab has recently proven what many people in the NF-κB community 
have long suspected: that basal NF-κB activation is required for survival of naive T cells, 
as shown in Figure 1.8 “Naïve”.  They did this by showing that transcription of the IL-7 
receptor (a required mediator for naïve T cell homeostasis) is dependent on NF-κB 
activation [93].  They were further able to elucidate that this mechanism is evolutionarily 
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conserved across human and mice, but is not related to tonic TCR signaling, as CD5 
was not down regulated in the IκBα DN (super repressed NF-κB model.)  
As NF-κB is very important for survival of antigen inexperienced T cells, it is also 
an important driver in survival of effector and memory T cell subsets.  Work by the Croft 
lab has recently shown that OX40 plays a crucial role in this process [94].  OX40 is a 
costimulatory molecule of the Tumor Necrosis Factor Receptor (TNFR) super family, 
and it is normally up regulated 18 – 48 hours post activation of the T cell.  Unlike other 
TNFR family members that normally activate NF-κB through MYD88, OX40 utilizes TCR 
based signaling pathways.  Signaling through OX40 has been shown to nucleate a 
complex of TRAF2, RIP, the CBM complex (discussed in a later section), PKCθ, and the 
IKK complex, leading to canonical activation of NF-κB via degradation of IκBα [94].  This 
canonical activation is much stronger than non-canonical signaling and lasts longer than 
NF-κB activation generated through the standard TRAFF pathway.  This is presumably 
based on trading of the CBM complex (discussed in depth in additional sections) for that 
of TRADD (the accepted ubiquitin ligase for TNF signaling to NF-κB.)  This point is 
illustrated in Figure 1.8 “Memory.”  
Finally, while many of the NF-κB family members have redundant functions [95], 
some have the ability to inhibit other family members, as has recently been shown for 
RelA and RelB.  Dogma has dictated that these two family members had little 
interaction and were activated through distinct pathways and by different T cell surface 
receptors.  RelA was known to be an activating family member controlled by IκBα, 
stimulated through TCR signaling, and the cornerstone of the canonical NF-κB pathway 
[96].  RelB, conversely, is the main player in the non-canonical NF-κB pathway, usually 
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host to RelA:p50 heterodimers.  Moreover, they were able to show that this RelA:RelB 
heterodimer was found in the nucleus and the cytoplasm and did not appear to fall 
under control of IκBα [99].  It remains to be elucidated if NF-κB heterodimers of 
RelA:p50 or cRel:p50 must compete with RelA:RelB heterodimers, already in the 
nucleus, for κB binding sites once canonical NF-κB signaling is activated post TCR 
signaling.    
Another family member with inhibitory properties is NF-κB2 (p100).  Through 
TLR, or other non-canonical stimulation routes, p100 is cleaved into the active p52.  
When signaling through the TCR occurs, however, p100 is upregulated and maintains 
its full length form.  The accumulation of this protein allows it to inhibit other family 
members through binding and cytoplasmic sequestration, thus functioning as a negative 
feedback loop to begin quenching TCR signals and return to cellular homeostasis post 
T cell activation [100]. 
Finally, while it is known that RelA and p50 are ubiquitously expressed and 
important for a plethora of canonical signaling pathways, cRel appears to be particularly 
important for T-lymphocytes.  The expression of both the IL-2 cytokine and its receptor 
(IL-2R) are directly regulated by cRel [79]; moreover, expression of cRel is highly 
upregulated in T-regulatory cells and it has been shown to govern transcription of 
FoxP3 [101]. 
 
1.4.2.3. Using p50 -/-cRel-/- Mice to Explore the Role of Canonical NF-κB in T Cells 
A great body of work has been completed by the Beg and Ohashi labs in 
determining the effect of p50 and cRel activation on gene transcription and activation of 
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T cells.  The Ohashi lab was able to show that only cRel was necessary to push cells 
towards activation, and away from anergy; while the loss of p50 had little to no effect on 
any readouts of functional activation.  Moreover, they were able to link PKCθ to cRel by 
demonstrating that many of the defects in PKCθ-/- T cells were due to decreased 
nuclear localization of cRel [102].    Additionally, they were able to track the deficiencies 
in cRel-/- T cells to a lack of the anti-apoptotic protein, Bcl-xL, and show that this 
reduction had a more substantial effect on CD8 T cells versus CD4 T cells [103].  
The Beg lab, concomitantly, showed cRel to be the more important of the two 
family members, and attributed additional phenotypic defects, such as dearth of IL-2 
production and reduced proliferation, to the loss of both p50 and cRel.  Utilizing p50-/-
cRel-/- CD4 T cells, they evinced a necessary role for NF-κB in TCR-stimulated 
production of IL-2 and Bcl-2 (both required for T cell survival.)  They also showed that 
post initial transcription of IL-2, NF-κB plays a minimal role in mediating IL-2 or AKT 
survival pathways [104].  Interestingly, while cRel deficient mice have been shown to 
have greatly reduced numbers of T-regulatory cells, the absence of this transcription 
factor does not appear to affect T-reg function, as there is no difference in suppressive 
ability between WT mice and their cRel-/- counterparts [105].  
 
1.4.3. Activation of NF-κB 
 
1.4.3.1. The Regulation and Role of Protein Kinase C (PKC) θ 
One unique function of PKCθ, that is just beginning to emerge, is the role it plays 
in transcription, as the Rao lab recently shown a role for nuclear PKCθ.  In several 
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elegant studies they showed PKCθ in a complex comprising RNA polymerase II, the 
adaptor 14-3-3z, and the histone kinase MSK-1.  This activated nuclear complex was 
found on the promoter site of inducible immune response genes of the adaptive cell 
lineage and  was associated with microRNA specific to cytokine regulation [106].  This 
phenomenon is illustrated in Figure 1.9D. 
 
1.4.3.1.1. PKCθ in the Immune Synapse 
PKCθ is the only PKC family member that is recruited to the IS upon TCR 
recognition of an APC presented target peptide [107].  Truncated mutants have shown 
that it is the N-terminal regulatory domain of PKCθ that it responsible for its lipid raft 
localization; the protein kinase Lck is also essential for this process [108].  Moreover, 
while it has long been known that PKCθ was required for the localization of CD28 in the 
IS [109], only recently did the Schwartzenberg lab reveal the protein responsible for 
aiding in the recruitment of PKCθ to the c-SMAC.  They implicated two proteins SLAM 
(signaling lymphocytic activation molecule) and SAP (signaling lymphocytic activation 
molecule-associated protein) as being important for the homing of PKCθ to the c-
SMAC, as shown in Figure 1.9B.  SAP was already known for its role as chaperone of 
Fyn into the SLAM complex, but they elucidated a mechanism by which SAP was, 
additionally, constitutively associated with PKCθ in T lymphocytes [110].  Interestingly, 
they targeted R78 as the site of PKCθ binding to SAP, as this site was already known to 
be the site of Fyn docking, but that interaction requires a neighboring tyrosine residue 
be phosphorylated [111], whereas PKCθ binding does not.  Furthermore, it appears that 
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Fyn binding has no effect on the SAP-PKCθ dimer being enfolded into the SLAM 
complex.    
 
1.4.3.1.2. PKCθ in Signal Transduction 
As early as 2000, scientists were aware that IKKβ was necessary for activation of 
NF-κB, and it was the work of the Nel lab [109] that showed physical association of 
PKCθ and the IKK complex in the IS of T cells during stimulation.  Moreover, they were 
able to show a role for PKCθ in the activation of the CD28 Response Element; this has 
led to an explosion of research on this novel PKC protein. 
Aside from its role in promoting the CBM complex (illustrated in Figure 1.9C) 
many additional functions of PKCθ, have been shown in T cells.  One such function is 
the down regulation of TCR molecules to recycle and amplify the signaling motif.  
Outside of physical degradation of proteins, and down regulation of receptors, 
phosphatases are the number one agent in signal down regulation and termination.  In 
2006, the Mustelin lab showed Hematopoietic Protein Tyrosine Phosphatase (HePTP), 
was one such protein.  Phosphorylated by PKCθ in the IS, this protein is then targeted 
to lipid rafts where it ablates TCR signaling by removing activating phosphate groups 
[112] The Geisler lab further  illustrated a role for PKCθ in down regulating TCR proteins 
complexed to MHC, and showed a concurrent role for PKCα in the down regulation of 
TCR molecules unbound to MHC [113].  They delineated a mechanism whereby 
phosphorylation on Ser126 of the CD3γ chain (either by PKCθ or PKCα) makes the di-
leucine motif available or binding by AP-2.  It is this binding that will allow for 
endocytosis of CD3 [114].The role of PKCθ in the degradation of the TCR is depicted in 
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Figure 1.9A.  Interestingly, further associations have been drawn to the overlapping 
functions of PKCθ and PKCα.  Although PKCθ has long been touted as the novel PKC 
required for TCR activation of NF-κB, recent studies by the Baier lab have shown that 
PKCθ-/- PKCα-/-  T cells caused much less GVHD in an allogenic transplant model (a 
measure of activation) than do single knockouts, whose phenotype is similar to WT T 
cells.  Moreover, they were able to show that activation of NF-AT was seriously 
abrogated in the double knock out mouse model when CD3 stimulation was applied 
[115].  They mechanistically linked depression of NF-AT activation to hyperactive 
GSK3β due to reduced phosphorylation of ser9.  As this modification was not evident in 
either single knockout, it appears both the novel PKCθ and the classical PKCα have the 
ability, and correct sub-spatial location, to enact the phosphorylation of this site on 
GSK3β and impact NF-AT activation [115].  The role of PKCθ in this process is 
illustrated in Figure 1.9A.  
An additional function of PKCθ that positively regulates TCR signaling, is its 
ability to mediate the ubiquitination and subsequent degradation of Cbl-b, a known 
negative regulator of TCR downstream targets PI3K, PLCγ1, and, ironically, PKCθ 
[116].  Although the Baier lab was able to show that Cbl-b and PKCθ associated shortly 
after stimulation of the TCR, and they could prove that this association was only 
possible with an activated PKCθ protein, no clear mechanism linking PKCθ to 
degradation of Cbl-b was forthcoming.  Although in the absence of PKCθ, Cbl-b levels 
remain high.  Even more incriminating, the autoimmune enhanced deregulated 
phenotype of Cbl-b-/- mice can be rescued by concomitant knock out of PKCθ [48]. 
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associated in Jurkat T cells, and while stimulation altered the location of both proteins 
within the plasma membrane space, it did not break the association.  However, over 
expression of PICOT was able to abrogate both AP-1 and NF-κB pointing to tight 
regulation of this pairing as crucial for controlled TCR signaling [117]; this is depicted in 
Figure 1.9A. 
PDK-1, PLCγ1, and Vav 1 have all been established as upstream of PKCθ [118] 
and numerous binding partners have been identified for PKCθ.  Perhaps PKCθ is most 
well known for its role in the CARMA1, Malt1, Bcl-10 (CBM) complex.  This is perceived 
as the main upstream complex linking TCR engagement with activation of NFκB [54]. 
Current etiology holds that PDK1 phosphorylates PKCθ while simultaneously recruiting 
it to the lipid raft; although, counter evidence points to PDK1 phosphorylation of PKCθ 
as a constitutive event that occurs directly after protein synthesis [119]. PKCθ then 
phosphorylates CARMA 1, allowing for its conformational change and recruitment of 
Bcl10 [120].  These two phenomena are illustrated in Figure 1.9C.   
 
1.4.3.2. The Regulation and Role of the CARMA1/Bcl-10/MALT1 (CBM) Complex 
CARMA1 is a CARD domain containing member of the MAGUK family, which 
favor binding to other scaffolding proteins through CARD:CARD domain interactions 
and being tethered to the cytoplasmic membrane, respectively.  Through initial studies 
in Jurkat T cells,  it became clear that CARMA1 was essential for the activation of     
NF-κB, but had no bearing on AP-1 or NF-AT activation; furthermore, this effect had to 
be downstream of PKCθ, as use of PMA and ionomycin could not rescue the defect in 
NF-κB activation.  
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The Lenardo lab was the first to illustrate modifications of CARMA1 and its role in 
the activation of NF-κB by the protein casein kinase 1α (ck1α) [121], which is depicted 
in Figure 1.10.  Interestingly, it seems to both positively and negatively regulate the 
process of complex assembly,  as it positively associates with the CBM directly after 
TCR signaling and enhances cytokine production, but then also phosphorylates 
CARMA1, aiding in its subsequent phosphorylation and inactivation.  Two other proteins 
known to positively regulate CARMA1 activation through phosphorylation are PKCθ and 
HPK1 [122, 123].  PKCθ has been identified as the kinase responsible for 
phosphorylating serines 564, 649, and 657 in the linker region of the CARMA1 
molecule, while HPK1 is the newly identified culprit applying phosphate groups to 
serines 549, 551, and 552, in the same area.  Both kinases have been proven 
necessary for full activation of CARMA1 and translocation of NF-κB heterodimers to the 
nucleus, as knocking out either PKCθ or HPK1 abrogates NF-κB signaling.  Moreover, 
in each case, phosphorylation of only 2 (of 3) serine sites seems to be sufficient.  With 
respect to PKCθ, mutation of either 564 or 657 abrogates CARMA1 activation, 
meanwhile mutation of S649A actually enhanced activation of IKKβ; demonstrating that 
this site may both positively and negatively regulate activation of CARMA1[124].  With 
respect to HPK1, serines 549 and 551, when mutated to alanine, abrogated activation 
of NF-κB in vivo (as gauged by IL-2 production); meanwhile, mutation of 552, only had 
an effect on CARMA1 activation in vitro [123].  These phosphorylation events are 
illustrated in Figure 1.10. 
Importantly, CARMA1 has been revealed as the protein necessary for binding the 
Bcl-10/Malt1 protein complex (through the CARD domain on Bcl10) and homing it to the 
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CARMA1 is responsible for the proper location of the CBM complex, and Bcl-10 and 
MALT perform the phosphorylation (of IKKβ) and the ubiquitination of (IKKγ), 
respectively,  that are necessary for NF-κB activation [127]. However, it was additionally 
shown that dephosphorylation of Bcl10 by Calcineurin [128] is also crucial for the 
complex formation, as shown in Figure 1.10. 
The Penninger lab was able to elucidate the next series of functions of CARMA1, 
by first showing that it was not required for proliferation or formation of the IS, as both 
were at WT levels in a CARMA-/- mouse model.  It was, however, still crucial for 
activation of NF-κB and cytokine production.  Furthermore, they delineated that while 
IKKβ appeared to migrate towards the focal contact point between the T cell and APC of 
its own volition, CARMA1 was necessary for the correct localization of IKKβ in the c-
SMAC compartment.  Moreover, they showed that IKKβ was not active in the absence 
of CARMA1 [129]. 
It was later in 2004, when the Vito lab would fully elucidate the physical and 
functional interactions between CARMA1 and the IKK complex: through association with 
IKKγ (NEMO.)  They were able to pull NEMO down with CARMA1, in a stimulation 
dependant manner.  They were also able to isolate Bcl-10 in NEMO immunoprecipitated 
fractions showing that the entire CBM complex was present, and further implicate 
MALT1 as the E3 Ubiquitin Ligase responsible for ubiquitination of IKKγ [130].  In 2007, 
the Kurosaki lab would implicate IKKβ in the additional phosphorylation of CARMA1 
[131], furthering the complex and intricate interaction between these two protein 
complexes, which are demonstrated in Figure 1.10.  
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As CARMA1 has been shown to be the initiator of CBM signaling to NF-κB 
activation, a role for Bcl-10 is emerging as the protein responsible for down regulating 
the activation signal.  The Krappman lab was able to show that approximately 3H after 
stimulation, there was a severe reduction in Bcl10 cytoplasmic levels.  Through the use 
of multiple antibodies and interrogation of the detergent insoluble fraction, they 
illustrated that this reduction in protein level was due to degradation of the protein, not 
post translational modification or cellular translocation [132].  As PMA, but not LPS, 
induced this degradation, combined with evidence that Bcl-10 was additionally 
phosphorylated directly before degradation, scientists honed in on PKCθ as the culprit 
mediating Bcl10 degradation.  Moreover, through mutational analysis, they were able to 
reveal that the CARD domain in Bcl10 was also necessary for degradation.  
Interestingly, they also showed through confocal microscopy that Bcl10 degradation did 
not track through the standard proteosomal degradation pathway, but instead homed to 
lysosomes for degradation [132].  Correspondingly they showed that ubiquitination was 
necessary for this trafficking to lysosomes and that this was mediated through the 
catalytic E3 ligases itch and NEDD-4, but not the RING finger E3 Ligase Cbl-b [132], 
which is known to promote the degradation of one of BCL-10’s negative regulators, 
PLCγ1.  This model of degradation is illustrated in Figure 1.10. 
However, as Newton has taught us, for every action, there is an equal and 
opposite reaction, and in this case it is an unlikely protein that staves off Bcl10 
degradation: the COP9 Signalisome (CSN).  This pleiotropic regulator of the 
ubiquitin/26S proteosome was known to be imperative for canonical NF-κB activation, 
as it controls degradation of IκBα. Using mutational analysis, the Krappman lab was 
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able to show that the CSN5 (one member of the CSN holocomplex) bound to 
ubiquitinated MALT1 post T cell activation, and only after the CBM complex had been 
formed [133].  Linear thought dictates that association of these two complexes would be 
necessary to bring IκBα to the CSN for proper degradation; however, proof of concept 
experiments utilizing knock down of CSN5 revealed that the protein serves additional 
functions.  Namely, it enhances the activation of IKKβ, and stabilizes Bcl10 by staving 
off degradation, as shown in Figure 1.10. 
Dogma explained AKTs involvement in the NF-κB pathway as negligible.  
Although there was always a correlation between the activation of the two pathways, it 
was believed that the only interplay was a rheostat function on the part of AKT.  
Essentially AKT was responsible for monitoring the “temperature of the cell”, and 
making sure the back ground landscape was in proper order to facilitate full activation of 
NF-κB [134].  Interestingly, the Kane lab has recently shown additional roles for Akt1 
and Akt 2 in the formation of the CBM complex.  Initially, they observed a reduction in 
transcription of NF-κB target genes when inhibitors against AKT1 and 2 were used.  
Working up the signaling chain, they determined that, in fact,  phosphorylation of IKKβ  
and degradation of IκBα were reduced in the presence of inhibitors of Akt1 and Akt2, as 
well [135].  Finally they were able to show a disruption in the formation of the CBM 
complex, but no effect on upstream mediators of complex formation.  Thus it was 
established that AKT1 and 2 play a positive regulatory role in the binding of CARMA1 to 
Bcl10, and resulting activation of NF-κB, although a direct mechanism remains to be 
elucidated, the event is depicted in Figure 1.10.   
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Two other proteins recently shown to be important for CBM formation are: ADAP 
(adhesion and degranulation-promoting adaptor protein) and PALS1 (Protein 
Associated with Lin Seven 1) [136, 137].  ADAP, which is recognized primarily for its 
ability to modulate integrin signaling via  control of LFA-1 (through the interaction of 
ADAP / LFA1 / SKAP55) and maintenance of the T cell:APC interface [138], also seems 
to both positively and negatively impact the CBM complex.  It is critical for honing TAK1 
and CARMA1 to the PKCθ  containing CD28 signalisome; yet several groups have 
shown that through a CARMA-mediated pathway, it also has the ability to disband the 
CBM [139].  PALS1, meanwhile, is known for participating in large multi-protein 
complexes that regulate cell polarity.  The Bidere lab, however, illustrated that it is also 
important for activation of NF-κB, as CARMA1 was not found to be associated with 
Bcl10 in the absence of PALS1, in Jurkat T lymphocytes [140].  The role of these two 
proteins is illustrated in Figure 1.10. 
Once the CBM complex is correctly formed, the main function appears to be bi-
functional in the activation of NF-κB: phosphorylation of IKKβ by the kinase TAK1, which 
always travels with the adaptor TAB1 [141], and ubiquitination of K63 on IKKγ, by the 
E3 Ligase Traf6 [142].  The importance of the CBM complex in T cell signaling cannot 
be overstated, as over expression of any of the constituents of the complex leads to 
spontaneous oligomerization and formation of the complex, which can lead to activation 
of NF-κB in the absence of upstream signal activation [143].  Moreover, the complex 
keeps expanding, and now it is known that both TRAF2 and TRAF6, along with UBC13 
(ubiquitin-conjugating enzyme 13) and UEV1A (ubiquitin-conjugating enzyme E2 variant 
1A) are required for the full activation of the IKK complex (phosphorylation of IKKβ  and 
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ubiquitination of IKKγ) leading to destruction of IκBα [144], as shown at the bottom of 
Figure 1.10.  This reveals the CBM as a point of intersection between the adaptive and 
innate immune responses, as it controls all canonical NF-κB activation, despite route of 
stimulation. 
 
1.4.3.3. The Regulation and Role of the IKK Complex 
 
1.4.3.3.1. The Role of IKKγ in T cell Activation 
 Dr. Karin has identified the IKK complex as containing two catalytic proteins 
(IKKα and IKKβ) and one regulatory subunit (IKKγ, aka NEMO) [85].  His work, along 
with that from Dr. Schmidt-Supprian placed the complex at the center of NF-κB 
activation via its ability to induce degradation of IκBα in 2000 [89]. Additional work by Dr. 
Li dictated that IKKγ had regulatory, not activating functions within the complex [145].   
Three years later, it was Dr. Ting who first established the necessity for IKKγ in IL-2 
production.  Using a Jurkat T cell line with knock down of IKKγ, he showed specific 
defects in IL-2 production compared to WT cells.  Moreover, he was able to trace this 
defect specifically to lack of phosphorylation of IKKβ, and loss of degradation of IκBα, 
rendering canonical NF-κB subunits unable to undergo nuclear translocation. 
Meanwhile, the AP-1 and NF-AT pathways remained unaffected [146]. 
 
1.4.3.3.2. The Role of IKKα in T cell Activation 
 Unfortunately, very little is known about the role of IKKα in T cell activation, and 
the general consensus of the field is that IKKβ is the required family member to illicit T 
 
47 
 
cellular activation from TCR ligation, while IKKα is a dispensable passenger [89].  In 
primary fibroblasts and COS cells, however, IKKα has been shown to have two unique 
functions that enhance NF-κB signaling, and could potentially be applicable to NF-κB 
activation in T cells via TCR signaling.  In 2000, the Gaynor lab first showed that in 
fibroblasts IKKα could phosphorylate and induce destruction of IκBα.  This is also true in 
T cells, but IKKβ has greater kinase activity and affinity for IκBα.  The novel finding, 
however, was that IKKα seemed to be responsible for IKKβ’s increase in kinase activity 
through direct phosphorylation of IKKβ by IKKα [147].  Three years later, they would 
demonstrate a nuclear role for IKKα, in large complexes with RelA and CREB-binding 
protein.  These complexes were formed upon cytokine treatment and honed to NF-κB 
responsive promoters where they would phosphorylate residues in histone H3, inducing 
subsequent acetylation [148].  Although these two roles will need to be verified in T 
cells, this dual functionality is completely plausible. 
 
1.4.2.3.3. The role of IKKβ in T cell Activation 
As early as 1999, the Nel lab conclusively proved that IKKβ was the premiere 
kinase between IKKα and IKKβ in TCR signaling.  They also showed that primary CD4 
T cells actually form two independent IKK complexes upon TCR stimulation, one 
heteromeric containing IKKα/ IKKβ / and IKKγ, and one homodimeric with two subunits 
of IKKβ and one subunit of IKKγ.  Additionally, while overexpression of IKKβ leads to 
hyperactivated T cells, overexpression of IKKα has no effect.  Moreover, inhibitors 
specific for IKKβ or knockdown of IKKβ ablated T cell activation, while interfering with 
expression or function of IKKα, did not inhibit T cell activation [149]. 
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As with many discoveries in Science, the finding by the Janssen-Heininger lab, 
that IKKβ was a direct target for Nitric Oxide (NO) was accidental, as they first believed 
that NO’s suppressive effects were based solely on the ability of NO to disrupt NF-κB 
binding to DN [150]. Through a series of elegant experiments, they proved that it was 
the cysteine residue at aa179 that became S-Nitrosylated and attenuated the kinase 
activity of IKKβ, but only after IKKβ had been activated, as the phosphorylation of 
surrounding sites (Ser177 & Ser181) provides the imperative negative charge to the 
region.  This was an important milestone in 2004 as it was one of the first papers to 
independently look at IKKβ (outside of the NF-κB super family in general [150].)  This 
phenomenon is illustrated in Figure 1.11A.  However, it would take until  2012 for 
dogma to view each member of the IKK complex (α,β,γ) as independent members of 
TCR induced NF-κB activation, when the Li lab [145] was able to show that IKKγ and 
IKKβ actually migrated to the IS (using detergent fractionation of lysates) at different 
kinetics and had disparate lengths of stay, showing that the complex was only formed 
right before degradation of IκBα. 
Most of the field views the phosphatase PP2A as a negative regulator of NF-κB 
signaling, with the Krammer lab recently showing that IκBα shows a higher degree of 
phosphorylation (and there is an increase in T cell proliferation) when PP2A is silenced 
[151].  Contradictorily, however, the Kahn lab has shown a positive regulatory role for 
PP2A with respect to IKKβ, by showing that PP2A had the ability to reduce the amount 
of negative phosphorylation that IKKβ will endure during the activation process, and that 
PP2A exerts this effect through complexing with IKKγ [152].  The conflict between these 
two studies may be explained by the Krammer’s lab use of specific siRNA against only 
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one subunit of the PP2A complex, B56γ, while the Kahn lab utilized the popular PP2A 
inhibitor okadaic acid to block the entire complex.  However, the conflict also draws light 
to the necessity of exact regulation of TCR signaling, and the fact that many proteins 
have the ability to be both positive and negative regulators, depending on where in the 
signaling chain they are located both spatially and temporally.  
While it has long been accepted that the role of IKKβ in NF-κB signaling was to 
phosphorylate IκBα [153]  and RelA [154] (to promote its degradation, and activation, 
respectively) in 2010, the Li lab showed an additional role for IKKβ outside of the 
activation of NF-κB, in the CD4 T cells of aged mice [155].  Here it was shown that IKKβ 
levels increase in CD4 T cells as the mouse ages, and that this increase correlates to, 
and appears to be the cause of, inhibited JNK activation, as shown in Figure 1.11C.  
This inhibition of JNK allows the cells to increase affinity for Bad to 14-3-3 (pro survival) 
while decreasing the interaction of Bad to Bcl-Xl (pro apoptotic), thus rendering the cells 
insensitive to activation induced cell death (AICD).  This age-associated increase in 
IKKβ also causes a corresponding increase in NF-κB activation, and aged T cells 
produce a much greater volume of proinflammatory cytokines than do their juvenile 
counterparts [155]. 
Moreover, the Krappmann lab demonstrated a role for IKKβ upstream of CBM 
complex formation.  They were actually investigating the role of PKCθ in assembly of 
the CBM complex utilizing the PKCθ specific inhibitor Rotterlin, when they realized that 
their negative control (use of BAY11-7085, a specific inhibitor of IKKβ) also blocked Bcl-
10 phosphorylation and CBM formation [156].  Further experimentation revealed that 
IKKβ was constitutively bound to Bcl-10 and Malt1 in unstimulated cells, placing this 
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important kinase even farther up the signaling chain, and proving that IKKβ was 
responsible for the assembly of the CBM, as phosphorylation of Bcl-10 (at multiple 
serine residues in the C-terminus, by IKKβ) is the event that allows CARMA1 to dock 
with Bcl-10 and Malt1.  Additionally, through the use of several lineage specific 
knockout mice and shRNA, they were also able to show that IKKγ  (the regulatory 
subunit of the IKK complex) or IKKα (a sister kinase in the complex – generally thought 
to be more impactful in TLR activation of NF-κB [157]) are not required for formation of 
the CBM; thus identifying this mechanism as an independent role for IKKβ, not a 
function of the IKK complex; these events are depicted in Figure 1.11B.    They went on 
to further demonstrate that this phosphorylation event served to not only enhance CBM 
complex formation and activation, but also served as a negative regulator of this 
pathway, as the phosphorylation of Bcl-10 disrupted Malt1– Bcl10 binding and ultimately 
down regulated ubiquitination of IKKγ [156]. 
Interestingly, the Zhong lab has also demonstrated a negative regulatory role for 
IKKβ [158].  They used a constitutively activated form of IKKβ, only expressed under the 
CD4+ lineage, to evince that those T cells had extremely high levels of Fas, PD1, and 
Blimp1 expression, as shown in Figure 1.11E.  The expression of these molecules is not 
only characteristic of an exhausted T cell, but also led to an increase in apoptosis and 
the corresponding decrease in survival.  Interestingly, in culture, the caIKKβ CD4 cells 
demonstrated a moderate basal level of activation (measured by cell surface increase of 
CD69L and CD25) but were unable to induce strong up regulation of these molecules 
when treated with anti-CD3/CD28, while there WT counterparts could.  They further 
tracked the activation defects in the cell toward more proximal signaling components 
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and realized that phosphorylation of Zap70 and PLCγ1were impaired, and that these 
defects led downstream to defects in calcium signaling and ERK phosphorylation [159]. 
Another potential way that IKKβ can negatively regulate T cell activation is 
through the phosphorylation / activation of Dok1.  The Sylla lab demonstrated that IKKβ 
had the ability to phosphorylate Dok1(shown in Figure 1.11D) in response to TNFα, IL-
1, and γ radiation; through in vitro experiments, they were able to elucidate the sites of 
phosphorylation as S439,S443, S446, and S450 [160].  While this mechanism has not 
been tested in response to TCR signaling, it seems logical that this would be a viable 
method to quench TCR signaling as Dok1 is known to bind and enhance multiple other 
negative regulators of TCR signaling including SHIP1, Nck, and Csk [30] and attenuate 
tyrosine kinase signaling [161].  This down regulation of TCR signaling is ultimately 
required to begin the overwhelming task of migration to the infection or tumor site, which 
is known to be facilitated by Dok1 [162].  
Meanwhile, a rebuttal to IKKβ as a negative regulator came in a 2013, Journal of 
Immunology paper from the Piccinini lab [163].  Where, to no one’s surprise, they 
showed that IKKβ was imperative for activation of NF-κB.  The novel aspect of this 
paper came in describing a new and necessary role for IKKβ in the activation of AP-1.  
They were able to show that IKKβ is responsible for the chromatin remodeling around 
the promoter sites of c-Fos and c-Jun which ultimately allow for transcription factor 
binding and AP-1 activation, as shown in Figure 1.11F.  Moreover, by inhibiting NF-κB 
activation, but not IKKβ, they were able to preserve AP-1 translocation to the nucleus; 
thus indicating this was a specific role for IKKβ, independent of its role in NF-κB 
activation.  Furthermore, they were able to show that this lack of AP-1 signaling in IKKβ 
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1.4.4. Activation of NF-AT  
 
1.4.4.1. Calcium-Dependent NF-AT Activation 
Long before a T cell will become activated, the landscape must be set to create 
the correct polarization of the membrane and cellular compartments to allow for robust 
and timely signal transduction.  With respect to calcium signaling, this requires three 
main feats be accomplished.  The first is keeping the cell in the right ionic state and that 
is accomplished  via sodium  (TRPM4) and potassium (KV1.3 & KCa3.1) channels [164], 
and  aided by cytoplasmic membrane bound calcium channels [165].  These channels 
(shown at the top of Figure 1.23) and pumps are activated and expressed at various 
levels and by a multitude of stimuli, but all function in concert to maintain the 
homeostasis of intracellular calcium at a low level and maintain the ionic potential 
across all cell membranes.   The second is ensuring that proteins necessary for 
transducing the calcium signal are kept at appropriate levels and are compartmentalized 
correctly for easy access during the stimulation chain.  Two major players in this 
process, whose levels are carefully monitored, are STIM1 and Orai1.  In fibroblasts, 
these two genes have been shown to be  regulated at the transcription level by NF-κB 
[166].  At the protein level, their fate lies in the hands of the ubiquitin ligase Nedd4-2, 
whose activation by AMPK depends on AMPK being kept in an unphosphorylated state, 
as phosphorylation by SGK1 leads to AMPK down regulation and a lack of Nedd4-2 
activation [167].  This phenomenon is illustrated in Figure 1.12.   
While other proteins levels are not monitored as scrupulously; there is a great 
need to make sure that they are correctly localized for the signaling chain to be 
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effective.  One such protein, whose cellular localization has been extensively studied, is 
PLCγ1.  In work by the Pareek lab, it has been shown that Coronin1 is responsible for 
pulling PLCγ1into the TCR complex after phosphorylation by Cdk5 [168], as shown in 
Figure 1.12.  Furthermore, the Domdkowski lab demonstrated that it was the protein 
RIAM that connected PLCγ1to the cytoskeleton allowing it to relocate with the formation 
of the IS [40], as shown in Figures 1.4 & 1.12.  Moreover, Julien Laconte demonstrated 
that I-COS was also necessary for this interaction and relocation of PLCγ1along the 
actin cytoskeleton [169], Figure 1.12.     
Finally, because T cell calcium influx is known to be regulated by Store Activated 
Calcium Entry (SOCE), the store must be stocked with calcium.  This is accomplished 
by Sarco-Endoplasmic Reticulum (SERCA) pumps and STIM2 [170].  STIM2 especially 
is known to regulate the basal levels of calcium within the S-ER, by sensing levels 
within and then utilizing the pumps to keep levels steady, as shown in Figure 1.12.   
Upon TCR ligation by an MHC with a cognate peptide, many events transpire in 
rapid succession, and after only ten seconds of contact, the first wave of calcium is 
being released.  This is a direct result of the following cascade of phosphorylation: Lck 
phosphorylates ITAMs on the TCR zeta chain creating a docking site for Zap70 [171]; 
Zap70, once bound recruits and phosphorylates LAT and Slp76, which in turn activate 
the Ras pathway and PLCγ1 via phosphorylation by Itk [37].  From there, PLCγ1 
cleaves phosphatidylinositol 4,5-bisphosphate (PIP2) into DAG (which will feed into the 
activation of NF-κB) and IP3 [49].  IP3 will then bind to the IP3 receptor on the S-ER, 
causing a small leak of the stored calcium.  This small amount of calcium has the ability 
to bind and change the conformation of STIM1.  This change in protein shape redirects 
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the entire S-ER to the cell membrane where it is now in the correct configuration to bind 
to ORAI1 [172]. This opens the ORAI channel and calcium begins to influx from the 
extracellular space, as illustrated at the bottom of figure 1.12.   
In addition to the ORAI channels that open to allow calcium to enter the cell, 
there is another family of channel proteins intimately linked to calcium signaling, the 
Transient Receptor Potential Cation (TRPC) channels [164].  Although these channels 
are non-selective for calcium, by allowing the flow of multiple ions across the 
membrane, they maintain osmotic pressure and drive the influx of calcium.  TRPC1 is 
also known to be constitutively associated with ORAI1 [173].  Another, non-selective, 
family of channel proteins required for calcium signaling, is the purinergic family.  These 
receptors respond to mechanical stress (created through the tethering of T cells to 
APCs) and allow flux of multiple ions across their path while contributing to ATP 
paracrine signaling and amplifying the calcium signal based on a limited number of 
TCRs  [174].  Many labs have delineated roles for P2X1 and 4, and more recently P2X7 
has risen to the forefront as indispensable for Calcium signaling [175].  This multitude of 
additional, non-selective, ion channels is depicted in Figure 1.12. 
Once the extracellular influx of calcium has begun, the second avalanche of 
signaling begins.  One of the first proteins modified by calcium interaction is Calmodulin.  
Once Calmodulin binds calcium, it phosphorylates Calmodulin Kinase II (CamKII), which 
is responsible for phosphorylating Calcineurin.  This phosphorylation conveys an 
activating conformation, and Calcineurin can then dephosphorylate NF-AT allowing it to 
translocate to the nucleus [176], as shown in Figure 1.12. The NF-AT pathway 
represents the most straight forward path from influx of calcium to transcription factor 
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almost immediately, following TCR stimulation.  It appears that only AKT2 has the ability 
to down modulate and decrease the duration of calcium signals.  This inhibitory effect 
seems to be defined by phosphorylated AKT2’s ability to competitively bind the IP3R of 
the S-ER, and block its interaction with Bcl-2 [177].  This event is illustrated on the right 
side of figure 1.12. 
A forthcoming, positive regulator of calcium signaling, shown by the Cao lab, is 
Vav1.  For many years, scientists have known that Vav1 homed to the LAT signalisome 
during T cell stimulation, and roles have been established for this storied protein in the 
activation of AP-1 and NF-κB [41, 59], but it was not until recently that it was proven to 
also be instrumental in the calcium and NF-AT pathway.  Through binding assays based 
on Vav1 mutants, the Cao lab evinced that Vav1 would bind Calmodulin through its 
calponin homology (CH) domain, but only during TCR stimulation, and only when 
Calmodulin was bound to calcium, as shown in Figure 1.12.  They were further able to 
delineate that the Vav1-/- T cells and Vav1 with a mutated CH domain had similar 
phenotypic profiles and detrimental calcium signaling during stimulation.  Interestingly, 
this does not seem to affect the phosphorylation / activation of PLCγ1, or the release of 
calcium from intercellular stores [46].  These results point to a mechanism whereby 
Vav1 – Calmodulin binding stabilizes and amplifies calcium signaling post calcium influx 
from the extracellular space. 
 
1.4.4.2. Calcium Independent NF-AT Activation 
Interestingly, the Ras pathway has also been implicated as imperative for NF-AT 
signaling in a calcium independent manner, as the use of a dominant negative Rac-1 or 
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MAPKK-1 rendered T cells unable to mount an NF-AT response, yet constitutively 
active MAPPKK-1 was not able to rescue the effects of absence of activated Ras [178].  
This indicates that these two pathways must cross-talk at several levels upon the 
activation landscape.  Moreover, they showed that Raf-1 was likely the MAPKKK that 
begins the phosphorylation cascade leading to the ultimate phosphorylation / activation 
of ERK-1 and ERK-2; this demonstrates the duality of Ras signaling, which appears to 
branch at Rac-1 / Raf1 [178]. 
Although it is widely accepted that NF-AT must be dephosphorylated for nuclear 
import, in 2004, the Yuan lab added another dimension of regulation with the discovery 
that NFAT1 is also sumoylated, as shown in Figure 1.12.  Through elegant in vitro and 
in vivo experiments, they flushed out Lys684 and 897 as the sites for sumoylation.  
Furthermore, they evinced a mechanism by which Lys684 was required for nuclear 
import and for additional sumoylation at Lys897; while Lys897 regulates nuclear 
anchorage [179]. 
An additional, well known, negative regulator of NF-AT is Glycogen Synthase 
Kinase-3 (GSK3) which is known to re-phosphorylate NF-AT at sites of Calcineurin 
dephosphorylation [180].  This event is depicted in Figure 1.12.  Interestingly, GSK3 has 
both cellular and nuclear roles.  In the cytoplasm, there is dynamic interplay between 
GSK3 and Calcineurin (a constant phosphorylation/dephosphorylation of NF-AT) in 
resting T cells which keeps NF-AT inactivated until there is a strong calcium signal 
favoring Calcineurin based dephosphorylation.  In the nucleus, GSK3 is responsible for 
the phosphorylation that will cause nuclear export of NF-AT [181]. 
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1.4.5. Pathway Interplay 
 
1.4.5.1. Dimers of AP-1 and NF-AT 
One of the most accepted phenomenon in T cell biology is the effect of 
cooperative binding of AP-1 and NF-AT on DNA [182].  While many labs have shown 
that the proteins can dimerize, and it is dogma that many transcription factors will bind 
to the same gene, the interplay between AP-1 and NF-AT is special in that it allows for 
different results in gene transcription depending on whether NF-AT binds DNA alone, or 
if it binds as a dimer of NF-AT and AP-1.  The Rao lab did a fantastic job of elucidating 
these two scenarios in 2000, when they illustrated that a tolerance phenotype was 
adopted by the cell in NF-AT only binding [183].  Concordantly, TNF and IL-13 were 
produced in abundance and the T cell was unable to undergo activation induced cell 
death (AICD).  Conversely, they demonstrated that activation dependant gene 
transcription required the AP-1 / NF-AT dimer, as IL-2,IL-3,IL-4,GM-CSF, MIP1a, and 
Fas ligand mRNA could not be produced in the absence of AP-1 [183]. 
 
1.4.5.2. Calcium Impacts NF-κB Signaling 
As early as 1994, the O’Neill lab demonstrated crosstalk between the calcium 
and NF-κB pathways.  As they were able to show that activated Calcineurin had the 
ability to enhance nuclear translocation of the p50/p65 heterodimer, and that this was 
accomplished via enhanced degradation of the main repressor of NF-κB signaling, IκBα 
[184].  In 1995, they expanded their work to also include a role for the calcium activated 
serine protease, Calpain, in the physical degradation of IκBα [185].  It wouldn’t be until 
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2011, however, that the work of the Marienfield lab would hone in on the exact 
mechanism of Calcineurin’s positive impact on NF-κB signaling.  They elicited a 
mechanism by which Calcineurin was not only responsible for NF-AT 
dephosphorylation, but that it also targeted dephosphorylated Bcl-10, and that this 
dephosphorylation was key to the formation of the CBM complex [128]. Because the 
CBM complex is upstream of IκBα degradation, this finally linked activated Calcineurin 
to activation of NF-κB, and explained the phenomenon demonstrated by the O’Neil lab 
seventeen years earlier.  These two phenomena are depicted in Figure 1.13. 
Once Calmodulin activates Calmodulin Kinase II (CamKII) another layer of NF-κB 
interplay is achieved, as multiple labs have shown intersection of CamKII with various 
components of the NF-κB pathway.  One of the first interactions came from the 
Gundstrom lab in 2001, where they demonstrated that inhibition of CamKII resulted in a 
complete loss of IκBα phosphorylation when T cells were stimulated.  Moreover, the 
reverse was also true, as over expression of CamKII led to activation of NF-κB in the 
absence of exogenous stimulation [186].  In 2010, they further delineated exactly how 
calcium was actually modifying the CBM complex.   Ironically, they were able to show 
two opposing fates: Calmodulin (interacting with Bcl-10) was a negative regulator, as 
this disrupted CARMA1 and Bcl-10 binding because Calmodulin competitively bound 
Bcl-10’s CARD domain (CARMA1’s docking site [187].)  Meanwhile, CamKII played a 
positive role in the pathway, as phosphorylation of CARMA1, by CamKII, leads to 
enhanced complex formation [188], as shown in Figure 1.13. 
Calcium even helps to dampen the NF-κB response at the tail end of signaling, 
and help to “re-set” the cellular landscape, as post activation, there has been a role 
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1.5. Summary of T cell Activation 
T cell activation is an extremely complex process that must be tightly regulated at 
every level to protect against unwanted activation and promote robust and timely 
activation in the correct setting.  Conventional knowledge has dictated that most signals 
move linearly from the cell surface to the nucleus; this model is easily worked, and one 
can see each regulatory step in an orderly fashion.  Recent research, however, is 
setting a landscape where pathways dynamically interact and signaling moves multi-
directionally.  Thus making the tight regulation of T cell activation, against a backdrop of 
seeming chaos, that much more impressive. 
 The first attempt at ordering the cellular chaos into distinct activation pathways is 
through the formation of the Immune Synapse.  This sets the board and creates distinct 
subcellular pockets that will harbor or exclude various proteins based on size, charge, 
and the ability to bind the actin cytoskeleton.  While most TCR signaling will be initiated 
in the periphery (p-SMAC), successfully bonded pMHC:TCR microclusters will soon join 
CD28 and PKCθ as they are shuttled towards the center (c-SMAC) of the IS for 
enhanced signaling potential (weak agonistic peptides) or degradation (strong agonistic 
peptides).  Concurrently, larger molecules, such as CD45, will use retrograde flow, and 
move to the distal (d-SMAC) end of the IS.  This makes the c-SMAC rich with positive 
regulators of T cell signaling, and repositioning of the mitochondria and S-ER, through 
cytoskeletal reorganization, stabilize calcium levels.  
 There are two main classes of proteins that coordinate the formation of the IS.  
Those that actually regulate the actin dynamics, such as WASP, WAVE2, and Talin, 
and those that are responsible for physically connecting specific TCR signaling proteins 
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to the actin cytoskeleton, such as TSG101(responsible for TCR), RIAM (PLCγ1), FLNa 
(CD28), SAP & SLAM (PKCθ)  Additionally, several proteins regulate the functions of 
these two classes of proteins ( i.e. Vav activates Cdc42 and Rac1which are required for 
WASp and WAVE mandated actin reorganization, respectfully; and  Zap70 regulates F-
actin via Talin.) 
The second level of regulation is the transduced signal, itself.  This is an intricate 
mix of protein interactions based predominately on the activities of kinases and 
phosphatases.  Once the TCR ligates a MHC loaded with a cognate peptide, it will pull 
CD8 and Lck into the complex, and help the phosphatase CD45 to free Lck from Csk’s 
phosphorylating repression.  Next, upwards of six sites will be phosphorylated, by Lck, 
on the CD3ζ/TCR associated ITAM.  This creates a binding site for Zap70, already 
phosphorylation heavy from unidentified kinases.   Zap70 will bind the TCR, auto-
phosphorylate, and phosphorylate LAT and Slp76, thus nucleating the LAT signalisome, 
and, through Slp76, merging TCR and CD28 signaling. 
PLCγ1, PI3K, and Itk all bind directly to phosphorylated LAT, which then expands 
its empire by bridging to Slp76 through their combined interaction with Grb2.  This 
macromolecular structure now contains PDK1, PKCθ, Vav1 and ADAP via Slp76.  Other 
proteins, such as LBK and HS1 provide anchorage for the signalisome, and Itk is 
additionally bound by Slp76 to solidify the stability of the complex.  In addition to forming 
a stable signalisome, this also correctly localizes all the proteins necessary for the next 
wave of signaling.  Through Vav1, Rac-1 will activate PI3K to transform PIP3 to PIP2, 
which will be cleaved into DAG and IP3, by an Itk phosphorylated PLCγ1.  The cleavage 
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of PIP2 into DAG and IP3 represents a critical branching of signal that will activate the 
NF-κB/AP-1, and NF-AT pathways, respectfully. 
DAG will activate PKCθ, and both feed into an already Vav1/Rac-1, Ras 
activated pathway, which, through cascading kinases, will arrive at phosphorylated c-
Jun.  This pathway will also allow for phosphorylated ERK2 to undergo nuclear 
translocation and initiate the transcription and translocation of c-Fos.  Once c-Fos is 
posttranslationally modified, via phosphorylation by the cleverly named Fos kinase, it 
will dimerize with c-Jun, and translocate to the nucleus as the fully activated AP-1 
transcription factor. 
Concurrently, DAG and PDK1 will phosphorylate PKCθ, who, along with PDK1, 
ck1a, CAMKII, IKKβ, and HPK1 will all convey activating phosphate groups onto 
CARMA1.  Meanwhile, Calcineurin will begin stripping phosphate groups from Bcl-10 
(already bound to Malt1) and IKKβ will add a strategically placed phosphate group to 
Bcl-10 that will allow for the binding of CARMA1 to Bcl-10 via their CARD domains, thus 
an activated CBM complex is formed, and stabilized by CSN5, AKT2, PALS1 and 
ADAP.  The complex will keep growing in constituents by adding TRAF2/6, TAK1:TAB1, 
and two ubiquitin E2 ligases (UEV1A and UBC13) until it has all functionally active 
protein motifs to endorse the next stage of NF-κB activation. 
Once the CBM+ complex has been formed, it will set to the task of fully activating 
IKKβ (through phosphorylation by TAK1) and ubiquitinating IKKγ (through MALT1).  
This will cause the degradation of IKKγ, and release IKKβ to phosphorylate IκBα.  
Phosphorylation of IκBα marks it for ubiquitination (by UEV1A and UBC13) and 
proteosomal degradation (by the calcium activated protease, calpain); thus releasing 
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the bound heterodimers of RelA:p50 or cRel:p50 to translocate to the nucleus and 
activate transcription. 
Meanwhile, IP3 generation will release calcium from intracellular stores and open 
the CRAC channels causing a surge in extracellular calcium to influx across the 
cytoplasmic membrane.  Once Calmodulin binds calcium (and Vav1 binds Calmodulin), 
it will activate CamKII, who will then phosphorylate/activate Calcineurin.  Calcineurin is 
the phosphatase responsible for removing the phosphate groups applied to NF-AT, by 
GSK3.  With additional sumoylation, applied by an as yet undiscovered protein, NF-AT 
will nuclear translocate, where most molecules will dimerize with AP-1 to ensure proper 
transcription of immune activation related genes. 
There are several negative regulators of TCR signaling.  PTEN, HPK1 and 
SHIP1 are all phosphatases that have the ability to undermine the LAT signalisome   
Moreover Dok1 and Dok2 competitively bind the phosphorylated TCRζ ITAMS and block 
Zap70 binding and activation.  Finally, Cbl-b, itch, NEDD4, and Nedd4-2 are all ubiquitin 
ligases that encourage proteosomal degradation of signaling components at every level.  
Interestingly, these negative regulators are always present in active complexes, so 
there is always dynamic interplay between activating and deactivating signals, and TCR 
activation never proceeds at full tilt. 
As explained above, negative regulators are always present in signaling 
complexes, but they generally do not gain the upper hand until the signal has 
propagated to the next level.  While there is a great deal of overlap, in certain cases, 
there is a difference between proteins that are negative regulators (i.e. Dok) and 
proteins that are responsible for signal down regulation and termination (i.e., HeTPT). 
 
66 
 
TCR signaling is down regulated in multiple ways, several of which are modulated by 
PKCθ.  PKCθ has the ability to phosphorylate Lck (and inactivate it); it can also directly 
phosphorylate the TCR or activate the phosphatase HePTP (both of which cause 
degradation of the TCR).  Degradation of Zap70 (via the activated calcium-dependent 
protease, calpain) is also a standard route of signal down regulation.  The CBM 
complex is additionally targeted for degradation through additional phosphorylation of 
CARMA1 (by ck1a), and phosphorylation and/or ubiquitination of Bcl-10 (by CamKII and 
itch/NEDD-4, respectively.) 
 
1.6 Goal of Dissertational Research 
 The goal of this independent research has been to elucidate the variety of ways 
that T cells missing the NF-κB subunits p50 and cRel are defective with respect to TCR 
based activation, thus enhancing the knowledge base as to the roles and 
responsibilities of these two transcription factors in T cells.  Through multiple assays, 
the interrogation of these cells, in a murine - CD8 setting, evinced that additional NF-κB 
family members (IKKβ and IKKγ) were also defunct in T cells lacking p50 and cRel. 
Moreover, it appears that many of the proximal defects (reduction in phosphorylation of 
TCR associated proteins and inhibited calcium influx) discovered in these cells are 
attributable to the reduction in expression and mis-localization of IKKβ.  While later 
stage defects, such as dearth of IL-2 production and corresponding reduction in 
proliferation, appear to be the result of poor initial signaling from the TCR exacerbated 
by loss of key transcriptional units (p50 and cRel).  Figure 1.14 illustrates the lackluster 
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how we believe IKKβ has the ability to enhance WT proximal TCR signaling through 
phosphorylation of Zap70.  
 
1.7. Objectives 
 The purpose of this work is to flush out phenotypic and mechanistic deficiencies 
in T cell Activation in the absence of PKCθ and p50/cRel, as such; the following 
objectives will be undertaken: 
1. Categorize deficits in PKC-/-  and p50-/-cRel-/- CD8 T cell activation by strong 
foreign antigen in vitro and in vivo 
2. Determine defects in gene regulation during activation of PKC-/-  and p50-/-cRel-
/- CD8 T cell by strong foreign antigen in vitro 
3. Discover which transcription factors undergo ablation of nuclear translocation in 
PKC-/-  and p50-/-cRel-/- CD8 T cell by strong foreign antigen or anti-CD3/anti-
CD28 in vitro 
4. Outline differences in the ability to influx calcium between WT, PKC-/-, and p50-/-
cRel-/- CD8 T cells stimulated with strong foreign antigen or anti-CD3/anti-CD28 
in vitro 
5. Interrogate various calcium channel proteins at the mRNA and protein levels in 
unstimulated WT, PKC-/-, and p50-/-cRel-/- CD8 T cells 
6. Use multiple inhibitors of calcium channel proteins and signaling to ascertain the 
role of various calcium channel proteins in WT, PKC-/-, and p50-/-cRel-/- CD8 T 
cells stimulated with strong foreign antigen or anti-CD3/anti-CD28 in vitro 
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7. Delineate differences in phosphorylation of TCR proximal signaling proteins in 
WT, PKC-/-, and p50-/-cRel-/- CD8 T cells stimulated with or anti-CD3/anti-CD28 
in vitro 
8. Assess the amount of IKKβ and IKKγ mRNA present in unstimulated WT and 
p50-/-cRel-/- CD8 T cells.  
9. Assess the amount of IKKβ and IKKγ protein present in unstimulated WT and 
p50-/-cRel-/- CD8 T cells through western blotting and confocal microscopy. 
10. Decipher differences in surface expression of CD3, TCR, and CD45 in WT and 
p50-/-cRel-/- CD8 T cells 
11. Evaluate caIKKβ expressed in E6-1 Jurkat T cells for its ability to enhance:  
a. phosphorylation of TCR proximal proteins 
b. calcium influx 
c. activate NF-κB 
12.   Evaluate loss of IKKγ in 3T8 Jurkat T cells for its ability to ablate: 
a. phosphorylation of TCR proximal proteins 
b. calcium influx 
13.   Assess the ability of IKKβ to phosphorylate Zap70 in Hek 293 Cells 
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CHAPTER 2 
 
A NOVEL ROLE FOR NF -κB IN PROXIMAL T CELL SIGNALING, REGULATING 
CALCIUM INFLUX & ACTIVATION OF NF-AT 1 
 
2.1. Abstract 
 In the conventional paradigm of T cell activation, parallel signal transduction 
pathways activate the transcription factors NF-κB, NF-AT and AP-1 to drive clonal 
expansion of T cells in response to antigen.  Genome-wide transcriptional profiling 
following antigen-induced CD8 T cell activation revealed that genes regulated by NF-AT 
were also reduced in the absence of NF-κB p50 and cRel subunits. Importantly, p50-/-
cRel-/- CD8 T cells had significantly diminished NF-AT and AP-1 activation compared to 
WT or PKC-/- CD8 T cells. Attenuated NF-AT activation after TCR engagement was 
associated with reduced calcium influx, and subpar activation of PLCγ.  Interestingly, 
pharmacological bypass of PLCγ regulated pathways largely rescued p50-/-cRel-/- T cell 
proliferative defects. These results indicate a crucial and unexpected requirement for 
NF-κB p50 and cRel subunits in proximal TCR signaling and calcium responses. They 
further suggest that key defects in T cells in the absence of NF-κB pathway components 
                                                          
1 Portions of this chapter have been previously published in the European Journal of Immunology, and 
have been reproduced here with permission from Wiley Science.    Additionally, all work presented herein 
was performed by Crystina Bronk, with the exception of the loading of the Microarray Chip and the 
Microarray Analysis which was performed by Sean Yoder. 
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may not be solely due to defunct gene transcription, but may also be due to impaired 
proximal T cell signaling defects.   
 
2.2. Introduction  
T cell activation is initiated by TCR binding to an MHC molecule loaded with 
cognate peptide and presented by professional Antigen Presenting Cells (APC) such as 
Dendritic Cells (DC).  This interaction initiates a signaling cascade requiring several key 
kinases, phosphatases, and scaffolding proteins that together drive T cell activation 
[191].  Two  key events in activation are phosphorylation of Zap70, which nucleates the 
formation of the LAT signalisome [192]  and phosphorylation of PLCγ1, which then 
cleaves PIP2 into IP3 and DAG [193].  IP3 is crucial for calcium influx which in turn is 
necessary to activate the NF-AT transcription factor [193]. On the other hand, DAG 
activates PKCs which are thought to be important for activation of the transcription 
factors AP-1 and NF-κB [108, 194]. These seemingly parallel cascades of transcription 
factors lead to induction of key genes necessary for T cell proliferation, survival and 
cytokine production.  
Canonical NF-κB signaling is initiated when CARMA1 forms a complex with 
Bcl10 and Malt1 [195, 196], which allows it to bind IKK complex proteins.  Of the three 
IKKs, α/β/γ, IKKβ is primarily responsible for phosphorylating IκBα, an inhibitory protein 
responsible for cytoplasmic retention of NF-B [197]. The phosphorylation of IκBα 
marks it for degradation leading to release of bound transcriptionally active 
heterodimers consisting of either p50+RelA or p50+cRel [197].  Studies of T cells have 
shown redundancy in function of these NF-κB subunits. While combined absence of 
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p50+RelA subverts mature T cell differentiation, the absence of p50+cRel does not 
impact thymic development, but instead impairs T cell function [198, 199].  PKC activity, 
in particular PKC, was believed to be crucial for NF-κB activation. However, recent 
studies, including our own, suggest that NF-ΚB can be activated in the absence PKC if 
T cells are activated by professional APC such as DCs [200]. Importantly, we also found 
that PKC-/- or p50-/-cRel-/- T cells are both incapable of initiating GVHD in allogenic 
recipient mice [200].   It is however not clear whether this impairment in alloreactivity is 
due to defects in similar or distinct signaling pathways. In particular, PKC deficiency 
negatively impacts NF-AT activation which likely contributes to the observed functional 
defects in PKC T cells [201].  
In the accepted paradigm of T cell activation, proximal T cell signaling mediators 
such as Zap70 and PLCγ drive induction of downstream transcription factors. While 
investigating signaling defects in PKC-/- and p50-/-cRel-/- CD8 T cells in response to 
foreign antigen in a syngenic model of infection, we surprisingly found that activation of 
transcription factors NF-AT and AP-1 were severely impaired in p50-/-cRel-/- T cells. This 
defect was traced to impairment in calcium influx and sub-optimal PLCγ activation. 
Importantly, proliferative defects in p50-/-cRel-/- T cells were largely rescued through 
pharmacological bypass of PLCγ. These important findings reveal an unexpected role 
for NF-κB in regulating proximal T cell signaling and further indicate that functional 
impairment created by the absence of NF-κB in T cells is also due to defects in 
activation of upstream signaling mediators. 
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2.3. Methods and Materials 
 
2.3.1. Mice and Primary T cells 
PKCθ-/-, OT-1 transgenic, and p50-/-cRel-/- mice have all been described 
previously [200].  All mice were maintained under specific pathogen free conditions, and 
all experiments using mice were carried out in accordance with institutional guidelines. 
T cells were isolated from spleens of control and experimental mice by CD4 and CD8 
MACS beads (Miltenyi Biotec), and cultured in RPMI supplemented with  10% FBS, L-
glutamine (2mM), Penicillin/Streptomycin (100 U/ml), β2ME (50mM), and Non-essential 
AA, Sodium Pyruvate, and HEPES (all 1mM). OT1 T cells were stimulated with BMDCs 
pulsed with 1μM SIINFEKL peptide.  Briefly, Bone Marrow cells were flushed from the 
Femurs and Tibias of WT.B6 (syngenic) mice and after red blood cell lysis, the 
remaining cells were cultured at 1e^6/mL/well of 24 plate in the presence of supernatant 
(3% vol/vol) from J558L cells transduced with murine GM-CSF in RPMI supplemented 
with  5% FBS, L-glutamine (2mM), Penicillin/Streptomycin (100 U/ml), β2ME (50mM), 
and Non-essential AA, Sodium Pyruvate, and HEPES (all 1mM) for one week, with 
media change every other day.  BMDCs were harvested through repeat pipetting, 
placed on low attachment plates at 1e^6 /mL / well, and reharvested 24 hours later.  
Cells were then harvested, again, placed in 15mL eppindorf tubes and incubated at 37˚ 
with the peptide for at least 3 hours.  Occasionally OT-1 T cells and all polyclonal cells 
were stimulated with either 1 or 10μg anti CD3/CD28 (ebioscince) and/or 50ng Phorbol 
12-Myristate 13-Acetate (PMA) and 500ng ionomycin (both Fisher) depending on assay. 
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2.3.2. T cell Proliferation Assay 
T cells were incubated at 1e5/ well in 96 well plates with culture medium and 
stimulants where indicated for 48 – 72 hours at 37ºC.  1μCi of Thymidine was added for 
the last 12 hours of culture.  Plates were flushed onto fiberglass plates and Microscint 
(both Perkin Elmer) was applied and read on the Top Count NXT (Packard) scintillation 
counter.   
 
2.3.3. In Vivo T cell Expansion and FACS Analysis 
OT-1+/CD45.2+/CD8+ T cells from WT, PKCθ-/-, and p50-/-cRel-/- mice were 
isolated from the spleen, and 1e6 were transplanted into CD45.1 immune competent 
hosts.  24hours later, the transplant and control mice were injected, IP, with 100μg 
OVA, 100μg anti-CD40, and 50μg PolyIC. Peripheral blood was acquired through 
submandibular bleed every 7 days thereafter.  Peripheral blood was RBC lysed (ACK 
Buffer – Fisher) and FC blocked (eBioscience). WBCs were then stained with CD45.1, 
CD45.2, and CD8 (eBioscience) and KB-OVA tetramer (MLB International) in PBS 
(Fisher) supplemented with 0.5% Bovine Serum Albumin, BSA (Sigma) for 30m on ice.  
Finally, cells were washed twice and data was collected on an LSRII (Beckman 
Dickinson) and analyzed with FlowJO 9.6 (TreeStar).  Gating strategy isolated only 
single cells (through Forward and Side Scatter) and DAPI- (live) cells. 
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2.3.4. Microarray Studies 
 
2.3.4.1. Sample Processing for Microarray Analysis  
One hundred nanograms of total RNA served as the mRNA source for 
microarray analysis.  The poly(A) RNA was converted to cDNA and then amplified and 
labeled with biotin using the Ambion Message Amp Premier RNA Amplification Kit (Life 
Technologies, Grand Island, NY) following the manufacturer’s protocol initially described 
by Van Gelder et al[202].  Hybridization with the biotin-labeled RNA, staining, and 
scanning of the chips followed the prescribed procedure outlined in the Affymetrix 
technical manual as described previously [203].  
 
2.3.4.2. Probe Arrays    
The oligonucleotide probe arrays used were the Mouse Genome 430 2.0 Arrays.  
This array contains over 45,000 probe sets designed from GenBank, dbEST, and 
RefSeq sequences that were clustered based on build 107 of the UniGene database.  
The clusters were further refined by comparison to the publicly available draft assembly 
of the mouse genome.  An estimated 39,000 distinct transcripts are detected including 
over 34,000 well substantiated mouse genes.  Each gene is represented by a series of 
oligonucleotides that are identical to the sequence in the gene as well as 
oligonucleotides that contain a homomeric (base transversion) mismatch at the central 
base position of the oligomer, which is used to measure cross-hybridization. 
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2.3.4.3. Data Analysis  
Scanned output files were visually inspected for hybridization artifacts and then 
analyzed using Affymetrix GeneChip Operating Software (GCOS) using the MAS 5.0 
algorithm. Signal intensity was scaled to an average intensity of 500 prior to performing 
a comparison analysis between paired samples.  Using the default settings, the GCOS 
software identifies the increased and decreased genes between any two samples with a 
statistical algorithm that assesses the behavior of 11 different oligonucleotide probes 
designed to detect the same gene [204].   
Several comparisons were performed in order to identify the genes that changed 
in response to stimulation with the OVA peptide.  First, genes that were affected by 
OVA treatment were identified in the wild-type mice, and then this list was further 
enriched for the genes were differentially expressed at an even greater degree in the 
knock-out mice after OVA treatment.  Probe sets that yielded a change p-value less 
than 0.05 between each pair of conditions, and with a fold change of greater than 1.4 
(increased or decreased) were identified as changed.  A gene was identified as 
consistently changed if it was identified as changed in all replicate experiments.  Lastly, 
genes that showed expression at or below background levels across all conditions 
signal intensity below 100) were filtered from the final list.  Data from the resulting lists 
of differentially expressed genes were visualized in the form of heat maps using the 
Cluster 3.0 and Java TreeView software applications [205, 206].  
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 2.3.5. Calcium Assay 
T cells were suspended at 1e6/mL in Calcium Buffer (No-Phenol Red RPMI 
(Fisher) with 2%FBS and 10% Probenecid (Thermo-Scientific)) and stained with 4μM 
Fluo-4 (Invitrogen) for 45m at 37˚C.  They were washed three times in Calcium Buffer 
(above) and replated at 2e5/well in a 96 well flat-bottom plate.  Cells were then rested 
for 20m at RT, and incubated at 37˚C for 10m immediately preceding the assay.  Where 
indicated, cells received the following: 10μg/mL anti-CD3/CD28 (mouse & human-
ebioscience), 500ng ionomycin (Fisher), and 3mM EGTA (Sigma). Samples were read 
on a Wallac EnVision 2102 Multilabel Reader from Perkin Elmer. 
 
2.3.6. Electrophoretic Mobility Shift Assay (EMSA) 
2 X 107 cells were washed in PBS then suspended in 10mM HEPES (pH7.9), 
10mM KCL, 0.1mM EDTA, 0.3% NP-40, and 1x Protease inhibitors for 5min. at 4°C, 
then centrifuged for 5 min at 1600g.  The supernatant (cellular extract) was removed 
and the remaining pellet was washed twice in the above buffer (minus the NP-40.)  
Finally the pellet was suspended in 20mM HEPES (pH7.9), 0.4M NaCl, 1mM EDTA, 
25% Glycerol, and vortexed intermittently as it incubated for 10min. at 4°C.  After 
centrifugation (16,000g for 5min.,) the supernatant (nuclear extract) was collected.  
To assay NF-κB activity, the following hairpin oligonucleotide probe was used: 
GAGAGGGGATTCCCCGATTACCTTTCGGGGAATCCCCTCT.  NF-AT: F-
ACGCCCAAAGAGGAAAATTTGTTTCA; R-TGTATGAAACAAATTTTCCTCTTTGGG.  
Briefly, the oligonucleotide probe was annealed and end-labeled with Gamma-ATP 
using T4 polynucleotide kinase according to the manufacturer’s instructions (New 
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England Biolabs). Labeled probes (100,000cpm/rxn) were incubated with 5μg of nuclear 
extracts, Binding Buffer (50mM Tris (pH7.6), 250mM NaCl, 2.5mM EDTA, 5mM DTT, 
1mg/mL BSA, 25% Glycerol) and 1µg poly-dIdC for 20min at room temperature and 
separated on a 10% non-denaturing polyacrylamide gel with 0.25X TBE running buffer. 
After electrophoresis, DNA-protein complexes were dried for two hours onto 3MM 
Chromatography paper (Whatman.)  The paper was then exposed to film for 4 - 18 
hours. 
 
2.3.7. Relative Quantitative RT-PCR (RT-qPCR) 
Table 2.1 Primer Sequences 
Gene  Forward Sequence Reverse Sequence 
18S rRNA TCAAGAACGAAAGTCGGAGG GGACATCTAAGGGCATCACA 
P2PX1 CGTCATCGGGTGGGTGTTTCTCTA AGGGCGCGGGATGTCGTCA 
P2PX4 CGGGACCCACAGCAACGGAGTCT TGTATCGAGGCGGCGGAAGGAGTA 
P2PX7 CCGGCCACAACTACACCACGAG GGCCAGACCGAAGTAGGAGAGG 
ORAI CATAAGGGCATGGATTACCG CGGGTACTGGTACTGCGTCT 
STIM1 CTCTAACACGCCCACCTCST CTTCCTGTGCCTTTTCAAGC 
CTLA-4 CAGGTGACCCAACCTTCAGT CAGTCCTTGGATGGTGAGGT 
IL-17 ATCCCTCAAAGCTCAGCGTGTC GGGTCTTCATTGCGGTGGAGAG 
 
Total RNA was extracted with the RNeasy Plant Kit (Qiagen), according to the 
manufacturer’s instructions. cDNA was synthesized from total RNA (0.2 μg) using the 
TaqMan® ReverseTranscriptase kit (Applied Biosystems). All RT-qPCR reactions were 
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performed in an ABI Prism 7300 Sequence Detection system (Applied Biosystems,) with 
Power SYBR® according to SYBR protocol (Applied Biosystems).  All experiments were 
conducted in triplicate and SDs are indicated in the figures.  The primers used were IL-
2, IL-21, and IFNγ (Realtime Primers) and the following sequences from IDT DNA: 
 
2.3.8. Western Blotting 
Whole Cell Extracts were prepared in 25mM Tris-HCl pH7.6, 2mMEDTA, 150mM 
NaCl, 0.5% NP-40, (Lysis Buffer) with late addition of 1mM PI, DFP, NaF, and NaVO3.  
A Bradford Assay (Applied Biosystems) was performed to standardize proteins on the 
DU 350 (Beckman Coulter) and samples were mixed with a 0.5% SDS loading buffer 
(Fisher) and run on a 10% acrylimide-bis gel and transferred to nitrocellulose paper.  
Membranes were blocked in Tris-buffered saline, 0.1% Tween 20 (TBS-T) with 3% BSA 
and 2% Milk (Carnation).  Then blots were incubated overnight at 4˚C with primary 
antibodies at 1:1000 in 5%BSA.TBS-T. After three TBS-T washes, the membrane was 
incubated with the proper secondary at 1:3000 in 5%Milk.TBS-T for 1.5 hours at room 
temperature. The specific bands were revealed by chemiluminescence (Western 
Lightning ® Plus-ECL, Perkin Elmer) and visualized by autoradiography (Amersham 
Hyperfilm-ECL, GE). Before reprobing, blots were stripped by incubation in 0.1 M 2-
mercaptoethanol, 2% SDS, 62.5 mM Tris-HCl (pH 6.8) for 30 min at 65˚C and the 
process began again, with blocking.  Primary western antibodies include: p65, NF-ATc1 
(Santa Cruz), ORAI (ProSci Incorporated), PLCγ1 (BD), pPLCγ1 (Y783), STIM1, anti-c-
Jun (9165) (Cell Signaling). HRP conjugated-β-actin, and all secondary antibodies 
(mouse, rabbit, and goat) were from Santa Cruz. 
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2.3.9. Statistical Analysis 
 All figures represent results from at least two (usually three) independent 
experiments.  When appropriate, data is given as the mean ± standard deviation.  P 
values are expressed as  
 
2.4. Results 
 
2.4.1. p50-/-cRel-/- CD8 T cells Exhibit Pronounced Clonal Expansion Defects In 
Vitro and In Vivo 
In previous studies, we found that absence of either PKC or p50 and cRel in T 
cells greatly impairs GVHD in allogenic recipients [200]. To better understand the roles 
of these proteins in regulating T cell function in response to cognate antigen, we 
crossed PKC-/- and p50-/-cRel-/- mice to OVA257-264 (SIINFEKL) specific OT1 TCR Tg  
mice. Stimulation of CD8 T cells from these mice with SIINFEKL (OVA) peptide-pulsed 
dendritic cells (DC) showed that while PKC-/- T cell proliferation was reduced compared 
to WT T cells, the most severe defect in proliferation was in p50-/-cRel-/-  T cells (Fig. 
2.1A).  In addition, IL-2 mRNA expression (used as a marker for activation of T cells) 
was also most significantly reduced in p50-/-cRel-/- T cells (Fig. 2.1B). Therefore, p50-/-
cRel-/- T cells have a more significantly defective in vitro proliferation response and 
greatly reduced IL2 expression compared to PKC-/- T cells. 
To determine the in vivo effect of T cell-specific absence of p50+cRel and PKC, 
we adoptively transferred CD45.2+/OT1+ WT, PKC-/- or p50-/-cRel-/-  CD8 T cells into 
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congenic WT CD45.1+ hosts.  24h later, CD45.2 transplant recipients, along with naïve 
CD45.1 mice, received TriVax, a vaccine formulation with peptide, anti-CD40, and 
PolyIC [207].  Every 7 days, thereafter, peripheral blood samples were acquired and 
analyzed to assess the degree of clonal expansion. As expected, WT T cells expanded 
vigorously, and by day 7, 60% of peripheral WBCs were the transplanted CD45.2- OVA-
specific T cells. Mirroring in vitro findings, PKC-/- T cells expansion was significantly  
reduced; however, the greatest impairment in expansion was in p50-/-cRel-/-  T cells (Fig. 
2.1C) which was evident at all time-points tested (Fig. 2.1D).  
Detrimental consequences of activation of large numbers of T cells are well 
documented (e.g., in the context of super-antigen administration or adoptive cell therapy 
with anti-tumor T cells [208] ).  To this effect, injection of BiVax (100μg OVA and 50μg 
PolyIC) vaccine 38 days after initial TriVax treatment of WT OT1 transplanted mice 
resulted in death of all four WT mice at day 3 (Fig 2.1E).  The PKC-/- group survived 
somewhat longer, and had to be euthanized on day six due to IACUC governing of 
moribund state; in contrast, mice receiving p50-/-cRel-/- T cell were completely protected 
from lethal effect of T cell re-stimulation. Interestingly, even the severely repressed 
proliferation of the p50-/-cRel-/- - OT1 transplanted T cells was enough to squash the 
endogenous proliferation, as shown in Figure 2.1F, in 85% of mice.  These results 
indicate that absence of p50+cRel results in substantially more pronounced impairment 
of T cell activation than PKCθ absence.  Thus, overall signaling responses controlled by 
p50+cRel may be distinct from those regulated by PKCθ, even though they are 
colloquially placed in the same pathway.  
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2.4.2 Differential Impact of p50+cRel versus PKCθ Absence on Activation-Induced 
Gene Expression in T cells 
 To develop a broader understanding of the consequences of p50-/-cRel-/- and 
PKCθ-/-, we performed genome-wide analysis of gene expression. To this end, OT1 
CD8 T cells from WT mice were co-cultured with un-pulsed DC and OT1 CD8 T cells 
from the three different genotypes were stimulated with SIINFEKL-pulsed DC, at 18h,  
we utilized magnetic column sorting to deplete DC from the culture, and mRNA from 
remaining T cells was used for microarray using Affymetrix Mouse Genome 430 2.0 
Array platform. First, genes that were affected by OVA peptide DC treatment versus no 
peptide (unstimulatory) DC were identified in the WT mice. Probe sets that yielded a 
change (p-value less than 0.05) between each pair of conditions, and with a fold change 
of greater than 1.4 (increased or decreased) were identified as changed.  In addition, a 
gene was identified as consistently changed if it was identified as changed in replicate 
experiments.  Lastly, genes that showed expression at or below background levels 
across all conditions (signal intensity below 100) were filtered from the final list. Using 
the above criteria, we identified genes differentially regulated in OVA-DC stimulated 
PKCθ-/- or p50-/-cRel-/- T cells compared to OVA-DC stimulated WT T cells.  
Out of a total of 45,101 probe sets, 10,400 were changed after WT T cell 
activation, with 4144 up-regulated and 6256 down-regulated in 2 replicate experiments. 
Focusing on the up-regulated 4144 probe sets, expression of 73 (corresponding to 55 
known genes; Table 2.2) was impaired in PKCθ-/- while 146 probe sets (112 genes; 
Table 2.2) were impaired in p50-/-cRel-/- T cells. A modest level of overlap in PKCθ and 
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Interestingly, in addition to IL2, transcription of several genes known to be regulated by 
calcium/NF-AT signaling, including IL3, STAT5B, IFNγ and CTLA4 [209-211] were 
found to be reduced in p50-/-cRel-/- T cells. These results are suggestive of potentially 
broader defects in absence of p50+cRel and, in particular, warranted a closer 
examination of NF-AT/calcium signaling in p50-/-cRel-/- T cells.  
 
2.4.3. p50-/-cRel-/- T cells Have Defects in NF-AT and AP1 Activation and Calcium 
Influx 
 We next determined activation of NF-AT, AP-1 and NF-κB in CD8 T cells from all 
three genotypes after stimulation with OVA-pulsed DCs.  WT T cells showed strong 
nuclear translocation of all three transcription factors (Fig. 2.3A) when stimulated with 
OVA-pulsed DC. Consistent with our previous results, NF-κB levels were not 
significantly impacted in PKC-/- T cells [200]; however, a more substantial reduction in 
NF-AT and AP-1 was seen (Fig. 2.3A).  As expected, p50-/-cRel-/- T cells showed 
significant reduction in NF-κB activity. Remarkably, both NF-AT and AP-1 levels were  
also greatly reduced in p50-/-cRel-/- T cells (Fig. 2.3A). A similar trend was also seen in 
polyclonal CD8 T cells from WT, PKCθ-/-, and p50-/-cRel-/- mice that were stimulated with 
anti-CD3/CD28 (Fig. 2.3B). Interestingly, in the polyclonal setting, p50-/-cRel-/- T cells 
underperformed PKCα-/-θ-/- T cells; even though this somewhat redundant duo of 
classical and novel PKC isoforms is known to impact all three major transcription factors 
[212].  In addition, western blotting of nuclear extracts showed greatly reduced presence 
of NF-ATc1 in p50-/-cRel-/- T cells after anti-CD3/CD28 stimulation (Fig. 2.3C). The 
reduction in NF-AT induction was, in fact more pronounced than that of NF-κB RelA/p65 
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As NF-AT activation requires calcium signals [213], we next determined calcium 
influx in T cells after stimulation. WT T cells showed rapid increase in calcium influx 
when stimulated with anti-CD3/CD28 (Fig. 2.3D). Importantly, calcium influx was 
reduced in PKC-/- but the reduction was most severe in p50-/-cRel-/- T cells. Additionally, 
this defect was preserved when cells were treated with thapsigargin (a SERCA pump 
inhibitor that forces activation of the CRAC pathway of calcium influx), Fig. 2.3E, 
demonstrates that even forced influx of calcium in PKCθ-/- and p50-/-cRel-/- CD8 T 
cells cannot achieve the capacity seen in WT CD8 T cells. We next determined calcium 
influx in T cells after stimulation with un-pulsed or OVA-pulsed DCs. WT T cells 
stimulated with OVA-pulsed DC showed substantially enhanced calcium influx 
compared to T cells with un-pulsed DCs (Fig. 2.4A). This difference was substantially 
reduced in PKC-/- T cells (Fig. 2.4B). Strikingly, no difference in calcium influx was seen 
in p50-/-cRel-/- T cells stimulated with un-pulsed versus OVA-pulsed DCs (Fig. 2.4C). In 
the above studies, we determined calcium influx after TCR engagement of naïve T cells. 
However, calcium influx is also important for continued T cell proliferation and cytokine 
expression [193, 214]. Importantly, calcium influx was also substantially reduced in p50-
/-cRel-/-  T cells post 48h stimulation with 1µg/mL anti-CD3/CD28 (Fig. 2.4D), although 
some recovery was evident.  Moreover, it appears that, at least for calcium influx, p50 
and cRel serve a redundant function as knock out of each NF-κB family member, 
independently, led to only a mild reduction in calcium influx, as shown in Figure 2.4E.  
Additionally, the mild depression of calcium influx in each of the single knock outs was 
mirrored by only a slight decrease in proliferation (Fig. 2.4F).  Together, our results 
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extracellular calcium is primarily mediated by calcium release-activated calcium (CRAC) 
channels. Two key regulators of calcium influx are STIM1/2 (ER Ca2+ sensors) and 
ORAI (a subunit of the CRAC channel) [193, 214]. Previous studies have implicated NF-
κB as regulating both STIM1 and ORAI expression in fibroblasts [215]. However, we did 
not see any reduction in STIM1 or ORAI mRNA (Fig. 2.5A) or protein (Fig. 2.5B) 
expression in unstimulated p50-/-cRel-/- T cells.  Moreover, we could not ascertain any 
differences between mRNA of the puronergic calcium channels either (Fig. 2.5C) 
suggesting that calcium influx defects are more likely associated with impairment in 
proximal TCR signaling.  
Upon TCR engagement, PLCγ1 cleaves PIP2 into IP3 (leading to calcium influx 
and NF-AT activation) and DAG (leading to PKC and AP-1/NF-κB activation).  Since 
p50-/-cRel-/- T cells have defects in both NF-AT and AP-1 activation, we next determined 
whether this was due to impaired PLCγ1 activation.  While total PLCγ1 levels were 
equivalent, a decrease in activation-induced phosphorylation (Y783) in pPLCγ1 was 
seen in p50-/-cRel-/- CD8 T cells (Fig. 2.5D). These results suggest that defects in 
proximal TCR signaling in p50-/-cRel-/- T cells may be responsible for defects in 
calcium/NF-AT and AP-1 activation.  Since calcium/NF-AT and AP1 also contribute to T 
cell activation and proliferation, we hypothesized that observed defects in p50-/-cRel-/- T 
cells may also be due to impaired PLCγ signaling rather than p50+cRel absence per 
se. To test this possibility, we used two agents that can bypass the need for activated 
PLCγ1 mediated IP3 and DAG generation: ionomycin (IO; calcium ionophore) and PMA 
(PKC inducer).  It is worth mentioning that while the actual second messengers DAG 
and IP3 are molecules that endure extreme turnover rates, and are marked easily for 
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degradation, the pharmalogical mimetics PMA and Ionomycin do not suffer the same 
fate.  Therefore, using this approach not only generates stronger initial activation of the 
PKC and calcium pathways, but continues to signal, long after the endogenous second 
messengers would have been destroyed and down regulated [216]. 
Intriguingly, IO+PMA largely rescued the proliferative defects in p50-/-cRel-/- T 
cells (Fig. 2.5E).   Moreover, the use of IO+PMA also had the ability to enhance calcium 
influx in the p50-/-cRel-/- CD8 T cells, almost to WT levels (Fig. 2.5F).  Additionally, this 
increase in calcium led to the corresponding increase in NF-AT and AP-1 nuclear 
translocation, as shown in Figure 2.5G.  Therefore, a significant component of defects in 
proliferation of p50-/-cRel-/- T cells stem from impaired proximal T cell signaling leading 
to activation of PLCγ1. Importantly, these results further indicate that key defects in T 
cell responses in the absence of NF-κB pathway components can be due to defects in 
proximal T cell signaling.  
 
2.5. Discussion 
Our results show an unexpected function of NF-κB in calcium influx and NF-AT 
activation.  We further show that this function is at least partly controlled through optimal 
activation of the crucial T cell signaling protein: PLCγ. Pharmacological rescue of p50-/-
cRel-/- T cell calcium influx, transcription factor nuclear localization, and proliferation 
evinced that a substantial component of defects in these cells are due to impaired 
PLCγ activation. However, we do not believe that p50-/-cRel-/-  cells are universally 
incapable of activation-induced signaling: first, expression of only a small set of 
transcripts was impacted in p50-/-cRel-/- T cells (3.5%) indicating that the vast majority of 
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activation-induced genes are not impacted. Second, rescue by IO+PMA indicates that 
p50-/-cRel-/- T cells are fully capable of robust proliferative responses, if stimulated in a 
manner that bypasses specific functional defects. Our results also indicate the novel  
function for NF-κB described here appears to be redundantly controlled by p50 and 
cRel, since CD8 T cells lacking either p50 or cRel showed only a slight reduction in 
calcium influx and proliferation.   
A key question is how PLCγactivation and calcium/NF-AT signaling is regulated 
by NF-κB. Given the fact that calcium influx was measured minutes after stimulation, it 
is unlikely that this is due to defective gene induction by activation-induced NF-κB. 
Instead, regulation of calcium influx likely represents a function for constitutive NF-κB 
activity.  We believe that similar, albeit less severe, defects in PKC-/- T cells seen here 
may suggest some possible answers. Both NF-κB subunits and PKC associate with 
the IKK complex [194], which is comprised of IKKα/β/γ. Importantly, IKKβ/γcan localize 
to the immune synapse (IS) where the key proximal signaling events are initiated [217, 
218]. It is possible that absence of either PKCθ or NF-κB subunits can somehow impact 
IKKβ/γ activation, localization, or stability. While IS presence of IKKβ is thought to be 
crucial for NF-κB activation, it is interesting to speculate that IKKβ regulates additional 
events in TCR signaling, which are adversely impacted by PKC or p50+cRel absence.  
Regardless of the precise mechanism, our results demonstrate a crucial role for NF-κB 
p50 and cRel subunits in calcium/NF-AT signaling that is mediated through optimal 
activation of the proximal TCR signaling mediator, PLCγ. Previous studies have 
defined a crucial role of the NF-κB pathway in promoting T cell survival [197]. The 
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results shown here indicate that in addition to promoting survival, NF-κB is also crucial 
for early T cell activation responses.  
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CHAPTER 3 
 
LOSS OF p50 AND cRel LEAD TO REDUCTION OF IKKβ AND DEFICIENT 
PHOSPHORYLATION OF PROXIMAL TCR SIGNALING PROTEINS2  
 
3.1. Abstract 
 In the accepted model of T cell activation, signals are transduced in a feed-
forward direction, and although there have always been negative and positive feedback 
loops, it is generally thought that downstream molecules do not impact upstream 
precursors during the first original signaling cascade.  In the previous chapter, I 
demonstrated that p50-/-cRel-/- CD8 T cells had significantly diminished NF-κB, NF-AT 
and AP-1 activation compared to WT or PKCθ-/- CD8 T cells, and was able to 
demonstrate that this was a direct result of reduced phosphorylation / activation of 
PLCγ1, leading to attenuated calcium influx.  In our current work, we focused on the 
molecular basis of sub optimal PLCγ1 activation, and discovered that both LCK and 
Zap70, and subsequently LAT phosphorylation were also reduced in the p50-/-cRel-/- T 
cells.  Importantly, we were also able to show that loss of p50 and cRel reduced IKKβ 
and IKKγ at both the mRNA and protein levels in murine, naïve CD8 T cells.  By 
expanding our study to Jurkat T cells, we teased apart the impact of IKKβ and IKKγ on 
proximal TCR signaling. Where, with the KO of IKKγ (and reduction of the IKK complex 
                                                          
2Portions of this chapter have been previously published in the European Journal of Immunology, and 
have been reproduced here with permission from Wiley Science.      
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as a whole), we correctly phenocopied the p50-/-cRel-/- T cell’s defects in activation.  
Moreover, through expression of a constitutively activated IKKβ (IKKβEE), we were able 
to generate the opposite phenotype, and increase proximal TCR protein 
phosphorylation and activation of Jurkat T cells. Finally, through transduction of Zap70 
and IKKβEE in Hek293 cells, we were able to show that IKKβ can phosphorylate Zap70 
in vitro. These results indicate a crucial and unexpected requirement for NF-κB subunits 
p50 and cRel in the stability and correct localization of the IKK complex; furthermore, 
they demonstrate an important role for IKKβ in the enhancement of proximal TCR 
signaling leading to greater calcium influx and fully activated NF-AT and NF-κB. 
 
3.2. Introduction 
 T cell signaling through the TCR is an extremely flexible, yet highly regulated, 
process that requires not only the correct subcellular localization of a myriad of proteins, 
but that several of these proteins be phosphorylated or dephosphorylated to propagate 
the chain.   Interestingly, the Weiss lab demonstrated that quite a bit of TCR signaling 
occurs in the basal state of naïve T cells, in the absence of TCR binding to an MHC 
loaded with a cognate peptide [19].  This assertion explains the rapid response rate of T 
cells when faced with antigen, as they have several components of the signaling chain 
already in an “on” position.  This also creates a space in which proteins are in constant 
flux of being phosphorylated and dephosphorylated and shuttled in and out of varying 
subcellular locations as complexes are created and dissolved moment to moment. 
.   Moreover, it is well documented that basal activation of NF-κB is required for T 
cell survival and homeostasis [94, 219].  Because several of the pathways activated by 
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NF-κB to promote survival involve proteins that also overlap with signaling chains 
eliciting activation of T cells, and because previous results had shown grave defects in 
the activation of p50-/-cRel-/- T cells, we hypothesized that NF-κB activity in the basal 
state of T cells could also positively impact T cell activation at the earliest of time points. 
Utilizing the OT1 transgenic trope, we previously evinced that our p50-/-cRel-/- 
CD8 T cells fell prey to a grave reduction in proliferation and cytokine production in 
response to strong antigen (both in vitro and in vivo.)  We further elucidated that these 
cells also had impaired activation of NF-AT, which appeared to be sequela to abrogated 
calcium influx and a diminution of PLCγ1 phosphorylation.  In the current work, we 
continued to catalogue additional proximal signaling proteins that showed a reduction in 
phosphorylation/activation.  To this end, we discovered that LCK, Zap70, and LAT 
phosphorylation were also impaired in the p50-/-cRel-/- T cells.  Furthermore, we 
discovered that absence of p50 and cRel negatively impacted the IKK complex leading 
to a reduction in the mRNA and protein levels of IKKβ and IKKγ, while concurrently 
showing that less IKKβ localized to lipid rafts in p50-/-cRel-/- T cells, in a basal state.  
By exploiting the human, CD4 Jurkat T cell lines (3T8 & E61) we were able to 
demonstrate that the defects in phosphorylation of proximal signaling proteins displayed 
in the p50-/-cRel-/- T cells were likely due to the paucity of the IKK complex, as 
knockdown of IKKγ (and the resulting complex degradation) recapitulated the activation 
defects in the p50-/-cRel-/- T cells.  Moreover, expression of a constitutively active IKKβ 
(IKKβEE) resulted in enhanced phosphorylation of proximal signaling proteins and 
activation of T cells.  Additionally, the use of an NF-κB super repressor, IκBα, had no 
effect on proximal phosphorylation or other early activation events, validating paucity of 
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the IKK Complex as the perpetrator of decreased TCR signaling, not the lack of NF-κB 
activation.   Finally, in a separate in vitro system, utilizing Hek 293 cells, we were able to 
show that IKKβ can directly phosphorylate Zap70.  
 
3.3. Methods & Materials 
 
3.3.1. Mice and Primary T cells 
OT-1 transgenic, and p50-/-cRel-/- mice have all been described previously 
[200].  All mice were maintained under specific pathogen free conditions, and all 
experiments using mice were carried out in accordance with institutional guidelines. T 
cells were isolated from spleens of control and experimental mice by CD4 and CD8 
MACS beads (Miltenyi Biotec), and cultured in RPMI supplemented with  10% FBS, L-
glutamine (2mM), Pennicillian /Streptomycin (100 U/ml), β2ME (50mM), and Non-
essential AA, Sodium Pyruvate, and HEPES (all 1mM).   OT-1 and polyclonal CD8 T 
cells were stimulated with either 1 or 10μg anti CD3/CD28 (ebioscince) and/or 50ng 
Phorbol 12-Myristate 13-Acetate (PMA) and 500ng Ionomycin (both Fisher) depending 
on assay. 
 
3.3.2. Cultured Cells, Transfections, and Infections 
The parental 3T8 cells and 3T8 cell lines transduced with IKKγ K.D. (3T8.8221) 
and GST (3T8.8221.11), and IKKγ put back (3T8.8221.16) were a kind gift from Dr. 
Adrianne Chang.  Jurkat E6-1 Cells were purchased from the ATCC and both Jurkat 
subsets were cultured in RPMI supplemented with 10% FBS, penicillin (100 U/ml), 
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streptomycin (100 U/ml), and L-glutamine (2 mM). Hek293 T cells were purchased from 
the ATCC and cultured in DMEM supplemented with 10% FBS, penicillin (100 U/ml), 
streptomycin (100 U/ml), and L-glutamine (2 mM). All transient (Hek293 – HA-Zap70, 
MiG, and IKKβEE) and stable (Jurkat - MiG, IκBα, and IKKβEE - described here) ([220]) 
transfections were performed using Fugene 6 (Roche Diagnostic Systems).  Briefly, 
25μL of Fugene was incubated with RPMI for 5m at RT.  Mixture was then added to 
plasmid DNA and incubated for 15m at RT.  Finally plasmid and Fugene were added to 
Cells and incubated overnight.  Cells were sorted or used 48 hours post transfection.  
Stable transfection of the Jurkat T cell line was accomplished through initial transfection 
of the MiG, IκBα, or IKKβEE plasmids into Hek293 cells with 4μg of the pCL-Eco 
packaging vector and Fugene 6.  Cells were cultured for 48h, and viral containing 
supernatant was collected.  This Retrovirus was used to infect the E6-1 Jurkat cells 
using high speed centrifugation.  Lines were confirmed and  established through sorting 
and expanding of GFP positive Cells for the MiG, IκBα, and IKKβEE Jurkat lines.   
 
3.3.3. Electrophoretic Mobility Shift Assay (EMSA) 
2 X 107 Cells were washed in PBS then suspended in 10mM HEPES (pH7.9), 
10mM KCL, 0.1mM EDTA, 0.3% NP-40, and 1x Protease inhibitors for 5min. at 4°C, 
then centrifuged for 5 min at 1600g.  The supernatant (cellular extract) was removed 
and the remaining pellet was washed twice in the above buffer (minus the NP-40.)  
Finally the pellet was suspended in 20mM HEPES (pH7.9), 0.4M NaCl, 1mM EDTA, 
25% Glycerol, and vortexed intermittently as it incubated for 10min. at 4°C.  After 
centrifugation (16,000g for 5min.,) the supernatant (nuclear extract) was collected.  
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To assay NF-κB activity, the following hairpin oligonucleotide probe was used: 
GAGAGGGGATTCCCCGATTACCTTTCGGGGAATCCCCTCT.  Briefly, the 
oligonucleotide probe was annealed and end-labeled with Gamma-ATP using T4 
polynucleotide kinase according to the manufacturer’s instructions (New England 
Biolabs). Labeled probes (100,000cpm/rxn) were incubated with 5μg of nuclear extracts, 
NFκB Binding Buffer (50mM Tris (pH7.6), 250mM NaCl, 2.5mM EDTA, 5mM DTT, 
1mg/mL BSA, 25% Glycerol) and 1µg poly-dIdC for 20min at room temperature and 
separated on a 10% non-denaturing polyacrylamide gel with 0.25× TBE running buffer. 
DNA-protein complexes were then dried for two hours onto 3MM Chromatography 
paper (Whatman.)  The paper was then exposed to film for 4 - 18 hours. 
 
3.3.4. Relative Quantitative RT-PCR (RT-qPCR) 
Table 3.1 Primer Sequences 
Gene  Forward Sequence Reverse Sequence 
18S rRNA TCAAGAACGAAAGTCGGAGG GGACATCTAAGGGCATCACA 
IKKα CTGAGGTTGGTGTCATTGG CAGAACTCTGTGTACAGGC 
IKKβ GTGTCAGCTGTATCCTTC GCTCCACAGCCTGCTCC 
IKKγ CTTTTGGGGTAGATGCG GGTTAAATACACATCGGTCTG 
 
Total RNA was extracted with the RNeasy Plant Kit (Qiagen), according to the 
manufacturer’s instructions. cDNA was synthesized from total RNA (0.2 μg) using the 
TaqMan® ReverseTranscriptase kit (Applied Biosystems). All RT-qPCR reactions were 
performed in an ABI Prism 7300 Sequence Detection system (Applied Biosystems,) with 
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Power SYBR® according to SYBR protocol (Applied Biosystems).  All experiments were 
conducted in triplicate and SDs are indicated in the figures.  The primers listed in the 
table were all from IDTDNA. 
 
3.3.5. Flow Cytometry 
Spleens were taken from WT, PKCθ-/-, and p50-/-cRel-/- mice, crushed, RBC 
lysed (ACK Buffer – Fisher), and FC blocked (eBioscience). WBCs were then stained 
with CD45, CD3, and CD8 (eBioscience) and KB-OVA tetramer (MLB International) in 
PBS (Fisher) supplemented with 0.5% Bovine Serum Albumin, BSA (Sigma) for 30m on 
ice. Cells were then washed twice and data was collected on an LSRII (Beckman 
Dickinson) and analyzed with FlowJO 9.6 (TreeStar). Gating strategy isolated only 
single Cells (through Forward and Side Scatter) and DAPI- (live) Cells. 
 
3.3.6. Western Blotting 
Whole Cell Extracts were prepared in 25mM Tris-HCl pH7.6, 2mMEDTA, 150mM NaCl, 
0.5% NP-40, (Lysis Buffer) with late addition of 1mM PI, DFP, NaF, and NaVO3.  
Ocasionaly, lysates were incubated for 30m at 37°C with 400U Lambda Phosphatase 
(New England Biolabs) / 30µg protein.   A Bradford Assay (Applied Biosystems) was 
performed to standardize proteins on the DU 350 (Beckman Coulter) and samples were 
mixed with a 0.5% SDS loading buffer (Fisher) and run on a 10% acrylimide-bis gel and 
transferred to nitrocellulose paper.  Membranes were blocked in Tris-buffered saline, 
0.1% Tween 20 (TBS-T) with 3% BSA and 2% Milk (Carnation).  Then blots were 
incubated overnight at 4˚C with primary antibodies at 1:1000 in 5%BSA.TBS-T. After 
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three TBS-T washes, the membrane was incubated with the proper secondary at 
1:3000 in 5%Milk.TBS-T for 1.5 hours at room temperature. The specific bands were 
revealed by chemiluminescence (Western Lightning ® Plus-ECL, Perkin Elmer) and 
visualized by autoradiography (Amersham Hyperfilm-ECL, GE). Before reprobing, blots 
were stripped by incubation in 0.1 M 2-mercaptoethanol, 2% SDS, 62.5 mM Tris-HCl 
(pH 6.8) for 30 min at 65˚C and the process began again, with blocking.  Primary 
western antibodies include: pLck (Y394) and anti-NF-ATc1 (H-110) (Santa Cruz); anti-
pLAT Y132 (4476) & anti-pLAT Y171 (73205) both from Abcam; PLCγ1 (BD), IKKα, 
IKKβ, IKKγ, pIKKα/β, Zap70, pZap70 (Y319), pPLCγ1 (Y783), anti-LAT (9166) (Cell 
Signaling). HRP conjugated-β-actin, and all secondary antibodies (mouse, rabbit, and 
goat) were from Santa Cruz. 
 
3.3.7. Spectrophotometer Based Calcium Assay 
T cells were suspended at 1e6/mL in Calcium Buffer (No-Phenol Red RPMI 
(Fisher) with 2%FBS and 10% Probenecid (Thermo-Scientific)) and stained with 4μM 
Fluo-4 (Invitrogen) for 45m at 37˚C.  They were washed three times in Calcium Buffer 
and replated at 2e5/well in a 96 well flat-bottom plate.  Cells were then rested for 20m at 
RT, and incubated at 37˚C for 10m immediately preceding the assay.  Where indicated, 
Cells received the following: 10μg/mL anti-CD3/CD28 (mouse & human-ebioscience), 
3mM EGTA (Sigma) and 1μM Thapsigargin (Thermo-Scientific), and 5mM CaCl2 
(Fisher).  Samples were read on a Wallac EnVision 2102 Multilabel Reader from Perkin 
Elmer. 
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3.3.8. Confocal Microscopy 
2e^6/2mL T cells were incubated for 10m at 4ºC with 2ng Cholera Toxin Subunit 
B Alexa Fluor 488 (Invitrogen)/mL PBS.  Cells were then washed twice and plated on 
Poly-Lysine D coated coverslips (Fisher) after settling for 10m, 150μL of 37º BD Cytofix 
was added to the cell mixture and incubated for 30m at RT.  Coverslips were washed 
gently 2X in PBS.  0.5% Triton-X (Sigma) in PBS was applied to the Cells for 5m at RT 
to permeabalize.  Cells were then washed in PBS, 2X and blocked in 3%BSA – PBS for 
30m.  Next, T cells were stained with indicated primary antibody (IKKβ or IKKγ – Cell 
signaling) at 1:50 in 3%BSA – PBS overnight, in the dark, at 4ºC.  Cells were then 
washed 3X and incubated with Goat-anti rabbit Alexa Fluor 647 (Invitrogen) at 1:500 in 
3%BSA – PBS for 1.5h, in the dark, at RT.  Finally Cells were washed 3X, and 
Vectashield with Dapi (Vector Labs) was used to affix them to slides.  Images were 
captured on the Leica TCS SP5 (Leica Microsystems) and analyzed using Definiens 
Tissue studio 3.0. 
 
3.3.9. Statistical Analysis 
 All figures represent results from at least two (usually three) independent 
experiments.  When appropriate data is given as the mean ± standard deviation.  P 
values are expressed as  
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3.4. Results 
 
3.4.1. Proximal T cell Signaling is Impaired in the Absence of p50 and cRel 
As previous work from the lab established that activation / proliferation 
deficiencies in the p50-/-cRel-/- CD8 T cells appeared to result from reduced 
phosphorylation / activation of PLCγ1, we next determined if other proximal signaling 
proteins also displayed a paucity of phosphorylation in the p50-/-cRel-/- CD8 T cells.  As 
you can see in Figure 3.1A, when stimulated with 10μg CD3/CD28, the p50-/-cRel-/- T 
cells evince a reduction in phosphorylation of three proximal signaling proteins: PLCγ1 
(Y783), Zap70 (Y319) and the activating site on LCK (Y394).  In Figure 3.1B, we 
additionally show that reduction in phosphorylation of Zap70 does diminish its activity 
level, as evinced by a reduction in phosphorylation of LAT at tyrosine residues 132 and 
171, which are direct targets of Zap70.   The inhibitory phosphorylation site on LCK (ser 
505) seemed to be equivalently occupied, but at different kinetics (Fig 3.1A).  It has 
been suggested by the Alexander [221] and Weiss [19] labs that LCK activity is based 
on the phosphatase CD45, and that the inhibitory site is much more vulnerable to  
dephosphorylation than the activating site.  When we assessed total levels of CD45 
using a pan antibody against all 8 isoforms in T cells [222], we found no difference in 
expression between WT and p50-/-cRel-/- CD8 T cells (Fig. 3.1C).  While we cannot 
exclude the possibilities that CD45 may be less active or excluded from the proper 
compartments in the p50-/-cRel-/- CD8 T cells, we do know that total expression of 
CD45 is unchanged. 
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assessed its cell surface expression.   When using the strong antigen system, OT1, we 
were able to show no difference in expression of CD3ε or OVA.Tetramer+ TCR (Fig. 
3.1C) in splenic CD8 T cells from WT or p50-/-cRel-/- OT1 mice.  Therefore, it appears 
that the discrepancies between WT and p50-/-cRel-/- activation signaling are not based 
on differential protein expression, as evinced through western blotting and flow 
cytometry, but based on phosphorylation differences at the level of LCK and Zap70, 
which in turn affect phosphorylation of LAT and PLCγ1. 
 
3.4.2. IKKβ/γ Protein Levels are Reduced in the Absence of p50 and cRel 
 As we began to catalogue which proteins were affected in the p50-/-cRel-/- CD8 
T cells, we also began to investigate other NF-κB family members that would have the 
ability to affect proximal T cell signaling, and could possibly be impacted by loss of p50 
and cRel.  Several labs have shown that NF-κB family members participate in large 
molecular weight complexes, and mathematical modeling has implicated multiple 
transcription factors in the regulation of their own family members [224, 225].   
Moreover, it is known that the IKKα/β/γ regulatory complex must be brought into the 
Immune Synapse for ultimate degradation of IκBα and translocation of NF-κB  
transcription factors to the nucleus [226].  We therefore hypothesized that (a) absence 
of p50 and cRel may transcriptionally or post-transcriptionally impact levels of IKKα/β/γ, 
and (b) IKKα/β/γ may have imperative functions, including altering the proximal TCR 
signaling cascade, beyond exclusive control of NF-κB  activation: both hypotheses were 
investigated.  
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 As mathematical modeling predicts that IKKβ has a cRel binding site near its 
promoter [224], we first assessed whether or not transcription of IKKα, β, or γ was 
diminished in the p50-/-cRel-/- CD8 T cells. As you can see in Figure 3.2A, levels of 
IKKβ and IKKγ (but not IKKα) were reduced in the polyclonal p50-/-cRel-/- when 
compared to WT T cells, and standardized by 18S ribosomal RNA.  Next, as shown in 
Figure 3.2B (western) and Figure 3.2C, D, and E (immunofluorescence) there was also 
a reduction in protein levels of IKKβ and IKKγ, sequela to the diminution of mRNA 
levels.  While further CHIP analysis would be needed to delineate that p50 and/or cRel 
are directly controlling expression of IKKβ and IKKγ, it is clear that the amount of these 
proteins is diminished when both p50 and cRel are absent.   Moreover, as shown in 
Figure 3.2F, there is a larger fraction of IKKβ associated with lipid rafts in unstimulated 
WT T cells than in the p50-/-cRel-/-.  Thus indicating that in WT T cells, a fraction of 
IKKβ is basally associated with lipid rafts to encourage rapid, robust TCR signaling.  
Meanwhile, the impairment in the subcellular localization of IKKβ in the p50-/-cRel CD8 
T cells, is an additional defect to the diminution of total IKKβ levels, and could explain 
the much lower level of activating phosphorylation seen in these cells. 
 
3.4.3. Using Jurkat T cells to Explore Molecular Mechanisms and the Role of 
IKKβ/γ 
To assess whether the plethora of defects we witnessed in the p50-/-cRel-/- CD8 
T cells could be recapitulated in a model where p50 and cRel were present and only the 
IKK complex was reduced, we began using the Jurkat 3T8 line, which has been 
transduced with a KD of IKKγ (3T3.8221).  As shown in Figure 3.3A, the T cells missing 
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IKKγ perfectly mirror the reduction of phosphorylation seen in PLCγ1, LCK, and Zap70 
that we witnessed in the p50-/-cRel-/- CD8 T cells.  Moreover, this reduction in 
activation of key signaling proteins also led to a decrease in calcium influx, as shown in 
Figure 3.3B.  Having demonstrated, in two models, that a reduction in IKKγ and IKKβ 
have a profound effect on the activation of Jurkat T cells, we next decided to evaluate 
overexpression of activated IKKβ in the E6-1 Jurkat line. 
We began the next series of experiments by retrovirally infecting the E6-1Jurkat 
line with three separate plasmids: MiG (the control vector) and IKKβEE (overexpression 
of IKKβ with glutamic acid replacing the serines 177 and 181 to lock the protein in an  
active conformation resulting in higher NF-κB activation, and for our purpose, a way of 
evaluating whether or not activated IKKβ could have a role outside of NF-κB  activation) 
[220], and IκBa, a super repressor of NF-κB, known to be downstream of proximal 
signaling and the IKK complex.   As shown in Figure 3.3C (western) the phosphorylation 
of PLCγ1, Zap70, and LCK are augmented with overexpression of activated IKKβ; there 
was no further reduction in phosphorylation of proximal proteins between the MiG and 
the IκBα (data not shown).  Figure 3.3D shows the corresponding increase in calcium 
influx in the IKKβ transfected Jurkat T cells.  Once again, there was no discernible 
difference between the MiG and IκBα with respect to calcium influx.  This suggests that 
repression of the canonical NF-κB pathway is not able to recapitulate the defects seen 
in the p50-/-cRel-/- T cells; indicating that loss of NF-κB activation is not the main driver 
for the impaired activation we see in the absence of p50 and cRel, and that there must 
be a more proximal mediator, with current data suggesting that reduction in IKKβ is the 
actual culprit.     
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In order to evaluate the level of repression of NF-κB in the IκBα line, and assure 
that the non-reduction in phosphorylation of proximal signaling proteins was truly 
representative of an NF-κB non-activated T cell, we performed qPCR, western blotting, 
and an EMSA on Jurkat T cells stimulated with PMA and Ionomycin, to bypass the 
proximal signaling cascade.  As you can see, all three transfected lines responded 
appropriately to stimuli with the IKKβEE line showing a massive increase in IL-2 and 
IκBα showing a 5 fold reduction from the MiG (Fig. 3.3E).  Moreover, as shown by 
EMSA in Figure 3.4A, the IKKβEE transfected cells not only increased NF-κB activity 
with PMA/Ionomycin treatment, but also had an elevated baseline (Lane7).  Incidentally, 
this also led to an increase in basal levels of nuclear NF-AT, as shown in Figure 3.4B, 
lane 7.  Meanwhile, the IκBα line was unable to initiate nuclear translocation of NF-κB 
subunits at any time point or stimulant concentration (Lanes 5 & 6).  Finally, through 
western blotting of nuclear extracts for NF-ATc1, we can see that IKKβEE has the ability 
to increase NF-AT nuclear translocation and activation (both basally and with the 
addition of PMA and ionomycin), but repression of NF-κB transcription (transfection of 
IκBα) has no bearing on activation of NF-AT (Fig. 3.4B). These results  seem to indicate 
that impaired proximal signaling in p50-/-cRel-/- T cells, leading to reduced calcium 
influx and activation of NF-AT, is likely due to the diminution, instability, or mis-location 
of IKKβ, not to the transcriptional requirements of p50 and cRel, per se; although these 
missing transfection subunits certainly exacerbate the defects. 
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 the migration of the HA-Zap70 protein.  Moreover, as shown in Figure 3.5B, when the 
cotransfected lysates were treated with Lambda Phosphatase, the “upper band” 
disappeared, indicating that the way in which IKKβ is modifying Zap70 is through 
phosphorylation. Additionally, as you can see in Figure 3.5C, the addition of caIKKβ in 
the Hek293 system also has the ability to enhance the autophosphorylation (Y319) of 
Zap70.  This demonstrates that the possible direct phosphorylation of Zap70 by IKKβ 
does increase Zap70’s total phosphorylation status and results in a more activated 
protein. 
 
3.5. Discussion  
Dogma states that phosphorylation of IKKβ (leading to degradation of IκBα and 
activation of NF-κB) lies many interactions downstream of activation of PLCγ1 [130, 
227]. And the work of the Marienfield lab demonstrated that you needed not only PLCγ1 
activation, but a hearty influx of calcium to activate Calcineurin and create the 
secondary signaling complex (CBM) which would activate IKKβ [128].  It is, therefore, 
quite easy to trace activation of PLCγ1 to phosphorylation of IKKβ and nuclear 
translocation of p50/cRel and p50/p65.  Our results, however, indicate that IKKβ is 
actually affecting T cell activation much farther upstream in the proximal T cell signaling 
cascade. 
In previous studies we elucidated that many of the phenotypic discrepancies in 
p50-/-cRel-/- activation were a result of greatly reduced calcium influx and activation of  
NF-AT, sequela to suboptimal phosphorylation/activation of PLCγ1.  In this study, we 
expanded our research to find mechanistic insight as to why phosphorylation of PLCγ1 
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By branching out into the human CD4 Jurkat T cell line, we were able to recapitulate our 
system in a different species (murine vs. human) and a different T cell type (CD8 vs. 
CD4); moreover, we could easily manipulate genes and pathways of interest to tease 
apart complex mechanisms.  In Figure 3.3 A&B, we showed that KD of IKKγ (and the 
resulting reduction of the total IKK complex) was able to mimic the defects we see in the 
p50-/-cRel-/- CD8 T cells, with respect to phosphorylation of proximal T cell signaling 
proteins and calcium influx.  Moreover, when a constitutively active IKKβ was 
overexpressed, in a different model, we generated the exact opposite results compared 
to the p50-/-cRel-/- and IKKγ KD data. Yet, inhibiting the NF-κB pathway (through 
transfection of super repressive IκBα) did not achieve the same phenotype as KD of 
IKKγ, or absence of p50 and cRel in T cells.  This highlights key differences between 
abolishment of NF-κB subunits and ablation of NF-κB activation, and implies that 
regulation or loss of certain NF-κB proteins can have dramatic effects on other family 
members.  Moreover, through in vitro work in the Hek293 system, we were able to show 
that IKKβ has the ability to enhance phosphorylation of Zap70.  This indicates a 
mechanism of action for IKKβ enhancing proximal TCR protein phosphorylation and 
activation through possibly direct phosphorylation of Zap70.   
The striking finding of this study comes in two parts, the first being the 
unexpected decrease in IKKβ seen at both the mRNA and protein expression level in 
the p50-/-cRel-/- CD8 T cells.  One possible explanation for this is simply that p50 (or 
more likely cRel) plays a part in the transcription of IKKβ [224].  Another possibility is 
that the entire IKK complex is reduced in the p50-/-cRel-/- mice; this is a more likely 
scenario, in which an overall less responsive cell would require many less units of such 
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an important signaling complex.  As the IKK complex theoretically exists for the sole 
purpose of IκBα degradation, and IκBα is only produced in high quantities after 
stimulation.  This theory is also supported by the similar decrease in protein levels of 
IKKγ.  Although we did not witness an effect on IKKα, many groups have shown IKKβ to 
be the superior and more represented kinase of the pair with respect to canonical NF-
κB signaling through the TCR [228].  Whether IKKβ itself is reduced in these p50-/-cRel-
/- T cells, leading to a reduction in complex formation, or the complex as a whole is less 
transcribed, the reduction in mRNA is a telling sign that this gene is being impacted at 
the transcriptional level and not only through post translational modifications or 
enhanced degradation of the IKK complex in p50-/-cRel-/-in T cells.  
The other striking finding of this research is the impairment in phosphorylation of 
early T cell signaling proteins, and the fact that in vitro, IKKβ has the ability to enhance 
phosphorylation of Zap70.  While the defects in proliferation, transcription and effector 
function can all be linearly attributed to the lack of the transcription factors p50 and 
cRel, the reduction in early phosphorylation events and calcium influx bears no direct 
action from these missing transcription factors.  However, it does reveal that the p50-/-
cRel-/- T cells may have additional defects, and that these alterations or reductions in 
signaling ability are present in the basal state of the cell.  The first proximal defect we 
documented was phosphorylation of Zap70, one of many proteins complexed around 
the TCR signaling cluster, and necessary for the phosphorylation of  PLCγ1 [71], 
another protein we see with decreased phosphorylation in this system.  Interestingly, it 
has been proposed by Yang et al [229] that the first step for Zap70 to become fully 
activated is phosphorylation at Ser-520.  Furthermore, he went on to espouse, in his 
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thesis [230], that the sequence surrounding Ser-520 is S520DVWS524.  He notes that this 
sequence is highly conserved evolutionarily, but for our purposes, it must also be noted 
that SDVWS is the exact sequence that IKKβ targets when phosphorylating IκBα. 
Although further experimentation is needed to evince that IKKβ is responsible for 
attaching the phosphate group to Ser520 on Zap70, it is circumstantially plausible, 
especially in light of the enhanced phosphorylation of Zap70 we see when IKKβEE is 
transfected into Jurkat T cells, or when Zap70 and IKKβ are cotransfected into Hek293 
cells.  This data has led us to working model (Figure 3.6) in CD8 T cells, in which IKKβ 
is not only indispensable for NF-κB activation, but also plays a role in enhancing 
proximal TCR signaling. 
Regardless of the mechanism of direct action that IKKβ may utilize to affect the 
phosphorylation/activation of Zap70, we have conclusively shown that IKKβ levels are 
reduced in p50-/-cRel-/- T cells, and that this reduction correlates with a diminished 
phosphorylation of Zap70.  With this event, many of the discrepancies and reductions in 
signaling seen farther down the chain are easily explainable.  A less active Zap70 would 
leads to sub-par phosphorylation of LAT, which reduces the nucleation potential of the 
LAT signalisome; this leads to a decrease in phosphorylation of PLCγ1.  PLCγ1 
functioning at a less than optimal state creates a paucity of IP3, which lowers the 
amount of calcium influx, therefore reducing the amount of activated NF-AT.  From 
here, any further readout (dearth of proliferation and IFNγ and IL-2 production) are 
easily accounted for by the lack of p50 and cRel and the reduction of NF-AT, three 
storied and fundamental transcription factors for CD8 T cell activation.   
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CHAPTER 4 
 
CONSTITUTIVELY ACTIVE IKKβ DOES NOT INCREASE EXPRESSION OF CRAC 
OR PURINERGIC CALCIUM CHANNEL PROTEINS 
 
4.1 Abstract 
 Previous work from our lab has shown that transducing Jurkat T cells with 
constitutively active IKKβ has the ability to enhance proximal TCR phosphorylation, and 
influx greater volumes of calcium, leading to superior activation of NF-AT and amplifying 
positive downstream effects, such as proliferation and IL-2 production.  Moreover, NF-
κB subunits p50/p65/p52 have recently been shown to regulate the CRAC proteins, 
STIM1 and ORAI1 in mast cells [215].  In this chapter, we attempt to elucidate the 
mechanism by which caIKKβ amplifies calcium signaling, by delving deeper into the 
proteins responsible for calcium import: the CRAC and purinergic calcium channels.  
We chose to assess the ability of activated NF-κB to modulate these two families of 
calcium channel proteins, with respect to mRNA and protein levels, and protein function.   
Additionally, a holistic view of calcium channel protein modulation by NF-κB was 
created by also generating cell lines in which NF-κB was repressed through 
overexpression of IκBα.  
The results generated herein confirm that IKKβEE cell lines have superior 
calcium signaling, and delineate a possible role for constitutively active IKKβ in 
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enhancing the function of the CRAC channel protein STIM1, as use of the specific 
STIM1 inhibitor Suramin had a more profound effect on calcium influx in the caIKKβ 
expressing cells.  They do not indicate a role for activated NF-κB in affecting the 
function of ORAI1’s pore forming ability, however.  Additionally, NF-κB does not appear 
to modulate the function of purinergic calcium channel proteins: P2X1, P2X4, or P2X7.  
Contradictory to published findings, we could not validate that NF-κB was the element 
responsible for transcriptional regulation of ORAI1 and STIM1; this discrepancy, 
however, is likely due to differences in cell type, NF-κB subunit, and stimulation route.  
In accordance with NF-κB’s inability to modify the function of purinergic channel 
proteins, NF-κB activity level also had no effect on the mRNA or protein levels of this 
calcium channel family. 
 
4.2. Introduction 
 Calcium is one of the most powerful and versatile second messengers in T cell 
signaling, and the previous decade has represented a flood of knowledge as to the 
complex protein interactions required to induce this cascade via influx of extracellular 
calcium.  Thirty years ago, The Store Operated Calcium Entry (SOCE) was one of the 
first pathways identified as crucial for calcium signaling in a multitude of nucleated cells, 
including T cells [231].  SOCE signaling is initiated by binding of IP3 (generated via 
cleavage of PIP2 by PLCγ1) to the IP3R on the Sarcoendoplasmic reticulum (S-ER).  
This allows for a small amount of calcium to seep out from the S-ER into the cytoplasm 
where it binds to STIM1 causing a conformation change that will allow for docking with 
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ORAI1 (the pore forming unit) and the translocation of the entire protein complex (and 
S-ER) to the cytoplasmic membrane [232].  
Although Transient Receptor Potential Cation (TRPC) channels are not selective 
for calcium, the Muallem lab has solidified the role of TRPC1 as intimately linked to the 
functional interaction of ORAI1 and STIM1, as knockdown of any of these three proteins 
rendered the SOCE pathway inactive, and thwarted further extracellular influx of 
calcium.  Moreover, they demonstrated that TRPC1 is constitutively associated with 
ORAI1 [173].  Furthermore, the Lang lab, through elegant experimentation in HEK293 
cells, was able to show that both ORAI 1 and STIM1 were transcriptionally regulated by 
NF-κB subunits p65/p50/and p52; as augmentation of these proteins led to increased 
transcript genesis and a corresponding increase in Calcium, while use of the NF-κB 
inhibitor, Wagonin, had the opposite effect [215].   
Another indispensable family of calcium channel proteins, demonstrated by the 
Junger lab, is the purinergic receptors. They illustrated a crucial role for ATP-gated 
calcium channel proteins (P2X1 and P2X4) in sustaining the necessary calcium level for 
activation of NF-AT and various downstream targets including production of IL-2 [233].  
Through time-lapse confocal microscopy, they were able to demonstrate that both P2X1 
and P2X4 home to the Immune Synapse during T cell activation.  Additionally, if these 
proteins were inhibited, calcium influx was abrogated, even in the presence of a fully 
functional SOCE pathway.  Moreover, they went on to delineate a role for P2X7, which 
although it does not home to the Immune Synapse, still seems indispensable, as P2X7 
gene transcripts are highly upregulated post TCR stimulation, and ablation of P2X7 fully 
inhibited calcium signaling in T cells [234].   
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In light of the known roles of these two important calcium channel protein 
families, we sought to discover the effect of activated or repressed NF-κB on calcium 
signaling and CRAC and purinergic protein levels and function.  To modify NF-κB 
activity, Jurkat E6-1 T cells were transduced with either MiG (control vector), IκBα 
(super repressed NF-κB), or IKKβEE (super activated NF-κB) and interrogated using 
several techniques. To assess the ability of NF-κB to modulate CRAC and purinergic 
protein expression, we first employed qPCR to delineate any change in transcript level.  
Sequela to that line of interrogation, cell lines indicating transcript upregulation of CRAC 
and purinergic proteins were further subjected to western blotting to determine if this 
upregulation would translate into an embellishment of protein levels.  To assess the 
ability of NF- κB to modify CRAC and purinergic protein function, several inhibitors were 
used to block various components of the calcium signaling pathway.  The two CRAC 
channel protein inhibitors used were: 2-aminoethoxybiphenyl borate (2-APB), known to 
restrain CRAC based calcium influx by inhibiting TRPC function [235], and  1-(b- (3-(p-
methoxyphenyl)-propyloxy-p-methoxyphenyl)-1H-imidazole hydrochloride (SK&F 
96365), known to disrupt SOCE at the level of cytoplasmic membrane receptors [236].  
The P2X inhibitors utilized were: Suramin, a non-selective antagonizer  of purinergic 
receptors [237]; 8,8'-(carbonylbis(imino-3,1-phenylene carbonylimino) bis(1,3,5-
naphthalenetrisulfonic acid) (NF023), a Suramin analogue specific for P2X1, with little to 
no activity against P2X4 and P2X7 [238]; and 2'- & 3'-O-(4benzoylbenzoyl)-ATP (o-
ATP), an antagonist specific for P2X7 [239].  By comparing the effect on calcium by 
each inhibitor (with regard also paid to the NF-κB activity level of the cell) we were able 
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to assess not only the contribution of individual channel proteins to intracellular calcium 
levels, but delineate the role of NF-κB in their function. 
Through these studies, we were able to show that IKKβEE has the ability to 
moderately enhance the mRNA levels of STIM1, P2X1, and P2X7 in unstimulated cells.  
This increase in mRNA levels, however, does not translate to increased protein levels.  
Additionally, while the use of various CRAC and purinergic channel protein inhibitors did 
validate the requirement of these proteins for proper calcium influx, only the function of 
STIM1 appears to be moderately enhanced by super activating the NF-κB pathway 
through expression of constitutively active IKKβ, although many further studies will be 
required to validate this effect and evince a mechanism. 
 
4.3. Methods and Materials  
 
4.3.1. Cultured Cells, Transfections, and Infections 
Jurkat E6-1 Cells were purchased from the ATCC and both cultured in RPMI 
supplemented with 10% FBS, penicillin (100 U/ml), streptomycin (100 U/ml), and L-
glutamine (2 mM).  All stable (Jurkat - MiG, IκBα, and IKKβEE described here ([220]) 
transfections were performed using Fugene 6 (Roche Diagnostic Systems).  Stable 
transfection of the Jurkat T cell line was accomplished through initial transfection of the 
MiG, IκBα, or IKKβEE plasmids into Hek293 cells with 4μg of the pCL-Eco packaging 
vector and Fugene 6.  Cells were cultured for 48h, and viral containing supernatant was 
collected.  This Retrovirus was used to infect the E6-1 Jurkat cells using high speed 
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centrifugation.  Lines were confirmed and  established through sorting and expanding of 
GFP positive Cells for the MiG, IκBα, and IKKβEE Jurkat lines.   
 
4.3.2. Relative Quantitative RT-PCR (RT-qPCR) 
Total RNA was extracted with the RNeasy Plant Kit (Qiagen), according to the 
manufacturer’s instructions. cDNA was synthesized from total RNA (0.2 μg) using the 
TaqMan® ReverseTranscriptase kit (Applied Biosystems). All RT-qPCR reactions were 
performed in an ABI Prism 7300 Sequence Detection system (Applied Biosystems,) with 
Power SYBR® according to SYBR protocol (Applied Biosystems).  All experiments were 
conducted in triplicate and SDs are indicated in the figures.  ORAI1 and STIM1 were 
purchased from Realtime Primers, all other primers were from IDTDNA with sequences 
listed below: 
 
Table 4.1 Primer Sequences 
Gene  Forward Sequence Reverse Sequence 
18S rRNA TCAAGAACGAAAGTCGGAGG GGACATCTAAGGGCATCACA 
P2PX1 CGTCATCGGGTGGGTGTTTCTCTA AGGGCGCGGGATGTCGTCA 
P2PX4 CGGGACCCACAGCAACGGAGTCT TGTATCGAGGCGGAAGGAGTA 
P2PX7 CCGGCCACAACTACACCACGA GGCCAGACCGAAGTAGGAGAGG 
ORAI2 CATAAGGGCATGGATTACCG CGGGTACTGGTACTGCGTCT 
STIM2 CTCTAACACGCCCACCTCAT CTTCCTGTGCCTTTTCAAGC 
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4.3.3. Western Blotting 
Whole Cell Extracts were prepared in 25mM Tris-HCl pH7.6, 2mMEDTA, 150mM 
NaCl, 0.5% NP-40, (Lysis Buffer) with late addition of 1mM PI, DFP, NaF, and NaVO3.  
A Bradford Assay (Applied Biosystems) was performed to standardize proteins on the 
DU 350 (Beckman Coulter) and samples were mixed with a 0.5% SDS loading buffer 
(Fisher) and run on a 10% acrylimide-bis gel and transferred to nitrocellulose paper.  
Membranes were blocked in Tris-buffered saline, 0.1% Tween 20 (TBS-T) with 3% BSA 
and 2% Milk (Carnation).  Then blots were incubated overnight at 4˚C with primary 
antibodies at 1:1000 in 5%BSA.TBS-T. After three TBS-T washes, the membrane was 
incubated with the proper secondary at 1:3000 in 5%Milk.TBS-T for 1.5 hours at room 
temperature. The specific bands were revealed by chemiluminescence (Western 
Lightning ® Plus-ECL, Perkin Elmer) and visualized by autoradiography (Amersham 
Hyperfilm-ECL, GE). Before reprobing, blots were stripped by incubation in 0.1 M 2-
mercaptoethanol, 2% SDS, 62.5 mM Tris-HCl (pH 6.8) for 30 min at 65˚C and the 
process began again, with blocking.  Primary western antibodies include: ORAI 1 (Pro 
Sci Inc - #ABIN1030562), STIM1 (Cell Signaling - #5668), and P2X7 (Cell Signaling - 
#13809). HRP conjugated-β-actin, and all secondary antibodies (mouse, rabbit, and 
goat) were from Santa Cruz. 
 
4.3.4. Spectrophotometer Based Calcium Assay 
T cells were suspended at 1e6/mL in Calcium Buffer (No-Phenol Red RPMI 
(Fisher) with 2%FBS and 10% Probenecid (Thermo-Scientific)) and stained with 4μM 
Fluo-4 (Invitrogen) for 45m at 37˚C.  They were washed three times in Calcium Buffer 
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and resuspended in Calcium Buffer with or without indicated calcium channel inhibitors 
for 2 hours.  Cells were then washed twice and replated at 2e5/well in a 96 well flat-
bottom plate.  Cells were then rested for 20m at RT, and incubated at 37˚C for 10m 
immediately preceding the assay.  Where indicated, Cells received the following: 
10μg/mL anti-CD3/CD28 (ebioscience), 3mM EGTA (Sigma) and 1μM Thapsigargin 
(Thermo-Scientific), and 5mM CaCl2 (Fisher).  Samples were read on a Wallac EnVision 
2102 Multilabel Reader from Perkin Elmer. 
 
4.3.5. Statistical Analysis 
 All figures represent results from at least two (usually three) independent 
experiments.  When appropriate data is given as the mean ± standard deviation.  P 
values are expressed as  
 
4.4. Results 
 
4.4.1. The Effect of Enhanced and Repressed NF-κB on Calcium Release and Activation 
Channel (CRAC) Proteins   
As previous work from the lab established that calcium influx could be enhanced 
in Jurkat T cells transduced with NF-κB super activating IKKβEE; several labs have 
reported inhibition of calcium influx when NF-κB was abrogated; and NF-κB has been 
shown to transcriptionally regulate CRAC channel proteins, we next determined if 
mRNA expression of ORAI and STIM proteins could be impacted by alterations in NF-
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the IκBα cell line, with respect to having a larger pool of sarcoendoplasmic calcium (as 
indicated by the larger spike in calcium release when thapsigargin degrades the SERCA 
pump (Fig 4.2A (3))) and the ability to influx extracellular calcium at a faster and more 
robust rate (Fig 4.2A (4)).  However, when 100μM SK&F was added to the cells, the 
percent of inhibition was equivalent (as shown in Figure 4.2B) indicating that the 
increased calcium influx in the IKKβEE cell line is likely not due to enhanced 
cytoplasmic pore formation by ORAI.    
Next, in an attempt to interrogate whether or not, the enhanced performance by 
the IKKβEE cell line, was indicative of increased function of STIM1 and/or 
STIM1/ORAI1/TRPC1 complex formation, we utilized the inhibitor 2-APB.  Here the 
results are much more drastic, as use of 100μM 2-APB was able to completely abrogate 
calcium influx in all three cell lines, while the forced release of calcium by thapsigargin 
induced depletion of the SERCA pumps still revealed a greater starting pool in the 
IKKβEE cell line (Figure 4.2C).  Plotted graphically (Figure 4.2D) it suggest that the 
IKKβEE cell line likely owes a portion of its enhanced calcium function to increased 
activity of STIM1, (compared to only 45% for MiG and IκBα) in calcium influx when 
these processes are inhibited by 2-APB. 
 
4.4.2. The Effect of Enhanced and Repressed NF-κB on Purinergic Calcium 
Receptors. 
Utilizing the same three cell lines as above, we next sought to determine the 
impact that NF-κB may have on the purinergic family of calcium channel proteins.  As 
you can see in Figure 4.3.A-C, P2X7 does show the expected increase in transcript 
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Interestingly, neither NF023 nor o-ATP had any effect on the ability of T cells to flux  
calcium at 10μM (Figure 4.4B); whereas a 100μM concentration of either inhibitor 
proved lethal (data not shown.)  Interestingly, the pan purinergic inhibitor, Suramin, had 
grave effects on all three cell types.  This resulted in highly erratic readings (as shown in 
Figure 4.4A), but overall, the percent calcium influx inhibition in the IKKβEE T cells was 
not statistically significantly different than that of the effect on MiG or IκBα cells (Figure  
4.3 E).  This data reveals that while the purinergic receptors are certainly important for T 
cell calcium influx, it does not appear that NF-κB status impacts the total protein level or 
function of this crucial family of calcium channel proteins.   
 
4.5. Discussion 
 Unexpectantly, we were not able to show that enhanced activation of NF-κB 
(through constructively active IKKβ) was able to upregulate gene transcription of ORAI 
or STIM1.  This data sits in opposition to recent findings that NF-κB was responsible for 
transcription of these two crucial CRAC channel proteins [215].  This likely points to key 
differences between the studies: the Lang lab utilized Hek 293 cells, while we used E6-
1 Jurkat T cells; we augmented the pathway leading to NF-κB subunit nuclear 
translocation, whereas the Lang lab transfected in additional p50/p65/ and p52.  The 
transfection of the p52 subunit, by the Lang lab, is especially controversial, as this non-
canonical family member would not be induced in normal TCR signaling until 18-24 
hours post stimulation, whereas calcium signaling occurs in the first few seconds; 
therefore, p52 was not a factor in our transfection model.  Additionally, although we saw 
modest increases in P2X1 and P2X7 mRNA in the IKKβEE line, it did not translate to 
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increased protein levels, so based on our data; activated NF-κB can not increase 
protein levels of CRAC or purinergic calcium channel proteins. 
 In terms of modifying calcium channel protein function, our results indicate that 
only STIM1 activity is possibly enhanced in the IKKβEE cell line, as calcium influx 
showed a greater amount of inhibition compared to the MiG and IκBα cell lines when 
cells were incubated with 2-APB, a STIM1 specific inhibitor; whereas SK&F, an ORAI 
inhibitor, affected all three transduced cell lines equivalently.  With respect to the 
purinergic receptors, although use of the inhibitors showed that this family of calcium 
channel proteins is indispensable (Suramin caused huge inhibition of calcium influx, and 
NF023 and o-ATP were lethal at equivalent concentrations), it does not appear that NF-
κB activity can modulate their function.  Low dose (10μM), specific inhibition of P2X1 
(NF023) and P2X7 (o-ATP) had no effect on calcium influx in any cell line, and Suramin 
inhibited all three cell lines equally.      
 An interesting caveat to our results of the effect of caIKKβ on calcium must be 
considered based on work done in neurons exploring the relationship between IKKβ and 
TRPC channels.  Here, the Tegeder lab demonstrated that IKKβ mediated negative 
effects on the TRPC channels, as TRPC channel sensitivity, calcium influx, and 
neuronal excitability were all increased when IKKβ was inhibited [240].  Interestingly, 
this would point to a contradictory situation in which activated IKKβ would decrease 
effectiveness of TRPC components of the SOC pathway, while concurrently leading to 
nuclear translocation of NF-κB which may induce upreglation of gene transcription of 
the ORAI and STIM, thus enhancing those components of the SOC pathway.   Although 
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this would need to be recapitulated in T cells, and evaluated for the effect of activated 
IKKβ on TRPC1, specifically. 
 Additionally, our current studies may bear repeating with use of anti-CD3/CD28 
in lieu of PMA/Ionomycin stimulation, as the Junger lab conclusively showed that TCR 
stimulation was required to elicit an upregulation in purinergic (P2X) channels 
(especially P2X7) [234], and PMA/Ionomycin bypass the TCR.  However, we did see a 
greater increase in P2X7 mRNA in the IKKβEE cell line, post stimulation; although this 
did not generate increased protein levels.  Moreover, the main focus of this study was 
on basal expression (both mRNA and protein levels) and how that could impact the 
immediate early calcium influx, thus rendering stimulation route irrelevant.   
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CHAPTER 5 
 
CONCLUDING REMARKS AND ATTRIBUTIONS OF NF-κB IN T CELL SIGNALING 
 NF-κB represents one of the most critical protein families in, not only cells of the 
hemopoetic lineage, but all nucleated cells, and across multiple organisms.  It regulates 
the transcription of genes important for almost every cellular process from growth and 
homeostasis, to effector functions, to both survival and apoptosis.  In the studies 
presented in this work, we chose to focus on NF-κB’s role in T cell activation, 
predominately in naïve CD8 T cells; and, in vitro, specifically focusing on the first 20 
minutes (earliest activation) and two to eighteen hours post stimulation (late-early 
activation) to gain a full spectrum readout on a T cell’s ability to: 1.) phosphorylate 
proximal TCR signaling proteins 2.) flux Calcium 3.) activate transcription factors, and 
4.) regulate and transcribe genes.  Utilizing primary murine CD8 T cells that were WT, 
PKCθ-/-, or p50-/-cRel-/-, the Jurkat E6-1 and 3T8 CD4 cell lines that expressed caIKKβ 
or drIκBα and IKKγ-/-, respectively, and Hek293 cells, the studies presented here define 
a novel role for NF-κB in T cell signaling.  Moreover, they reveal that primary, murine, 
naïve CD8 T cells that lack p50 and cRel have lower levels of IKKβ and IKKγ and 
display serious detriments in their ability to phosphorylate proximal TCR proteins, influx 
calcium, and activate NF-AT. Moreover, these defects amplify as they move from 
extracellular receptor ligation towards transcription regulation in the nucleus leaving 
these cells virtually incapable of displaying effector functions or proliferating. 
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Studies in Jurkat T cells allowed us to mechanistically unravel the above 
phenomena and indicate that the lack of the IKK complex is most likely the culprit for 
reduction in proximal TCR protein phosphorylation.  These studies were additionally 
backed up by studies in Hek293 cells which indicated that IKKβ has the ability to 
enhance phosphorylation of Zap70.  This indicates that a lack of IKKβ results in 
decreased phosphorylation / activation of Zap70, and that this “weak” start generates far 
less activated PLCγ1, which ultimately reduces the level of IP3 PLCγ1, can generate, 
and diminishes calcium influx.  Aside from this monumental effect on PLCγ1 (and the 
direct impact this has on decreasing calcium influx and further downstream effector 
functions) we have also shown that IKKβ may have the ability to modify the function of 
the CRAC channel protein STIM1, which is necessary for extracellular calcium influx. 
 
5.1. A Novel Role for NF-κB in Proximal T Cell Signaling, Regulating Calcium 
Influx & Activation of NF-AT 
 In the second chapter, we examined the effect of absence of PKCθ and p50/cRel 
on primary CD8 T cells during activation.  We documented that while absence of PKCθ 
had moderately depreciative effects on calcium influx, transcriptional regulation, and 
proliferation, loss of p50/cRel had gravely detrimental impacts on the above listed 
factors.  Through microarray, we were able to tease apart the somewhat inclusive role 
played by PKCθ and p50/cRel in regulating gene transcription.  Surprisingly, only a 
small amount of activation induced genes were disrupted in either knockout model 
(3.5%: p50-/-cRel-/- and 1.7%: PKCθ).  In the p50-/-cRel-/- T cells, however, this small 
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percentage of deregulation had the ability to all but shut down activation elicited through 
anti CD3/CD28 treatment or culture with strong antigen pulsed APC.  
Interestingly, many genes of the small subset which were impacted in the p50-/-
cRel-/- , are classically defined and molecularly confirmed targets of the transcription 
factor NF-AT, such as IL3, IFNγ, and CTLA-4 [209-211].  This led us to explore the 
ability of p50-/-cRel-/- T cells to activate NF-AT upon stimulation.  The resulting data 
categorized their ability as abysmal, with the p50-/-cRel-/- showing barely any presence 
of NF-AT in the nucleus through EMSA.  Moreover, those cells also evinced the 
expected loss of nuclear NF-κB, and a somewhat more abrogated loss of nuclear AP-1.  
The PKCθ-/- T cells again displayed a more mild reduction in nuclear translocation of 
NF-AT NF-κB, and AP-1, as compared to p50-/-cRel-/-, although use of PKCα-/-PKCθ-/- 
T cells enhanced the diminution.  Once again, this phenomenon was consistent, despite 
route of stimulation.  
As calcium signaling is the main driver of NF-AT activation and nuclear 
translocation, we next looked to see if that would also be hampered in the p50-/-cRel-/- 
CD8 T cells, and, in fact, it was.  As the p50-/-cRel-/- were barely able to bring in 
extracellular calcium, compared to the slight reduction in the PKCθ-/- T cell’s ability to 
flux calcium.  The inequality in calcium influx ability points to a huge difference in the 
function of PKCθ and p50/cRel, two entities presumed to activate the same pathways.  
Arguably, there may be redundancy of function in other members of the PKC family  
that mask the true capabilities of PKCθ in the context of cellular activation, or the use of 
strong antigens may bypass the requirement for PKCθ in the assays we have selected 
to ascertain function. 
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In an attempt to delineate the cause of calcium influx blockade in p50-/-cRel-/- T 
cells, we first evaluated expression of two calcium channel proteins believed to be 
regulated by NF-κB: STIM1 and Orai1.  Disappointingly, there was no perturbation of 
these calcium signaling agents at the mRNA or protein levels.  Additionally, P2PX1, 
P2PX4, and P2PX7 (all purinergic calcium channel proteins) were also expressed at 
WT levels in the p50-/-cRel-/- CD8 T cells.  Next, we looked to activation of PLCγ1 (via 
phosphorylation status of Y783) as a possible potentiator of poor calcium influx and 
signaling.  Here, we discovered a key defect (reduction in phosphorylation of PLCγ1) in 
the p50-/-cRel-/- T cells that would explain the downstream deleterious effects of 
reduced calcium influx, transcription activation, and proliferation.  Further substantiating 
that the signaling deficient phenotype of p50-/-cRel-/- T cells was due to defects in 
PLCγ1 activation, the use of PMA and ionomycin (pharmacological agents that activate 
T cells via a method that bypasses PLCγ1) was able to rescue the proliferation defects 
of the p50-/-cRel-/- T cells, and returned calcium influx and transcription factor nuclear 
localization to WT levels.  This sheds light on two important points: 1.) Many of the 
activation defects of the p50-/-cRel-/- CD8 T cells are due to subpar activation of 
proximal TCR proteins and immediate-early signaling cascades, not simply lack of 
transcriptional regulation of genes by p50 and cRel and 2.) p50-/-cRel-/- T cells can 
activate and proliferate (robustly) once the initial hurdle of activation is overcome.   
This work represents a thorough evaluation of T cell activation in the absence of 
PKCθ or p50/cRel, and concretely defining the functionality of these proteins in this 
arena is a top priority, as the ability to limit or exploit T cell activation (and both entities 
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are drugable targets) is crucial for prevention of GVHD and T cell based autoimmunity 
and control of infection and cancer, respectively.  
 
5.2. Loss of p50 and cRel Lead to a Reduction of IKKβ and Deficient 
Phosphorylation of Proximal TCR Proteins 
 In Chapter Two, we cataloged deficiencies in p50-/-cRel CD8 T cells proliferation, 
transcription of immune activation related genes, and activation of transcription factors, 
calcium influx, and phosphorylation/activation of PLCγ1.  In Chapter Three, we 
attempted to elucidate the underlying mechanism that would disrupt proximal TCR 
signaling in the absence of p50/cRel.   To this end, we first assessed whether or not 
other proximal proteins also displayed a reduction in phosphorylation/activation, and 
discovered that Zap70, LAT, and to a lesser extent Lck, phosphorylation was also 
diminished in the p50-/-cRel-/- T cells.  Next, we looked at expression of cell surface 
proteins required for TCR signaling, by Flow Cytometry.  Here, we could evince no 
difference between WT and p50-/-cRel-/- T cells with respect to TCR, CD3ε, or CD45; 
thus pinpointing the subpar phosphorylation of Zap70 as the proximal defect in p50-/-
cRel-/- T cells. 
 In light of the above findings, we expanded our research to look at other NF-κB 
family members that could be involved in this proximal level of T cell signaling: mainly, 
the IKK complex.  This heterotrimer composed of two catalytic subunits (IKKα and IKKβ) 
and one regulatory subunit (IKKγ) is known to home to the Immune Synapse during T 
cell activation; thus placing it in the correct subcellular compartment to affect proximal 
TCR signaling.  Here, we discovered another key defect in the p50-/-cRel-/- T cells, as 
 
140 
 
they had reduced expression of IKKβ and IKKγ at both the mRNA and protein levels.  
Moreover, the localization of these two proteins also seemed to be altered in the p50-/-
cRel-/- T cells, as through confocal microscopy, we demonstrated that unstimulated WT 
T cells had a greater volume of IKKβ colocalized with lipid rafts, than did p50-/-cRel-/- T 
cells. 
 Armed with the knowledge that a reduction in the levels of IKKβ and IKKγ could 
be causing the plethora of defects in the p50-/-cRel-/- T cells, we moved into the 
human, CD4 Jurkat T cell line and manipulated protein expression to help flush out a 
mechanism.  We first looked at T cell activation responses in the 3T8 Jurkat line that 
had a knockout of IKKγ.  Pleasantly, we found that loss of IKKγ perfectly recapitulated 
the phenotype of p50-/-cRel-/- T cells with respect to proximal TCR protein 
phosphorylation and calcium influx.  
Next, in E6-1 Jurkat T cells, we retrovirally infected cell with either a constitutively 
activated IKKβ to (to enhance NF-κB signaling) or degradation resistant IκBα (to 
severely repress NF-κB signaling.)   With respect to the caIKKβ plasmid, the cells 
performed beautifully, and were able to greatly enhance every level of activation 
assessed (proximal TCR protein phosphorylation, calcium influx, and transcription of IL-
2) over cells transfected with a control (MiG) vector.  The transfection of IκBα on the 
other hand, had no deleterious effect on activation based signaling in the Jurkat model, 
although they demonstrated complete repression of NF-κB, as judged by the inability of 
NF-κB to undergo nuclear translocation in response to stimuli.   Moreover, these cells 
produced a dearth of IL-2, demonstrating that while repressed NF-κB signaling may not 
effect proximal activation of T cells, it has a tremendous negative effect on gene 
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transcription (distal activation).  The lack of proximal activation impairment in the IκBα 
cells sheds light on the fact that within our caIKKβ cells, the positive signaling effects we 
were demonstrating could most likely be attributed to activated IKKβ, not the 
downstream enhancement of the NF-κB pathway.  Finally, for proof of principal, we 
adopted the Hek293 system, and here, through cotransfection of IKKβ and Zap70, we 
were able to show that IKKβ has the ability to enhance phosphorylation of Zap70 
directly. 
 
5.3. Constitutively Active IKKβ Does Not Increase Expression of CRAC or 
Purinergic Calcium Channel Proteins 
As Orai1 and STIM1 have both been described as targets of NF-κB, we originally 
hypothesized that these genes would be deregulated and under transcribed in the 
absence of p50/cRel.  However, in chapter three, this was proven false, as no difference 
was shown between WT and p50-/-cRel-/- mRNA or protein levels of these two CRAC 
channel proteins.  In the fourth chapter we attempted to sus out the mechanism behind 
this phenomenon utilizing human, CD4, Jurkat T cells.  To this end, the cell line was 
retrovirally infected with either MiG (control vector), IκBα (super repressed NF-κB), or 
IKKβEE (super activated NF-κB) and assayed for mRNA and protein levels of CRAC 
and purinergic calcium channel proteins unstimulated or after two or six hours of 
treatment with PMA and ionomycin.  Although IKKβEE appeared to slightly enhance the 
mRNA transcripts of STIM1 (CRAC) and P2X1 and P2X7 (purinergic), this did not 
translate to increased protein levels.   
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To ascertain whether or not NF-κB was able to modulate the function of these 
proteins, the same three cell lines were assayed for their ability to influx calcium in the 
absence or presence of pre-incubation with several known independent inhibitors of 
CRAC and purinergic calcium channel proteins.  In this arena, only the function of 
STIM1 appeared to possibly be enhanced by constitutively activated IKKβ, as the 2-
APB inhibitor (known to inhibit STIM1 function) led to much greater inhibition in the 
IKKβEE cell line, compared to controls, indicating that this pathway could be important 
for enhanced calcium influx in the caIKKβ cell line, although many additional 
experiments are required for validation. 
 
5.4. Concluding Remarks 
Activation of T cells by interaction of the TCR with an MHC molecule loaded with 
a cognate peptide is one of the most intricate and regulated biological processes to be 
discovered.  Decades of work have helped to outline the proteins involved in this 
process, and painstaking experiments have parsed each of these proteins into specific 
catalytic and regulatory domains, even highlighting the exact amino acids required for 
phosphorylation or additional post translational modifications.  The scope of this 
dissertation has been to define the role of NF-κB subunits and overall activity with 
respect to T cell signaling.  To that end, we have discovered that NF-κB subunits 
generally congregate in large supermacramolecular complexes, and ablation of one 
subunit (p50 or cRel) can affect stability of other subunits (IKKβ or IKKγ) within the 
family.    
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Additionally, this work demonstrates that phosphorylation of proximal TCR 
proteins, calcium influx, and activation of NF-AT are all inhibited in the absence of p50 
and cRel, and that this is likely due to the corresponding decrease in IKKβ.  Moreover, 
utilizing the human, CD4, Jurkat T cell line, we determined that knockdown of IKKγ and 
the accompanying decrease in all IKK complex members (α/β) recapitulated the p50-/-
cRel-/- T cell activation defects; whereas  constitutively active IKKβ could enhance 
phosphorylation of proximal TCR proteins, calcium influx, and activation of NF-AT.  
Utilizing Hek293 cells we were also able to delineate that IKKβ has the ability to directly 
enhance the phosphorylation of Zap70, and we believe that this is the mechanism of 
action for enhanced proximal signaling in WT compared to p50-/-cRel-/- T cells. 
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